{ "Version": 79, "ExpressionProfiles": [ { "Type": "Transporter", "Species": "Human", "Molecule": "P-gp", "Category": "European (P-gp modified, CYP3A4 36 h)", "Parameters": [ { "Path": "Organism|Bone|Intracellular|P-gp|Relative expression", "Value": 0.0242518189 }, { "Path": "Organism|Brain|Intracellular|P-gp|Relative expression", "Value": 0.07608904 }, { "Path": "Organism|Gonads|Intracellular|P-gp|Relative expression", "Value": 0.017417973 }, { "Path": "Organism|Heart|Intracellular|P-gp|Relative expression", "Value": 0.0419198107 }, { "Path": "Organism|Kidney|Intracellular|P-gp|Relative expression", "Value": 0.7092198582 }, { "Path": "Organism|LargeIntestine|Intracellular|P-gp|Relative expression", "Value": 0.1108416465 }, { "Path": "Organism|LargeIntestine|Mucosa|ColonAscendens|Intracellular|P-gp|Relative expression", "Value": 0.3971631206 }, { "Path": "Organism|LargeIntestine|Mucosa|ColonDescendens|Intracellular|P-gp|Relative expression", "Value": 0.3971631206 }, { "Path": "Organism|LargeIntestine|Mucosa|ColonSigmoid|Intracellular|P-gp|Relative expression", "Value": 0.3971631206 }, { "Path": "Organism|LargeIntestine|Mucosa|ColonTransversum|Intracellular|P-gp|Relative expression", "Value": 0.3971631206 }, { "Path": "Organism|Liver|Pericentral|Intracellular|P-gp|Relative expression", "Value": 0.1916810427 }, { "Path": "Organism|Liver|Periportal|Intracellular|P-gp|Relative expression", "Value": 0.1916810427 }, { "Path": "Organism|Lung|Intracellular|P-gp|Relative expression", "Value": 0.0657549316 }, { "Path": "Organism|Muscle|Intracellular|P-gp|Relative expression", "Value": 0.0128342959 }, { "Path": "Organism|Pancreas|Intracellular|P-gp|Relative expression", "Value": 0.0142510688 }, { "Path": "Organism|SmallIntestine|Intracellular|P-gp|Relative expression", "Value": 0.2808543974 }, { "Path": "Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|P-gp|Relative expression", "Value": 1.0 }, { "Path": "Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|P-gp|Relative expression", "Value": 1.0 }, { "Path": "Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|P-gp|Relative expression", "Value": 1.0 }, { "Path": "Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|P-gp|Relative expression", "Value": 1.0 }, { "Path": "Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|P-gp|Relative expression", "Value": 1.0 }, { "Path": "Organism|Spleen|Intracellular|P-gp|Relative expression", "Value": 0.0742555692 }, { "Path": "Organism|Stomach|Intracellular|P-gp|Relative expression", "Value": 0.0260852897 }, { "Path": "P-gp|Reference concentration", "Value": 1.41, "Unit": "µmol/l" }, { "Path": "P-gp|t1/2 (intestine)", "Value": 23.0, "Unit": "h" }, { "Path": "P-gp|t1/2 (liver)", "Value": 36.0, "Unit": "h" } ], "TransportType": "Efflux", "Expression": [ { "Name": "Bone", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Intracellular" }, { "Name": "Brain", "TransportDirection": "EffluxBrainInterstitialToPlasma", "CompartmentName": "Plasma" }, { "Name": "Brain", "TransportDirection": "EffluxBrainTissueToInterstitial", "CompartmentName": "Interstitial" }, { "Name": "Fat", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Intracellular" }, { "Name": "Gonads", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Intracellular" }, { "Name": "Heart", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Intracellular" }, { "Name": "Kidney", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Interstitial" }, { "Name": "Kidney", "TransportDirection": "ExcretionKidney", "CompartmentName": "Intracellular" }, { "Name": "Stomach", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Intracellular" }, { "Name": "SmallIntestine", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Intracellular" }, { "Name": "Duodenum", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Interstitial" }, { "Name": "Duodenum", "TransportDirection": "EffluxMucosaIntracellularToLumen", "CompartmentName": "Intracellular" }, { "Name": "UpperJejunum", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Interstitial" }, { "Name": "UpperJejunum", "TransportDirection": "EffluxMucosaIntracellularToLumen", "CompartmentName": "Intracellular" }, { "Name": "LowerJejunum", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Interstitial" }, { "Name": "LowerJejunum", "TransportDirection": "EffluxMucosaIntracellularToLumen", "CompartmentName": "Intracellular" }, { "Name": "UpperIleum", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Interstitial" }, { "Name": "UpperIleum", "TransportDirection": "EffluxMucosaIntracellularToLumen", "CompartmentName": "Intracellular" }, { "Name": "LowerIleum", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Interstitial" }, { "Name": "LowerIleum", "TransportDirection": "EffluxMucosaIntracellularToLumen", "CompartmentName": "Intracellular" }, { "Name": "LargeIntestine", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Intracellular" }, { "Name": "Caecum", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Interstitial" }, { "Name": "Caecum", "TransportDirection": "EffluxMucosaIntracellularToLumen", "CompartmentName": "Intracellular" }, { "Name": "ColonAscendens", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Interstitial" }, { "Name": "ColonAscendens", "TransportDirection": "EffluxMucosaIntracellularToLumen", "CompartmentName": "Intracellular" }, { "Name": "ColonTransversum", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Interstitial" }, { "Name": "ColonTransversum", "TransportDirection": "EffluxMucosaIntracellularToLumen", "CompartmentName": "Intracellular" }, { "Name": "ColonDescendens", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Interstitial" }, { "Name": "ColonDescendens", "TransportDirection": "EffluxMucosaIntracellularToLumen", "CompartmentName": "Intracellular" }, { "Name": "ColonSigmoid", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Interstitial" }, { "Name": "ColonSigmoid", "TransportDirection": "EffluxMucosaIntracellularToLumen", "CompartmentName": "Intracellular" }, { "Name": "Rectum", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Interstitial" }, { "Name": "Rectum", "TransportDirection": "EffluxMucosaIntracellularToLumen", "CompartmentName": "Intracellular" }, { "Name": "Periportal", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Interstitial" }, { "Name": "Periportal", "TransportDirection": "ExcretionLiver", "CompartmentName": "Intracellular" }, { "Name": "Pericentral", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Interstitial" }, { "Name": "Pericentral", "TransportDirection": "ExcretionLiver", "CompartmentName": "Intracellular" }, { "Name": "Lung", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Intracellular" }, { "Name": "Muscle", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Intracellular" }, { "Name": "Pancreas", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Intracellular" }, { "Name": "Skin", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Intracellular" }, { "Name": "Spleen", "TransportDirection": "EffluxIntracellularToInterstitial", "CompartmentName": "Intracellular" }, { "Name": "BloodCells", "TransportDirection": "EffluxBloodCellsToPlasma" }, { "Name": "VascularEndothelium", "TransportDirection": "EffluxInterstitialToPlasma" } ] }, { "Type": "Enzyme", "Species": "Human", "Molecule": "CYP3A4", "Category": "European (P-gp modified, CYP3A4 36 h)", "Parameters": [ { "Path": "CYP3A4|Reference concentration", "Value": 4.32, "Unit": "µmol/l" }, { "Path": "CYP3A4|t1/2 (intestine)", "Value": 23.0, "Unit": "h" }, { "Path": "CYP3A4|t1/2 (liver)", "Value": 36.0, "Unit": "h" }, { "Path": "Organism|Brain|Intracellular|CYP3A4|Relative expression", "Value": 0.0041682898325 }, { "Path": "Organism|Gonads|Intracellular|CYP3A4|Relative expression", "Value": 0.00078691079081 }, { "Path": "Organism|Kidney|Intracellular|CYP3A4|Relative expression", "Value": 0.0053603428126 }, { "Path": "Organism|Liver|Pericentral|Intracellular|CYP3A4|Relative expression", "Value": 1.0 }, { "Path": "Organism|Liver|Periportal|Intracellular|CYP3A4|Relative expression", "Value": 1.0 }, { "Path": "Organism|Lung|Intracellular|CYP3A4|Relative expression", "Value": 0.00042695753798 }, { "Path": "Organism|SmallIntestine|Intracellular|CYP3A4|Relative expression", "Value": 0.0727697702 }, { "Path": "Organism|SmallIntestine|Mucosa|Duodenum|Intracellular|CYP3A4|Relative expression", "Value": 0.0727697702 }, { "Path": "Organism|SmallIntestine|Mucosa|LowerIleum|Intracellular|CYP3A4|Relative expression", "Value": 0.0727697702 }, { "Path": "Organism|SmallIntestine|Mucosa|LowerJejunum|Intracellular|CYP3A4|Relative expression", "Value": 0.0727697702 }, { "Path": "Organism|SmallIntestine|Mucosa|UpperIleum|Intracellular|CYP3A4|Relative expression", "Value": 0.0727697702 }, { "Path": "Organism|SmallIntestine|Mucosa|UpperJejunum|Intracellular|CYP3A4|Relative expression", "Value": 0.0727697702 } ], "Localization": "Intracellular, BloodCellsIntracellular, VascEndosome", "Ontogeny": { "Name": "CYP3A4" } } ], "Individuals": [ { "Name": "Härtter 2012 SD, n=19", "Seed": 968530812, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 40.526, "Unit": "year(s)" }, "Weight": { "Value": 72.632, "Unit": "kg" }, "Height": { "Value": 174.053, "Unit": "cm" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Eichelbaum 1984, n=1\u001f", "Seed": -2045030578, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 25.0, "Unit": "year(s)" }, "Weight": { "Value": 91.0, "Unit": "kg" }, "Height": { "Value": 201.115, "Unit": "cm" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Smith 1984, n=8", "Seed": 1569567109, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "WhiteAmerican_NHANES_1997", "Gender": "MALE", "Age": { "Value": 26.6, "Unit": "year(s)" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Blume, Mutschler 1994, n=24", "Seed": 1649318031, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 30.54, "Unit": "year(s)" }, "Weight": { "Value": 75.88, "Unit": "kg" }, "Height": { "Value": 179.25, "Unit": "cm" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Maeda 2011, n=8", "Seed": 846556953, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "Japanese_Population", "Gender": "MALE", "Age": { "Value": 26.0, "Unit": "year(s)" }, "Weight": { "Value": 64.3, "Unit": "kg" }, "Height": { "Value": 176.25, "Unit": "cm" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Wing 1985, n=1", "Seed": 209332546, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 21.0, "Unit": "year(s)" }, "Weight": { "Value": 70.0, "Unit": "kg" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "McAllister, Kirsten 1982, n=20", "Seed": 210558984, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 25.2, "Unit": "year(s)" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Freedman 1981, n=1", "Seed": 556085593, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 40.0, "Unit": "year(s)" }, "Weight": { "Value": 72.0, "Unit": "kg" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Abernethy 1993, n=1", "Seed": 617216828, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 20.0, "Unit": "year(s)" }, "Weight": { "Value": 79.0, "Unit": "kg" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Vogelgesang 1984, n=1", "Seed": 636367828, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 25.0, "Unit": "year(s)" }, "Weight": { "Value": 79.5, "Unit": "kg" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "John 1992, n=6", "Seed": 644002703, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 26.0, "Unit": "year(s)" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Sawicki, Janicki 2002, n=12", "Seed": 645574750, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 26.2, "Unit": "year(s)" }, "Weight": { "Value": 70.67, "Unit": "kg" }, "Height": { "Value": 171.8, "Unit": "cm" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Choi 2008, n=12", "Seed": 705586046, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "Asian_Tanaka_1996", "Gender": "MALE", "Age": { "Value": 23.8, "Unit": "year(s)" }, "Weight": { "Value": 66.3, "Unit": "kg" }, "Height": { "Value": 172.0, "Unit": "cm" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Ratiopharm 1988, n=16", "Seed": 717692562, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 31.0, "Unit": "year(s)" }, "Weight": { "Value": 77.0, "Unit": "kg" }, "Height": { "Value": 177.0, "Unit": "cm" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Ratiopharm 1989, n=16", "Seed": 717758468, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 26.0, "Unit": "year(s)" }, "Weight": { "Value": 74.0, "Unit": "kg" }, "Height": { "Value": 179.0, "Unit": "cm" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Johnson 2001, n=12", "Seed": 725752093, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 28.5, "Unit": "year(s)" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Boehringer 2018, n=12", "Seed": 728577281, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 39.0, "Unit": "year(s)" }, "Weight": { "Value": 86.0, "Unit": "kg" }, "Height": { "Value": 181.0, "Unit": "cm" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Härtter 2012 MD, n=20", "Seed": 797382593, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 38.0, "Unit": "year(s)" }, "Weight": { "Value": 73.0, "Unit": "kg" }, "Height": { "Value": 175.0, "Unit": "cm" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Hla 1987, n=10", "Seed": 799032281, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 34.0, "Unit": "year(s)" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Mikus 1990, n=1", "Seed": 817052484, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 34.0, "Unit": "year(s)" }, "Weight": { "Value": 76.5, "Unit": "kg" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "van Haarst 2009, n=10", "Seed": 1068782375, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 25.5, "Unit": "year(s)" }, "Weight": { "Value": 73.5, "Unit": "kg" }, "Height": { "Value": 179.0, "Unit": "cm" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Blume, Mutschler 1983, n=12", "Seed": 1137070750, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "FEMALE", "Age": { "Value": 27.0, "Unit": "year(s)" }, "Weight": { "Value": 65.0, "Unit": "kg" }, "Height": { "Value": 168.0, "Unit": "cm" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Blume, Mutschler 1990, n=24", "Seed": 1137160578, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 25.0, "Unit": "year(s)" }, "Weight": { "Value": 74.0, "Unit": "kg" }, "Height": { "Value": 180.0, "Unit": "cm" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Blume, Mutschler 1989, n=18", "Seed": 1137232171, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 26.0, "Unit": "year(s)" }, "Weight": { "Value": 70.0, "Unit": "kg" }, "Height": { "Value": 179.0, "Unit": "cm" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Blume, Mutschler 1987, n=12", "Seed": 1137275031, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 28.0, "Unit": "year(s)" }, "Weight": { "Value": 66.0, "Unit": "kg" }, "Height": { "Value": 175.0, "Unit": "cm" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Barbarash 1988, n=6", "Seed": 1150876046, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 30.5, "Unit": "year(s)" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Abernethy 1985, n=1", "Seed": 1151206687, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 24.0, "Unit": "year(s)" }, "Weight": { "Value": 67.0, "Unit": "kg" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Johnston 1981, n=6", "Seed": 1153175125, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 26.0, "Unit": "year(s)" }, "Weight": { "Value": 64.7, "Unit": "kg" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Mooy 1985, n=5", "Seed": 1158337906, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 37.5, "Unit": "year(s)" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Streit 2005, n=10", "Seed": 1159871687, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 26.0, "Unit": "year(s)" }, "Weight": { "Value": 73.5, "Unit": "kg" }, "Height": { "Value": 179.5, "Unit": "cm" } }, "Parameters": [ { "Path": "Organism|Liver|EHC continuous fraction", "Value": 1.0, "ValueOrigin": { "Source": "Unknown" } } ], "ExpressionProfiles": [ "P-gp|Human|European (P-gp modified, CYP3A4 36 h)", "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Backman 1994", "Seed": 114811484, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "FEMALE", "Age": { "Value": 23.5, "Unit": "year(s)" }, "Weight": { "Value": 67.5, "Unit": "kg" } }, "ExpressionProfiles": [ "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)", "P-gp|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Jorgensen 1988, n = 12", "Seed": 354326781, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 52.8, "Unit": "year(s)" } }, "ExpressionProfiles": [ "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)", "P-gp|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Karim 1995, n = 12", "Seed": 375046171, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 25.0, "Unit": "year(s)" }, "Weight": { "Value": 73.0, "Unit": "kg" }, "Height": { "Value": 177.0, "Unit": "cm" } }, "ExpressionProfiles": [ "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)", "P-gp|Human|European (P-gp modified, CYP3A4 36 h)" ] }, { "Name": "Shand 1981, n = 6", "Seed": 376698437, "OriginData": { "CalculationMethods": [ "SurfaceAreaPlsInt_VAR1", "Body surface area - Mosteller" ], "Species": "Human", "Population": "European_ICRP_2002", "Gender": "MALE", "Age": { "Value": 51.5, "Unit": "year(s)" } }, "ExpressionProfiles": [ "CYP3A4|Human|European (P-gp modified, CYP3A4 36 h)", "P-gp|Human|European (P-gp modified, CYP3A4 36 h)" ] } ], "Compounds": [ { "Name": "R-Verapamil", "IsSmallMolecule": true, "Lipophilicity": [ { "Name": "logP", "Parameters": [ { "Name": "Lipophilicity", "Value": 2.8407448658, "Unit": "Log Units", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] } ], "FractionUnbound": [ { "Name": "Measurement", "Species": "Human", "Parameters": [ { "Name": "Fraction unbound (plasma, reference value)", "Value": 5.1, "Unit": "%", "ValueOrigin": { "Source": "Publication", "Method": "InVivo" } } ] } ], "Solubility": [ { "Name": "Measurement", "Parameters": [ { "Name": "Solubility at reference pH", "Value": 46.0, "Unit": "mg/ml" }, { "Name": "Reference pH", "Value": 6.54 } ] } ], "IntestinalPermeability": [ { "Name": "Fitted", "Parameters": [ { "Name": "Specific intestinal permeability (transcellular)", "Value": 3.5447164381E-06, "Unit": "cm/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] } ], "Permeability": [ { "Name": "Fitted", "Parameters": [ { "Name": "Permeability", "Value": 0.0994098912, "Unit": "cm/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] } ], "PkaTypes": [ { "Type": "Base", "Pka": 8.75, "ValueOrigin": { "Source": "Unknown" } } ], "Processes": [ { "InternalName": "GlomerularFiltration", "DataSource": "GFR", "Species": "Human", "Parameters": [ { "Name": "GFR fraction", "Value": 1.0 } ] }, { "InternalName": "ActiveTransport_InVitro_VesicularAssay_MM", "DataSource": "Paper", "Molecule": "P-gp", "Parameters": [ { "Name": "In vitro Vmax/transporter", "Value": 0.00057724, "Unit": "pmol/min/pmol transporter" }, { "Name": "Km", "Value": 1.01, "Unit": "µmol/l" }, { "Name": "kcat", "Value": 12.5970868779, "Unit": "1/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ], "Description": "A transporter mediated unidirectional transfer of a compound across a cellular membrane is described as saturable process following Michaelis-Menten type kinetics. The corresponding kcat value is calculated from a specific Vmax normalized to the amount of transporter as input value which was determined in a vesicular transport assay." }, { "InternalName": "NoncompetitiveInhibition", "DataSource": "Non-competitive", "Molecule": "P-gp", "Parameters": [ { "Name": "Ki", "Value": 0.0383697779, "Unit": "µmol/l", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] }, { "InternalName": "IrreversibleInhibition", "DataSource": "MBI", "Molecule": "CYP3A4", "Parameters": [ { "Name": "kinact", "Value": 0.038, "Unit": "1/min" }, { "Name": "K_kinact_half", "Value": 27.63, "Unit": "µmol/l" } ] }, { "InternalName": "MetabolizationLiverMicrosomes_MM", "DataSource": "Norverapamil", "Molecule": "CYP3A4", "Metabolite": "R-Norverapamil", "Parameters": [ { "Name": "In vitro Vmax for liver microsomes", "Value": 1.27, "Unit": "nmol/min/mg mic. protein" }, { "Name": "Km", "Value": 19.59, "Unit": "µmol/l" }, { "Name": "kcat", "Value": 34.9352466212, "Unit": "1/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] }, { "InternalName": "MetabolizationLiverMicrosomes_MM", "DataSource": "D617", "Molecule": "CYP3A4", "Parameters": [ { "Name": "In vitro Vmax for liver microsomes", "Value": 1.17, "Unit": "nmol/min/mg mic. protein" }, { "Name": "Km", "Value": 35.34, "Unit": "µmol/l" }, { "Name": "kcat", "Value": 43.9812289146, "Unit": "1/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] } ], "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Parameters": [ { "Name": "Molecular weight", "Value": 454.611, "Unit": "g/mol" } ] }, { "Name": "S-Verapamil", "IsSmallMolecule": true, "Lipophilicity": [ { "Name": "logP", "Parameters": [ { "Name": "Lipophilicity", "Value": 2.8407448658, "Unit": "Log Units", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] } ], "FractionUnbound": [ { "Name": "Measurement", "Species": "Human", "Parameters": [ { "Name": "Fraction unbound (plasma, reference value)", "Value": 11.0, "Unit": "%", "ValueOrigin": { "Source": "Publication", "Method": "InVivo" } } ] } ], "Solubility": [ { "Name": "Measurement", "Parameters": [ { "Name": "Solubility at reference pH", "Value": 46.0, "Unit": "mg/ml" }, { "Name": "Reference pH", "Value": 6.54 } ] } ], "IntestinalPermeability": [ { "Name": "Fitted", "Parameters": [ { "Name": "Specific intestinal permeability (transcellular)", "Value": 3.5447164381E-06, "Unit": "cm/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] } ], "Permeability": [ { "Name": "Fitted", "Parameters": [ { "Name": "Permeability", "Value": 0.0994098912, "Unit": "cm/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] } ], "PkaTypes": [ { "Type": "Base", "Pka": 8.75, "ValueOrigin": { "Source": "Unknown" } } ], "Processes": [ { "InternalName": "GlomerularFiltration", "DataSource": "GFR", "Species": "Human", "Parameters": [ { "Name": "GFR fraction", "Value": 1.0 } ] }, { "InternalName": "ActiveTransport_InVitro_VesicularAssay_MM", "DataSource": "Paper", "Molecule": "P-gp", "Parameters": [ { "Name": "In vitro Vmax/transporter", "Value": 0.00057724, "Unit": "pmol/min/pmol transporter" }, { "Name": "Km", "Value": 1.01, "Unit": "µmol/l" }, { "Name": "kcat", "Value": 12.5970868779, "Unit": "1/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ], "Description": "A transporter mediated unidirectional transfer of a compound across a cellular membrane is described as saturable process following Michaelis-Menten type kinetics. The corresponding kcat value is calculated from a specific Vmax normalized to the amount of transporter as input value which was determined in a vesicular transport assay." }, { "InternalName": "NoncompetitiveInhibition", "DataSource": "Non-competitive", "Molecule": "P-gp", "Parameters": [ { "Name": "Ki", "Value": 0.0383697779, "Unit": "µmol/l", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] }, { "InternalName": "IrreversibleInhibition", "DataSource": "MBI", "Molecule": "CYP3A4", "Parameters": [ { "Name": "kinact", "Value": 0.034, "Unit": "1/min" }, { "Name": "K_kinact_half", "Value": 3.85, "Unit": "µmol/l" } ] }, { "InternalName": "MetabolizationLiverMicrosomes_MM", "DataSource": "Norverapamil", "Molecule": "CYP3A4", "Metabolite": "S-Norverapamil", "Parameters": [ { "Name": "In vitro Vmax for liver microsomes", "Value": 1.02, "Unit": "nmol/min/mg mic. protein" }, { "Name": "Km", "Value": 9.72, "Unit": "µmol/l" }, { "Name": "kcat", "Value": 26.1743386639, "Unit": "1/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] }, { "InternalName": "MetabolizationLiverMicrosomes_MM", "DataSource": "D617", "Molecule": "CYP3A4", "Parameters": [ { "Name": "In vitro Vmax for liver microsomes", "Value": 0.86, "Unit": "nmol/min/mg mic. protein" }, { "Name": "Km", "Value": 23.64, "Unit": "µmol/l" }, { "Name": "kcat", "Value": 56.4245798193, "Unit": "1/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] } ], "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Parameters": [ { "Name": "Molecular weight", "Value": 454.611, "Unit": "g/mol" } ] }, { "Name": "R-Norverapamil", "IsSmallMolecule": true, "Lipophilicity": [ { "Name": "logP", "Parameters": [ { "Name": "Lipophilicity", "Value": 2.8407448658, "Unit": "Log Units", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] } ], "FractionUnbound": [ { "Name": "Measurement", "Species": "Human", "Parameters": [ { "Name": "Fraction unbound (plasma, reference value)", "Value": 5.1, "Unit": "%", "ValueOrigin": { "Source": "Other", "Method": "Assumption" } } ] } ], "Solubility": [ { "Name": "Measurement", "Parameters": [ { "Name": "Solubility at reference pH", "Value": 46.0, "Unit": "mg/ml" }, { "Name": "Reference pH", "Value": 6.54 } ] } ], "IntestinalPermeability": [ { "Name": "Fitted", "Parameters": [ { "Name": "Specific intestinal permeability (transcellular)", "Value": 3.5447164381E-06, "Unit": "cm/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] } ], "Permeability": [ { "Name": "Fitted", "Parameters": [ { "Name": "Permeability", "Value": 0.0994098912, "Unit": "cm/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] } ], "PkaTypes": [ { "Type": "Base", "Pka": 8.75, "ValueOrigin": { "Source": "Unknown" } } ], "Processes": [ { "InternalName": "rCYP450_MM", "DataSource": "D620", "Molecule": "CYP3A4", "Parameters": [ { "Name": "In vitro Vmax/recombinant enzyme", "Value": 9.0, "Unit": "pmol/min/pmol rec. enzyme" }, { "Name": "Km", "Value": 144.0, "Unit": "µmol/l" }, { "Name": "kcat", "Value": 145.6385399671, "Unit": "1/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] }, { "InternalName": "GlomerularFiltration", "DataSource": "GFR", "Species": "Human", "Parameters": [ { "Name": "GFR fraction", "Value": 1.0 } ] }, { "InternalName": "ActiveTransport_InVitro_VesicularAssay_MM", "DataSource": "Paper", "Molecule": "P-gp", "Parameters": [ { "Name": "In vitro Vmax/transporter", "Value": 0.00057724, "Unit": "pmol/min/pmol transporter" }, { "Name": "Km", "Value": 1.01, "Unit": "µmol/l" }, { "Name": "kcat", "Value": 3.3916609583, "Unit": "1/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ], "Description": "A transporter mediated unidirectional transfer of a compound across a cellular membrane is described as saturable process following Michaelis-Menten type kinetics. The corresponding kcat value is calculated from a specific Vmax normalized to the amount of transporter as input value which was determined in a vesicular transport assay." }, { "InternalName": "NoncompetitiveInhibition", "DataSource": "Non-competitive", "Molecule": "P-gp", "Parameters": [ { "Name": "Ki", "Value": 0.0383697779, "Unit": "µmol/l", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] }, { "InternalName": "IrreversibleInhibition", "DataSource": "MBI", "Molecule": "CYP3A4", "Parameters": [ { "Name": "kinact", "Value": 0.048, "Unit": "1/min" }, { "Name": "K_kinact_half", "Value": 6.1, "Unit": "µmol/l" } ] } ], "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Parameters": [ { "Name": "Molecular weight", "Value": 440.584, "Unit": "g/mol" } ] }, { "Name": "S-Norverapamil", "IsSmallMolecule": true, "Lipophilicity": [ { "Name": "logP", "Parameters": [ { "Name": "Lipophilicity", "Value": 2.8407448658, "Unit": "Log Units", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] } ], "FractionUnbound": [ { "Name": "Measurement", "Species": "Human", "Parameters": [ { "Name": "Fraction unbound (plasma, reference value)", "Value": 11.0, "Unit": "%", "ValueOrigin": { "Source": "Other", "Method": "Assumption" } } ] } ], "Solubility": [ { "Name": "Measurement", "Parameters": [ { "Name": "Solubility at reference pH", "Value": 46.0, "Unit": "mg/ml" }, { "Name": "Reference pH", "Value": 6.54 } ] } ], "IntestinalPermeability": [ { "Name": "Fitted", "Parameters": [ { "Name": "Specific intestinal permeability (transcellular)", "Value": 3.5447164381E-06, "Unit": "cm/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] } ], "Permeability": [ { "Name": "Fitted", "Parameters": [ { "Name": "Permeability", "Value": 0.0994098912, "Unit": "cm/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] } ], "PkaTypes": [ { "Type": "Base", "Pka": 8.75, "ValueOrigin": { "Source": "Unknown" } } ], "Processes": [ { "InternalName": "rCYP450_MM", "DataSource": "D620", "Molecule": "CYP3A4", "Parameters": [ { "Name": "In vitro Vmax/recombinant enzyme", "Value": 6.5, "Unit": "pmol/min/pmol rec. enzyme" }, { "Name": "Km", "Value": 36.0, "Unit": "µmol/l" }, { "Name": "kcat", "Value": 41.0994047535, "Unit": "1/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] }, { "InternalName": "GlomerularFiltration", "DataSource": "GFR", "Species": "Human", "Parameters": [ { "Name": "GFR fraction", "Value": 1.0 } ] }, { "InternalName": "ActiveTransport_InVitro_VesicularAssay_MM", "DataSource": "Paper", "Molecule": "P-gp", "Parameters": [ { "Name": "In vitro Vmax/transporter", "Value": 0.00057724, "Unit": "pmol/min/pmol transporter" }, { "Name": "Km", "Value": 1.01, "Unit": "µmol/l" }, { "Name": "kcat", "Value": 3.3916609583, "Unit": "1/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ], "Description": "A transporter mediated unidirectional transfer of a compound across a cellular membrane is described as saturable process following Michaelis-Menten type kinetics. The corresponding kcat value is calculated from a specific Vmax normalized to the amount of transporter as input value which was determined in a vesicular transport assay." }, { "InternalName": "NoncompetitiveInhibition", "DataSource": "Non-competitive", "Molecule": "P-gp", "Parameters": [ { "Name": "Ki", "Value": 0.0383697779, "Unit": "µmol/l", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '30b - final' on 2019-12-30 13:23" } } ] }, { "InternalName": "IrreversibleInhibition", "DataSource": "MBI", "Molecule": "CYP3A4", "Parameters": [ { "Name": "kinact", "Value": 0.08, "Unit": "1/min" }, { "Name": "K_kinact_half", "Value": 2.9, "Unit": "µmol/l" } ] } ], "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Parameters": [ { "Name": "Molecular weight", "Value": 440.584, "Unit": "g/mol" } ] }, { "Name": "Sum-Verapamil", "IsSmallMolecule": true, "Lipophilicity": [ { "Name": "logP", "Parameters": [ { "Name": "Lipophilicity", "Value": 2.8407448658, "Unit": "Log Units", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification" } } ] } ], "FractionUnbound": [ { "Name": "Measurement", "Species": "Human", "Parameters": [ { "Name": "Fraction unbound (plasma, reference value)", "Value": 8.05, "Unit": "%" } ] } ], "Solubility": [ { "Name": "Measurement", "Parameters": [ { "Name": "Solubility at reference pH", "Value": 46.0, "Unit": "mg/ml" }, { "Name": "Reference pH", "Value": 6.54 } ] } ], "IntestinalPermeability": [ { "Name": "Fitted", "Parameters": [ { "Name": "Specific intestinal permeability (transcellular)", "Value": 3.5447164381E-06, "Unit": "cm/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification" } } ] } ], "Permeability": [ { "Name": "Fitted", "Parameters": [ { "Name": "Permeability", "Value": 0.0994098912, "Unit": "cm/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification" } } ] } ], "PkaTypes": [ { "Type": "Base", "Pka": 8.75, "ValueOrigin": { "Source": "Unknown" } } ], "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Parameters": [ { "Name": "Molecular weight", "Value": 454.611, "Unit": "g/mol" } ] }, { "Name": "Sum-Norverapamil", "IsSmallMolecule": true, "Lipophilicity": [ { "Name": "logP", "Parameters": [ { "Name": "Lipophilicity", "Value": 2.8407448658, "Unit": "Log Units", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification" } } ] } ], "FractionUnbound": [ { "Name": "Measurement", "Species": "Human", "Parameters": [ { "Name": "Fraction unbound (plasma, reference value)", "Value": 8.05, "Unit": "%" } ] } ], "Solubility": [ { "Name": "Measurement", "Parameters": [ { "Name": "Solubility at reference pH", "Value": 46.0, "Unit": "mg/ml" }, { "Name": "Reference pH", "Value": 6.54 } ] } ], "IntestinalPermeability": [ { "Name": "Fitted", "Parameters": [ { "Name": "Specific intestinal permeability (transcellular)", "Value": 3.5447164381E-06, "Unit": "cm/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification" } } ] } ], "Permeability": [ { "Name": "Fitted", "Parameters": [ { "Name": "Permeability", "Value": 0.0994098912, "Unit": "cm/min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification" } } ] } ], "PkaTypes": [ { "Type": "Base", "Pka": 8.75, "ValueOrigin": { "Source": "Unknown" } } ], "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Parameters": [ { "Name": "Molecular weight", "Value": 440.584, "Unit": "g/mol" } ] } ], "Formulations": [ { "Name": "Solution", "FormulationType": "Formulation_Dissolved" }, { "Name": "Retard Tablet Verapamil (Knoll)", "FormulationType": "Formulation_Tablet_Weibull", "Parameters": [ { "Name": "Dissolution time (50% dissolved)", "Value": 155.2445399403, "Unit": "min", "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '240 mg retard (Isoptin RR) QD vs Verabeta 240 RR' on 2019-12-31 11:13" } }, { "Name": "Lag time", "Value": 0.0, "Unit": "min" }, { "Name": "Dissolution shape", "Value": 2.3662989419, "ValueOrigin": { "Source": "ParameterIdentification", "Method": "ParameterIdentification", "Description": "Value updated from '240 mg retard (Isoptin RR) QD vs Verabeta 240 RR' on 2019-12-31 11:13" } }, { "Name": "Use as suspension", "Value": 1.0 } ] } ], "Protocols": [ { "Name": "Härtter 2012, Verapamil 120 mg SD, R-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.545, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Härtter 2012, Verapamil 120 mg SD, S-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.545, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Eichelbaum 1984, R-Verapamil 50 mg iv (5 min)", "ApplicationType": "Intravenous", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 46.288, "Unit": "mg" }, { "Name": "Infusion time", "Value": 5.0, "Unit": "min" } ] }, { "Name": "Maeda 2011, Verapamil 16 mg po SD (sol), R-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 7.406, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" } ] }, { "Name": "Maeda 2011, Verapamil 16 mg po SD (sol), S-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 7.406, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" } ] }, { "Name": "Blume, Mutschler 1994, 240 mg po QD (SR), R-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 111.091, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 6.0, "ValueOrigin": { "Source": "Unknown" } }, { "Name": "TimeBetweenRepetitions", "Value": 24.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "TimeUnit": "h" }, { "Name": "Blume, Mutschler 1994, 240 mg po QD (SR), S-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 111.091, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 6.0, "ValueOrigin": { "Source": "Unknown" } }, { "Name": "TimeBetweenRepetitions", "Value": 24.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "TimeUnit": "h" }, { "Name": "Smith 1984, Verapamil 10 mg iv (bol), R-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "IntravenousBolus", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 4.629, "Unit": "mg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Smith 1984, Verapamil 10 mg iv (bol), S-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "IntravenousBolus", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 4.629, "Unit": "mg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Mooy 1985, Verapamil 3mg iv (5min) SD, R-Vera", "ApplicationType": "Intravenous", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 1.388651, "Unit": "mg" }, { "Name": "Infusion time", "Value": 5.0, "Unit": "min" } ] }, { "Name": "Mooy 1985, Verapamil 3mg iv (5min) SD, S-Vera", "ApplicationType": "Intravenous", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 1.388651, "Unit": "mg" }, { "Name": "Infusion time", "Value": 5.0, "Unit": "min" } ] }, { "Name": "Mooy 1985, Verapamil 80mg po SD, R-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 37.03069, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Mooy 1985, Verapamil 80mg po SD, S-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 37.03069, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Streit 2005, Verapamil 5mg iv (10min) SD, S-Vera", "ApplicationType": "Intravenous", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 2.314418, "Unit": "mg" }, { "Name": "Infusion time", "Value": 10.0, "Unit": "min" } ] }, { "Name": "Streit 2005, Verapamil 5mg iv (10min) SD, R-Vera", "ApplicationType": "Intravenous", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 2.314418, "Unit": "mg" }, { "Name": "Infusion time", "Value": 10.0, "Unit": "min" } ] }, { "Name": "Johnston 1981, Verapamil 0.1mg/kg iv (5min) SD, S-Vera", "ApplicationType": "Intravenous", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 0.04628836, "Unit": "mg/kg" }, { "Name": "Infusion time", "Value": 5.0, "Unit": "min" } ] }, { "Name": "Johnston 1981, Verapamil 0.1mg/kg iv (5min) SD, R-Vera", "ApplicationType": "Intravenous", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 0.04628836, "Unit": "mg/kg" }, { "Name": "Infusion time", "Value": 5.0, "Unit": "min" } ] }, { "Name": "Johnston 1981, Verapamil 120mg po SD, R-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.54603, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Johnston 1981, Verapamil 120mg po SD, S-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.54603, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Abernethy 1985, Verapamil 10mg iv (10min) SD, R-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Intravenous", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 4.628836, "Unit": "mg" }, { "Name": "Infusion time", "Value": 10.0, "Unit": "min" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 12.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Abernethy 1985, Verapamil 10mg iv (10min) SD, S-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Intravenous", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 4.628836, "Unit": "mg" }, { "Name": "Infusion time", "Value": 10.0, "Unit": "min" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 12.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Abernethy 1985, Verapamil 120mg po SD, R-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.54603, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 12.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Abernethy 1985, Verapamil 120mg po SD, S-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.54603, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 12.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Barbarash 1988, Verapamil 10mg iv (10min) SD, S-Vera", "ApplicationType": "Intravenous", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 4.628836, "Unit": "mg" }, { "Name": "Infusion time", "Value": 10.0, "Unit": "min" } ] }, { "Name": "Barbarash 1988, Verapamil 10mg iv (10min) SD, R-Vera", "ApplicationType": "Intravenous", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 4.628836, "Unit": "mg" }, { "Name": "Infusion time", "Value": 10.0, "Unit": "min" } ] }, { "Name": "Barbarash 1988, Verapamil 120mg po SD, R-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.54603, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Barbarash 1988, Verapamil 120mg po SD, S-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.54603, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Wing 1985, Verapamil 10mg iv (10min) SD, R-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Intravenous", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 4.628836, "Unit": "mg" }, { "Name": "Infusion time", "Value": 10.0, "Unit": "min" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Wing 1985, Verapamil 10mg iv (10min) SD, S-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Intravenous", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 4.628836, "Unit": "mg" }, { "Name": "Infusion time", "Value": 10.0, "Unit": "min" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Wing 1985, Verapamil 80mg po SD, R-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 37.030688, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Wing 1985, Verapamil 80mg po SD, S-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 37.030688, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "McAllister, Kirsten 1982, Verapamil 10mg iv (5min) SD, S-Vera", "ApplicationType": "Intravenous", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 4.628836, "Unit": "mg" }, { "Name": "Infusion time", "Value": 5.0, "Unit": "min" } ] }, { "Name": "McAllister, Kirsten 1982, Verapamil 10mg iv (5min) SD, R-Vera", "ApplicationType": "Intravenous", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 4.628836, "Unit": "mg" }, { "Name": "Infusion time", "Value": 5.0, "Unit": "min" } ] }, { "Name": "Smith 1984, Verapamil 120mg po SD, S-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.54603, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Smith 1984, Verapamil 120mg po SD, R-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.54603, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Freedman 1981, Verapamil 13.1mg iv (13min) SD, R-Vera", "ApplicationType": "Intravenous", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 6.063775, "Unit": "mg" }, { "Name": "Infusion time", "Value": 13.0, "Unit": "min" } ] }, { "Name": "Freedman 1981, Verapamil 13.1mg iv (13min) SD, S-Vera", "ApplicationType": "Intravenous", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 6.063775, "Unit": "mg" }, { "Name": "Infusion time", "Value": 13.0, "Unit": "min" } ] }, { "Name": "Abernethy 1993, Verapamil 20mg iv (30min) SD, R-Vera", "ApplicationType": "Intravenous", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 9.257672, "Unit": "mg" }, { "Name": "Infusion time", "Value": 30.0, "Unit": "min" } ] }, { "Name": "Abernethy 1993, Verapamil 20mg iv (30min) SD, S-Vera", "ApplicationType": "Intravenous", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 9.257672, "Unit": "mg" }, { "Name": "Infusion time", "Value": 30.0, "Unit": "min" } ] }, { "Name": "Vogelgesang 1984, R-Verapamil 250mg po SD", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 231.4418, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Maeda 2011, Verapamil 0.1 mg po SD (sol), R-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 0.04628836, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" } ] }, { "Name": "Maeda 2011, Verapamil 0.1 mg po SD (sol), S-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 0.04628836, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" } ] }, { "Name": "Maeda 2011, Verapamil 3 mg po SD (sol), R-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 1.388651, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" } ] }, { "Name": "Maeda 2011, Verapamil 3 mg po SD (sol), S-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 1.388651, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" } ] }, { "Name": "Maeda 2011, Verapamil 80 mg po SD (sol), S-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 37.03069, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" } ] }, { "Name": "Maeda 2011, Verapamil 80 mg po SD (sol), R-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 37.03069, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" } ] }, { "Name": "John 1992, Verapamil 40mg po (tab) SD, R-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 18.51534, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "John 1992, Verapamil 40mg po (tab) SD, S-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 18.51534, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Sawicki, Janicki 2002, Verapamil 40mg po (tab) SD, R-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 18.51534, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Sawicki, Janicki 2002, Verapamil 40mg po (tab) SD, S-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 18.51534, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Choi 2008, Verapamil 60 mg po (caps) SD, R-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 27.77302, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Choi 2008, Verapamil 60 mg po (caps) SD, S-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 27.77302, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Ratiopharm 1988, Verapamil 80mg po SD, R-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 37.03069, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Ratiopharm 1988, Verapamil 80mg po SD, S-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 37.03069, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Ratiopharm 1989, Verapamil 80mg (2 40mg tabs) po SD, R-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 18.51534, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] }, { "Name": "Schema 2", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 18.51534, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Ratiopharm 1989, Verapamil 80mg (2 40mg tabs) po SD, S-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 18.51534, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] }, { "Name": "Schema 2", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 18.51534, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Johnson 2001, Verapamil 80mg po tid 7rep, R-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 37.03069, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 7.0 }, { "Name": "TimeBetweenRepetitions", "Value": 8.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Johnson 2001, Verapamil 80mg po tid 7rep, S-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 37.03069, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 7.0 }, { "Name": "TimeBetweenRepetitions", "Value": 8.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Boehringer 2018, Verapamil 120mg po (IR tab) SD, R-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.54603, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Boehringer 2018, Verapamil 120mg po (IR tab) SD, S-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.54603, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Härtter 2012, Verapamil 120 mg bid, R-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.545, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 7.0 }, { "Name": "TimeBetweenRepetitions", "Value": 12.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Härtter 2012, Verapamil 120 mg bid, S-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.545, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 7.0 }, { "Name": "TimeBetweenRepetitions", "Value": 12.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Hla 1987, Verapamil 120mg po (tab) SD, R-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.54603, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Hla 1987, Verapamil 120mg po (tab) SD, S-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.54603, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Hla 1987, Verapamil 120mg po (tab) MD, R-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.54603, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] }, { "Name": "Schema 2", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.54603, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 24.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 18.0 }, { "Name": "TimeBetweenRepetitions", "Value": 12.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Hla 1987, Verapamil 120mg po (tab) MD, S-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.54603, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] }, { "Name": "Schema 2", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.54603, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 24.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 18.0 }, { "Name": "TimeBetweenRepetitions", "Value": 12.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Mikus 1990, Verapamil 160mg po (sol) SD, R-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 74.06138, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Mikus 1990, Verapamil 160mg po (sol) SD, S-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 74.06138, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "van Haarst 2009, Verapamil 180mg PO BID 3days, R-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 83.31905, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 5.0 }, { "Name": "TimeBetweenRepetitions", "Value": 12.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "van Haarst 2009, Verapamil 180mg PO BID 3days, S-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 83.31905, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 5.0 }, { "Name": "TimeBetweenRepetitions", "Value": 12.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Blume, Mutschler 1987, Verapamil 120mg po SD, R-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.54603, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Blume, Mutschler 1987, Verapamil 120mg po SD, S-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.54603, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Blume, Mutschler 1989, Verapamil 80mg po SD, R-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 37.03069, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" } ] }, { "Name": "Blume, Mutschler 1989, Verapamil 80mg po SD, S-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 37.03069, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" } ] }, { "Name": "Blume, Mutschler 1990, Verapamil 40mg po SD, R-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 18.51534, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Blume, Mutschler 1990, Verapamil 40mg po SD, S-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 18.51534, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Blume, Mutschler 1983, Verapamil 40mg po SD, R-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 18.51534, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Blume, Mutschler 1983, Verapamil 40mg po SD, S-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 18.51534, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Eichelbaum 1984, R-Verapamil 25 mg iv (5 min)", "ApplicationType": "Intravenous", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 23.14418, "Unit": "mg" }, { "Name": "Infusion time", "Value": 5.0, "Unit": "min" } ] }, { "Name": "Eichelbaum 1984, R-Verapamil 5 mg iv (5 min)", "ApplicationType": "Intravenous", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 4.628836, "Unit": "mg" }, { "Name": "Infusion time", "Value": 5.0, "Unit": "min" } ] }, { "Name": "Eichelbaum 1984, S-Verapamil 5 mg iv (5 min)", "ApplicationType": "Intravenous", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 4.628836, "Unit": "mg" }, { "Name": "Infusion time", "Value": 5.0, "Unit": "min" } ] }, { "Name": "Eichelbaum 1984, S-Verapamil 7.5 mg iv (5 min)", "ApplicationType": "Intravenous", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 6.943254, "Unit": "mg" }, { "Name": "Infusion time", "Value": 5.0, "Unit": "min" } ] }, { "Name": "Eichelbaum 1984, S-Verapamil 10 mg iv (5 min)", "ApplicationType": "Intravenous", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 9.257672, "Unit": "mg" }, { "Name": "Infusion time", "Value": 5.0, "Unit": "min" } ] }, { "Name": "Backman 1994, Verapamil 80mg po TID, R-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 37.03069, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 5.0 }, { "Name": "TimeBetweenRepetitions", "Value": 8.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Backman 1994, Verapamil 80mg po TID, S-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 37.03069, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 5.0 }, { "Name": "TimeBetweenRepetitions", "Value": 8.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "McAllister 1982, Verapamil 80mg po SD, S-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 37.03069, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "McAllister 1982, Verapamil 80mg po SD, R-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 37.03069, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "McAllister 1982, Verapamil 160mg po SD, R-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 74.06138, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "McAllister 1982, Verapamil 160mg po SD, S-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 74.06138, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 1.0 }, { "Name": "TimeBetweenRepetitions", "Value": 0.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "McAllister 1982, Verapamil 120 mg SD, R-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.545, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "McAllister 1982, Verapamil 120 mg SD, S-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.545, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Jorgensen 1988, Verapamil 120mg PO BID, R-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.54603, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 15.0 }, { "Name": "TimeBetweenRepetitions", "Value": 12.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Jorgensen 1988, Verapamil 120mg PO BID, S-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.54603, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 15.0 }, { "Name": "TimeBetweenRepetitions", "Value": 12.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Jorgensen 1988, Verapamil 240mg PO MD, R-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 111.0921, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 8.0 }, { "Name": "TimeBetweenRepetitions", "Value": 24.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Jorgensen 1988, Verapamil 240mg PO MD, S-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 111.0921, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 8.0 }, { "Name": "TimeBetweenRepetitions", "Value": 24.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Karim 1995, Verapamil 240mg PO SD, R-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 111.0921, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Karim 1995, Verapamil 240mg PO SD, S-Vera", "ApplicationType": "Oral", "DosingInterval": "Single", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 111.0921, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] }, { "Name": "Shand 1981, Verapamil 120 mg TID, R-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.545, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 7.0 }, { "Name": "TimeBetweenRepetitions", "Value": 8.0, "Unit": "h" } ] } ], "TimeUnit": "h" }, { "Name": "Shand 1981, Verapamil 120 mg TID, S-Vera", "DosingInterval": "Single", "Schemas": [ { "Name": "Schema 1", "SchemaItems": [ { "Name": "Schema Item 1", "ApplicationType": "Oral", "FormulationKey": "Formulation", "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "InputDose", "Value": 55.545, "Unit": "mg" }, { "Name": "Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ] } ], "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "NumberOfRepetitions", "Value": 7.0 }, { "Name": "TimeBetweenRepetitions", "Value": 8.0, "Unit": "h" } ] } ], "TimeUnit": "h" } ], "ObserverSets": [ { "Name": "Sum-Verapamil", "Observers": [ { "Name": "Sum-Verapamil Plasma (Peripheral Venous Blood)", "Dimension": "Concentration (molar)", "ContainerCriteria": [ { "Tag": "PeripheralVenousBlood", "Type": "MatchTag" } ], "Formula": { "Name": "Sum-Verapamil", "Formula": "fQ_art*(C_pls_art_R+C_pls_art_S)+fQ_bon*(C_pls_bon_R+C_pls_bon_S)+fQ_fat*(C_pls_fat_R+C_pls_fat_S)+fQ_mus*(C_pls_mus_R+C_pls_mus_S)+fQ_skn*(C_pls_skn_R+C_pls_skn_S)", "References": [ { "Alias": "C_pls_art_R", "Dimension": "Concentration (molar)", "Path": "Organism|ArterialBlood|Plasma|R-Verapamil|Concentration" }, { "Alias": "C_pls_bon_R", "Dimension": "Concentration (molar)", "Path": "Organism|Bone|Plasma|R-Verapamil|Concentration" }, { "Alias": "C_pls_fat_R", "Dimension": "Concentration (molar)", "Path": "Organism|Fat|Plasma|R-Verapamil|Concentration" }, { "Alias": "C_pls_mus_R", "Dimension": "Concentration (molar)", "Path": "Organism|Muscle|Plasma|R-Verapamil|Concentration" }, { "Alias": "C_pls_skn_R", "Dimension": "Concentration (molar)", "Path": "Organism|Skin|Plasma|R-Verapamil|Concentration" }, { "Alias": "C_pls_art_S", "Dimension": "Concentration (molar)", "Path": "Organism|ArterialBlood|Plasma|S-Verapamil|Concentration" }, { "Alias": "C_pls_bon_S", "Dimension": "Concentration (molar)", "Path": "Organism|Bone|Plasma|S-Verapamil|Concentration" }, { "Alias": "C_pls_fat_S", "Dimension": "Concentration (molar)", "Path": "Organism|Fat|Plasma|S-Verapamil|Concentration" }, { "Alias": "C_pls_mus_S", "Dimension": "Concentration (molar)", "Path": "Organism|Muscle|Plasma|S-Verapamil|Concentration" }, { "Alias": "C_pls_skn_S", "Dimension": "Concentration (molar)", "Path": "Organism|Skin|Plasma|S-Verapamil|Concentration" }, { "Alias": "fQ_art", "Dimension": "Fraction", "Path": "Organism|ArterialBlood|Peripheral blood flow fraction" }, { "Alias": "fQ_bon", "Dimension": "Fraction", "Path": "Organism|Bone|Peripheral blood flow fraction" }, { "Alias": "fQ_fat", "Dimension": "Fraction", "Path": "Organism|Fat|Peripheral blood flow fraction" }, { "Alias": "fQ_mus", "Dimension": "Fraction", "Path": "Organism|Muscle|Peripheral blood flow fraction" }, { "Alias": "fQ_skn", "Dimension": "Fraction", "Path": "Organism|Skin|Peripheral blood flow fraction" } ], "Dimension": "Concentration (molar)" }, "MoleculeList": { "ForAll": false, "MoleculeNamesToInclude": [ "R-Verapamil" ] }, "Type": "Container" } ] }, { "Name": "Sum-Norverapamil", "Observers": [ { "Name": "Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Dimension": "Concentration (molar)", "ContainerCriteria": [ { "Tag": "PeripheralVenousBlood", "Type": "MatchTag" } ], "Formula": { "Name": "Sum-Norverapamil", "Formula": "fQ_art*(C_pls_art_RN+C_pls_art_SN)+fQ_bon*(C_pls_bon_RN+C_pls_bon_SN)+fQ_fat*(C_pls_fat_RN+C_pls_fat_SN)+fQ_mus*(C_pls_mus_RN+C_pls_mus_SN)+fQ_skn*(C_pls_skn_RN+C_pls_skn_SN)", "References": [ { "Alias": "C_pls_art_RN", "Dimension": "Concentration (molar)", "Path": "Organism|ArterialBlood|Plasma|R-Norverapamil|Concentration" }, { "Alias": "C_pls_bon_RN", "Dimension": "Concentration (molar)", "Path": "Organism|Bone|Plasma|R-Norverapamil|Concentration" }, { "Alias": "C_pls_fat_RN", "Dimension": "Concentration (molar)", "Path": "Organism|Fat|Plasma|R-Norverapamil|Concentration" }, { "Alias": "C_pls_mus_RN", "Dimension": "Concentration (molar)", "Path": "Organism|Muscle|Plasma|R-Norverapamil|Concentration" }, { "Alias": "C_pls_skn_RN", "Dimension": "Concentration (molar)", "Path": "Organism|Skin|Plasma|R-Norverapamil|Concentration" }, { "Alias": "C_pls_art_SN", "Dimension": "Concentration (molar)", "Path": "Organism|ArterialBlood|Plasma|S-Norverapamil|Concentration" }, { "Alias": "C_pls_bon_SN", "Dimension": "Concentration (molar)", "Path": "Organism|Bone|Plasma|S-Norverapamil|Concentration" }, { "Alias": "C_pls_fat_SN", "Dimension": "Concentration (molar)", "Path": "Organism|Fat|Plasma|S-Norverapamil|Concentration" }, { "Alias": "C_pls_mus_SN", "Dimension": "Concentration (molar)", "Path": "Organism|Muscle|Plasma|S-Norverapamil|Concentration" }, { "Alias": "C_pls_skn_SN", "Dimension": "Concentration (molar)", "Path": "Organism|Skin|Plasma|S-Norverapamil|Concentration" }, { "Alias": "fQ_art", "Dimension": "Fraction", "Path": "Organism|ArterialBlood|Peripheral blood flow fraction" }, { "Alias": "fQ_bon", "Dimension": "Fraction", "Path": "Organism|Bone|Peripheral blood flow fraction" }, { "Alias": "fQ_fat", "Dimension": "Fraction", "Path": "Organism|Fat|Peripheral blood flow fraction" }, { "Alias": "fQ_mus", "Dimension": "Fraction", "Path": "Organism|Muscle|Peripheral blood flow fraction" }, { "Alias": "fQ_skn", "Dimension": "Fraction", "Path": "Organism|Skin|Peripheral blood flow fraction" } ], "Dimension": "Concentration (molar)" }, "MoleculeList": { "ForAll": false, "MoleculeNamesToInclude": [ "R-Norverapamil" ] }, "Type": "Container" } ] }, { "Name": "Sum-Verapamil fe to urine", "Observers": [ { "Name": "Sum-Verapamil fe to urine", "Dimension": "Fraction", "ContainerCriteria": [ { "Tag": "Urine", "Type": "MatchTag" } ], "Formula": { "Name": "Sum-Verapamil fe to urine", "Formula": "(TotalDrugMassR+TotalDrugMassS)>0 ? ((UrineConcR+UrineConcS)*Volume)/(TotalDrugMassR+TotalDrugMassS) : 0", "References": [ { "Alias": "TotalDrugMassR", "Dimension": "Amount", "Path": "R-Verapamil|Total drug mass" }, { "Alias": "UrineConcR", "Dimension": "Concentration (molar)", "Path": "Organism|Kidney|Urine|R-Verapamil|Concentration" }, { "Alias": "UrineConcS", "Dimension": "Concentration (molar)", "Path": "Organism|Kidney|Urine|S-Verapamil|Concentration" }, { "Alias": "Volume", "Dimension": "Volume", "Path": "Organism|Kidney|Urine|Volume" }, { "Alias": "TotalDrugMassS", "Dimension": "Amount", "Path": "S-Verapamil|Total drug mass" } ], "Dimension": "Fraction" }, "MoleculeList": { "ForAll": false, "MoleculeNamesToInclude": [ "R-Verapamil" ] }, "Type": "Amount" } ] }, { "Name": "Sum-Norverapamil fe to urine", "Observers": [ { "Name": "Sum-Norverapamil fe to urine", "Dimension": "Fraction", "ContainerCriteria": [ { "Tag": "Urine", "Type": "MatchTag" } ], "Formula": { "Name": "Sum-Norverapamil fe to urine", "Formula": "(TotalDrugMassR+TotalDrugMassS)>0 ? ((UrineConcRN+UrineConcSN)*Volume)/(TotalDrugMassR+TotalDrugMassS) : 0", "References": [ { "Alias": "TotalDrugMassR", "Dimension": "Amount", "Path": "R-Verapamil|Total drug mass" }, { "Alias": "UrineConcRN", "Dimension": "Concentration (molar)", "Path": "Organism|Kidney|Urine|R-Norverapamil|Concentration" }, { "Alias": "UrineConcSN", "Dimension": "Concentration (molar)", "Path": "Organism|Kidney|Urine|S-Norverapamil|Concentration" }, { "Alias": "Volume", "Dimension": "Volume", "Path": "Organism|Kidney|Urine|Volume" }, { "Alias": "TotalDrugMassS", "Dimension": "Amount", "Path": "S-Verapamil|Total drug mass" } ], "Dimension": "Fraction" }, "MoleculeList": { "ForAll": false, "MoleculeNamesToInclude": [ "R-Norverapamil" ] }, "Type": "Amount" } ] }, { "Name": "Sum-Verapamil fe to feces", "Observers": [ { "Name": "Sum-Verapamil fe to feces", "Dimension": "Fraction", "ContainerCriteria": [ { "Tag": "Feces", "Type": "MatchTag" } ], "Formula": { "Name": "Sum-Verapamil fe to feces", "Formula": "(TotalDrugMassR+TotalDrugMassS)>0 ? (MR+MS)/(TotalDrugMassR+TotalDrugMassS) : 0", "References": [ { "Alias": "TotalDrugMassR", "Dimension": "Amount", "Path": "R-Verapamil|Total drug mass" }, { "Alias": "MR", "Dimension": "Amount", "Path": "..|..|R-Verapamil" }, { "Alias": "MS", "Dimension": "Amount", "Path": "..|..|S-Verapamil" }, { "Alias": "TotalDrugMassS", "Dimension": "Amount", "Path": "S-Verapamil|Total drug mass" } ], "Dimension": "Fraction" }, "MoleculeList": { "ForAll": false, "MoleculeNamesToInclude": [ "R-Verapamil" ] }, "Type": "Amount" } ] }, { "Name": "Sum-Norverapamil fe to feces", "Observers": [ { "Name": "Sum-Norverapamil fe to feces", "Dimension": "Fraction", "ContainerCriteria": [ { "Tag": "Feces", "Type": "MatchTag" } ], "Formula": { "Name": "Sum-Norverapamil fe to feces", "Formula": "(TotalDrugMassR+TotalDrugMassS)>0 ? (MRN+MSN)/(TotalDrugMassR+TotalDrugMassS) : 0", "References": [ { "Alias": "TotalDrugMassR", "Dimension": "Amount", "Path": "R-Verapamil|Total drug mass" }, { "Alias": "MRN", "Dimension": "Amount", "Path": "..|..|R-Norverapamil" }, { "Alias": "MSN", "Dimension": "Amount", "Path": "..|..|S-Norverapamil" }, { "Alias": "TotalDrugMassS", "Dimension": "Amount", "Path": "S-Verapamil|Total drug mass" } ], "Dimension": "Fraction" }, "MoleculeList": { "ForAll": false, "MoleculeNamesToInclude": [ "R-Norverapamil" ] }, "Type": "Amount" } ] } ], "Simulations": [ { "Name": "iv_R-Verapamil 50 mg (5 min), Eichelbaum 1984, n=1", "Model": "4Comp", "ObservedData": [ "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 50 mg - Plasma - indiv." ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 25.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 100.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Eichelbaum 1984, R-Verapamil 50 mg iv (5 min)|Application_1|ProtocolSchemaItem|Infusion time", "Value": 5.0, "Unit": "min" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil|Fraction excreted to urine", "Organism|Lumen|Feces|R-Verapamil|Fraction excreted to feces" ], "OutputMappings": [ { "Scaling": "Log", "Path": "iv_R-Verapamil 50 mg (5 min), Eichelbaum 1984, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 50 mg - Plasma - indiv." } ], "Individual": "Eichelbaum 1984, n=1\u001f", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Eichelbaum 1984, R-Verapamil 50 mg iv (5 min)" } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "Min": 1.0, "Max": 1200.0, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "iv_R-Verapamil 50 mg (5 min), Eichelbaum 1984, n=1-R-Verapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "iv_R-Verapamil 50 mg (5 min), Eichelbaum 1984, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 1 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "iv_R-Verapamil 50 mg (5 min), Eichelbaum 1984, n=1|Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#FF8000", "LegendIndex": 3 } }, { "Name": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 50 mg - Plasma - indiv.-R-Verapamil-Peripheral Venous Blood-Plasma-Individual", "X": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 50 mg - Plasma - indiv.|Time", "Y": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 50 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|Individual", "CurveOptions": { "LegendIndex": 4, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil_clean_06\niv_R-Verapamil 50 mg (5 min), Eichelbaum 1984, n=1\n2020-07-01 08:07" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" } ] }, { "Name": "po_Verapamil 120 mg SD (IR), Haertter 2012, n=19", "Model": "4Comp", "ObservedData": [ "Härtter et al. 2012 - 120mg po SD - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)", "Härtter et al. 2012 - 120mg po SD - R-Verapamil - PO - 120 mg - Plasma - agg. (n=19)", "Härtter et al. 2012 - 120mg po SD - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)", "Härtter et al. 2012 - 120mg po SD - S-Verapamil - PO - 120 mg - Plasma - agg. (n=19)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 25.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "End time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 100.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Härtter 2012, Verapamil 120 mg SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Härtter 2012, Verapamil 120 mg SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil|Fraction excreted to urine", "Organism|Kidney|Urine|S-Verapamil|Fraction excreted to urine", "Organism|Lumen|Feces|R-Verapamil|Fraction excreted to feces", "Organism|Lumen|Feces|S-Verapamil|Fraction excreted to feces" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 120 mg SD (IR), Härtter 2012, n=19|Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Härtter et al. 2012 - 120mg po SD - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)" }, { "Scaling": "Log", "Path": "po_Verapamil 120 mg SD (IR), Härtter 2012, n=19|Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Härtter et al. 2012 - 120mg po SD - R-Verapamil - PO - 120 mg - Plasma - agg. (n=19)" }, { "Scaling": "Log", "Path": "po_Verapamil 120 mg SD (IR), Härtter 2012, n=19|Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Härtter et al. 2012 - 120mg po SD - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)" }, { "Scaling": "Log", "Path": "po_Verapamil 120 mg SD (IR), Härtter 2012, n=19|Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Härtter et al. 2012 - 120mg po SD - S-Verapamil - PO - 120 mg - Plasma - agg. (n=19)" } ], "Individual": "Härtter 2012 SD, n=19", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Härtter 2012, Verapamil 120 mg SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Härtter 2012, Verapamil 120 mg SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "Min": 0.0, "Max": 25.0, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "Min": 1.0, "Max": 150.0, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "po_Verapamil 120 mg SD (IR), Haertter 2012, n=19-R-Verapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg SD (IR), Haertter 2012, n=19|Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#FF8000", "LegendIndex": 1 } }, { "Name": "po_Verapamil 120 mg SD (IR), Haertter 2012, n=19-R-Norverapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg SD (IR), Haertter 2012, n=19|Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#ECD33A", "LegendIndex": 5 } }, { "Name": "po_Verapamil 120 mg SD (IR), Haertter 2012, n=19-S-Verapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg SD (IR), Haertter 2012, n=19|Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#76923C", "LegendIndex": 7 } }, { "Name": "po_Verapamil 120 mg SD (IR), Haertter 2012, n=19-S-Norverapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg SD (IR), Haertter 2012, n=19|Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000C0", "LegendIndex": 8 } }, { "Name": "Härtter et al. 2012 - 120mg po SD - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)-R-Norverapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Härtter et al. 2012 - 120mg po SD - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)|Time", "Y": "Härtter et al. 2012 - 120mg po SD - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|R-Norverapamil|ArithmeticMean", "CurveOptions": { "Color": "#ECD33A", "LegendIndex": 13, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Härtter et al. 2012 - 120mg po SD - R-Verapamil - PO - 120 mg - Plasma - agg. (n=19)-R-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Härtter et al. 2012 - 120mg po SD - R-Verapamil - PO - 120 mg - Plasma - agg. (n=19)|Time", "Y": "Härtter et al. 2012 - 120mg po SD - R-Verapamil - PO - 120 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#FF8000", "LegendIndex": 14, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Härtter et al. 2012 - 120mg po SD - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)-S-Norverapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Härtter et al. 2012 - 120mg po SD - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)|Time", "Y": "Härtter et al. 2012 - 120mg po SD - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|S-Norverapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000C0", "LegendIndex": 15, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Härtter et al. 2012 - 120mg po SD - S-Verapamil - PO - 120 mg - Plasma - agg. (n=19)-S-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Härtter et al. 2012 - 120mg po SD - S-Verapamil - PO - 120 mg - Plasma - agg. (n=19)|Time", "Y": "Härtter et al. 2012 - 120mg po SD - S-Verapamil - PO - 120 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|S-Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#76923C", "LegendIndex": 16, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil_clean_06\npo_Verapamil 120 mg SD (IR), Härtter 2012, n=19\n2020-07-01 08:10" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 16 mg SD (sol), Maeda 2011, n=8", "Model": "4Comp", "ObservedData": [ "Maeda 2011 - Verapamil 16 mg - Verapamil - PO - 16 mg - Plasma - agg. (n=8)", "Maeda 2011 - Verapamil 16 mg - Norverapamil - Norverapamil - PO - 16 mg - Plasma - agg. (n=8)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 25.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "End time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 100.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Maeda 2011, Verapamil 16 mg po SD (sol), R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" }, { "Path": "Applications|Maeda 2011, Verapamil 16 mg po SD (sol), S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 16 mg SD (sol), Maeda 2011, n=8|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Maeda 2011 - Verapamil 16 mg - Verapamil - PO - 16 mg - Plasma - agg. (n=8)" }, { "Scaling": "Log", "Path": "po_Verapamil 16 mg SD (sol), Maeda 2011, n=8|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Maeda 2011 - Verapamil 16 mg - Norverapamil - Norverapamil - PO - 16 mg - Plasma - agg. (n=8)" } ], "Individual": "Maeda 2011, n=8", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Maeda 2011, Verapamil 16 mg po SD (sol), R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Maeda 2011, Verapamil 16 mg po SD (sol), S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "Min": -0.7299401, "Max": 20.37651, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "Min": 0.002515392, "Max": 34.86747, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "po_Verapamil 16 mg SD (sol), Maeda 2011, n=8-R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 16 mg SD (sol), Maeda 2011, n=8|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#76923C", "LegendIndex": 6 } }, { "Name": "po_Verapamil 16 mg SD (sol), Maeda 2011, n=8-R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 16 mg SD (sol), Maeda 2011, n=8|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 5 } }, { "Name": "Maeda 2011 - Verapamil 16 mg - Verapamil - PO - 16 mg - Plasma - agg. (n=8)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Maeda 2011 - Verapamil 16 mg - Verapamil - PO - 16 mg - Plasma - agg. (n=8)|Time", "Y": "Maeda 2011 - Verapamil 16 mg - Verapamil - PO - 16 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#000000", "LegendIndex": 12, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Maeda 2011 - Verapamil 16 mg - Norverapamil - Norverapamil - PO - 16 mg - Plasma - agg. (n=8)-Norverapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Maeda 2011 - Verapamil 16 mg - Norverapamil - Norverapamil - PO - 16 mg - Plasma - agg. (n=8)|Time", "Y": "Maeda 2011 - Verapamil 16 mg - Norverapamil - Norverapamil - PO - 16 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean", "CurveOptions": { "Color": "#76923C", "LegendIndex": 13, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil_clean_06\npo_Verapamil 16 mg SD (sol), Maeda 2011, n=8\n2020-07-01 08:14" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 240 mg QD (SR), Blume, Mutschler 1994, n=24", "Model": "4Comp", "ObservedData": [ "Blume, Mutschler 1994 - Verapamil - Verapamil - PO - 240 mg - Plasma - agg. (n=24)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 150.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Blume, Mutschler 1994, 240 mg po QD (SR), R-Vera|Retard Tablet Verapamil (Knoll)|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Blume, Mutschler 1994, 240 mg po QD (SR), R-Vera|Retard Tablet Verapamil (Knoll)|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Blume, Mutschler 1994, 240 mg po QD (SR), R-Vera|Retard Tablet Verapamil (Knoll)|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Blume, Mutschler 1994, 240 mg po QD (SR), R-Vera|Retard Tablet Verapamil (Knoll)|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Blume, Mutschler 1994, 240 mg po QD (SR), R-Vera|Retard Tablet Verapamil (Knoll)|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Blume, Mutschler 1994, 240 mg po QD (SR), R-Vera|Retard Tablet Verapamil (Knoll)|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Blume, Mutschler 1994, 240 mg po QD (SR), S-Vera|Retard Tablet Verapamil (Knoll)|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Blume, Mutschler 1994, 240 mg po QD (SR), S-Vera|Retard Tablet Verapamil (Knoll)|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Blume, Mutschler 1994, 240 mg po QD (SR), S-Vera|Retard Tablet Verapamil (Knoll)|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Blume, Mutschler 1994, 240 mg po QD (SR), S-Vera|Retard Tablet Verapamil (Knoll)|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Blume, Mutschler 1994, 240 mg po QD (SR), S-Vera|Retard Tablet Verapamil (Knoll)|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Blume, Mutschler 1994, 240 mg po QD (SR), S-Vera|Retard Tablet Verapamil (Knoll)|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 240 mg QD (SR), Blume, Mutschler 1994, n=24|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Blume, Mutschler 1994 - Verapamil - Verapamil - PO - 240 mg - Plasma - agg. (n=24)" } ], "Individual": "Blume, Mutschler 1994, n=24", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Blume, Mutschler 1994, 240 mg po QD (SR), R-Vera", "Formulations": [ { "Name": "Retard Tablet Verapamil (Knoll)", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Blume, Mutschler 1994, 240 mg po QD (SR), S-Vera", "Formulations": [ { "Name": "Retard Tablet Verapamil (Knoll)", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "Min": -4.608547, "Max": 159.393, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "Min": 13.03049, "Max": 294.3577, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "po_Verapamil 240 mg QD (SR), Blume, Mutschler 1994, n=24-R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 240 mg QD (SR), Blume, Mutschler 1994, n=24|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 5 } }, { "Name": "Blume, Mutschler 1994 - Verapamil - Verapamil - PO - 240 mg - Plasma - agg. (n=24)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Blume, Mutschler 1994 - Verapamil - Verapamil - PO - 240 mg - Plasma - agg. (n=24)|Time", "Y": "Blume, Mutschler 1994 - Verapamil - Verapamil - PO - 240 mg - Plasma - agg. (n=24)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "LegendIndex": 8, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 240 mg QD (SR), Blume, Mutschler 1994, n=24\n2022-01-18 15:32" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "iv_Verapamil 3 mg SD (5min), Mooy 1985, n=5", "Model": "4Comp", "ObservedData": [ "Mooy et al. 1985 - Normal volunteers, 3mg IV - Verapamil - IV - 3 mg - Plasma - agg. (n=5)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 12.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Mooy 1985, Verapamil 3mg iv (5min) SD, R-Vera|Application_1|ProtocolSchemaItem|Infusion time", "Value": 5.0, "Unit": "min" }, { "Path": "Applications|Mooy 1985, Verapamil 3mg iv (5min) SD, S-Vera|Application_1|ProtocolSchemaItem|Infusion time", "Value": 5.0, "Unit": "min" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "iv_Verapamil 3 mg SD (5min), Mooy 1985, n=5|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Mooy et al. 1985 - Normal volunteers, 3mg IV - Verapamil - IV - 3 mg - Plasma - agg. (n=5)" } ], "Individual": "Mooy 1985, n=5", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Mooy 1985, Verapamil 3mg iv (5min) SD, R-Vera" } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Mooy 1985, Verapamil 3mg iv (5min) SD, S-Vera" } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "iv_Verapamil 3 mg SD (5min), Mooy 1985, n=5|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "iv_Verapamil 3 mg SD (5min), Mooy 1985, n=5|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Mooy et al. 1985 - Normal volunteers, 3mg IV - Verapamil - IV - 3 mg - Plasma - agg. (n=5)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Mooy et al. 1985 - Normal volunteers, 3mg IV - Verapamil - IV - 3 mg - Plasma - agg. (n=5)|Time", "Y": "Mooy et al. 1985 - Normal volunteers, 3mg IV - Verapamil - IV - 3 mg - Plasma - agg. (n=5)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 18, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\niv_Verapamil 3 mg SD (5min), Mooy 1985, n=5\n2022-01-18 17:45" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 80 mg SD, Mooy 1985, n=6", "Model": "4Comp", "ObservedData": [ "Mooy et al. 1985 - Normal volunteers, 80mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=6)", "Mooy et al. 1985 - Normal volunteers, 80mg PO - Norverapamil - PO - 80 mg - Plasma - agg. (n=6)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 12.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Mooy 1985, Verapamil 80mg po SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Mooy 1985, Verapamil 80mg po SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 80 mg SD, Mooy 1985, n=6|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Mooy et al. 1985 - Normal volunteers, 80mg PO - Norverapamil - PO - 80 mg - Plasma - agg. (n=6)" }, { "Scaling": "Log", "Path": "po_Verapamil 80 mg SD, Mooy 1985, n=6|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Mooy et al. 1985 - Normal volunteers, 80mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=6)" } ], "Individual": "Mooy 1985, n=5", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Mooy 1985, Verapamil 80mg po SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Mooy 1985, Verapamil 80mg po SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 80 mg SD, Mooy 1985, n=6|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 80 mg SD, Mooy 1985, n=6|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Mooy et al. 1985 - Normal volunteers, 80mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=6)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Mooy et al. 1985 - Normal volunteers, 80mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=6)|Time", "Y": "Mooy et al. 1985 - Normal volunteers, 80mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 18, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Mooy et al. 1985 - Normal volunteers, 80mg PO - Norverapamil - PO - 80 mg - Plasma - agg. (n=6)-Norverapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Mooy et al. 1985 - Normal volunteers, 80mg PO - Norverapamil - PO - 80 mg - Plasma - agg. (n=6)|Time", "Y": "Mooy et al. 1985 - Normal volunteers, 80mg PO - Norverapamil - PO - 80 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean", "CurveOptions": { "Color": "#008000", "LegendIndex": 17, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 80 mg SD, Mooy 1985, n=6\n2022-01-18 17:48" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "iv_Verapamil 5 mg SD (5min), Streit 2005, n=10", "Model": "4Comp", "ObservedData": [ "Streit 2005 - intravenous verapamil during normoxia (5 mg) - Verapamil - IV - 5 mg - Plasma - agg. (n=10)", "Streit et al. 2005 - intravenous verapamil during normoxia (5 mg) - Norverapamil - IV - 5 mg - Plasma - agg. (n=10)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 20.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 14.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Applications|Streit 2005, Verapamil 5mg iv (10min) SD, R-Vera|Application_1|ProtocolSchemaItem|Infusion time", "Value": 10.0, "Unit": "min" }, { "Path": "Applications|Streit 2005, Verapamil 5mg iv (10min) SD, S-Vera|Application_1|ProtocolSchemaItem|Infusion time", "Value": 10.0, "Unit": "min" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "iv_Verapamil 5 mg SD (5min), Streit 2005, n=10|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Streit 2005 - intravenous verapamil during normoxia (5 mg) - Verapamil - IV - 5 mg - Plasma - agg. (n=10)" }, { "Scaling": "Log", "Path": "iv_Verapamil 5 mg SD (5min), Streit 2005, n=10|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Streit et al. 2005 - intravenous verapamil during normoxia (5 mg) - Norverapamil - IV - 5 mg - Plasma - agg. (n=10)" } ], "Individual": "Streit 2005, n=10", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Streit 2005, Verapamil 5mg iv (10min) SD, R-Vera" } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Streit 2005, Verapamil 5mg iv (10min) SD, S-Vera" } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "iv_Verapamil 5 mg SD (5min), Streit 2005, n=10|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "iv_Verapamil 5 mg SD (5min), Streit 2005, n=10|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Streit 2005 - intravenous verapamil during normoxia (5 mg) - Verapamil - IV - 5 mg - Plasma - agg. (n=10)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Streit 2005 - intravenous verapamil during normoxia (5 mg) - Verapamil - IV - 5 mg - Plasma - agg. (n=10)|Time", "Y": "Streit 2005 - intravenous verapamil during normoxia (5 mg) - Verapamil - IV - 5 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 17, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Streit et al. 2005 - intravenous verapamil during normoxia (5 mg) - Norverapamil - IV - 5 mg - Plasma - agg. (n=10)-Norverapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Streit et al. 2005 - intravenous verapamil during normoxia (5 mg) - Norverapamil - IV - 5 mg - Plasma - agg. (n=10)|Time", "Y": "Streit et al. 2005 - intravenous verapamil during normoxia (5 mg) - Norverapamil - IV - 5 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean", "CurveOptions": { "Color": "#008000", "LegendIndex": 18, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\niv_Verapamil 5 mg SD (5min), Streit 2005, n=10\n2022-01-18 18:10" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "iv_Verapamil 0.1 mg/kg SD (5min), Johnston 1981, n=6", "Model": "4Comp", "ObservedData": [ "Johnston 1981 - Verapamil IV - Verapamil - IV - 0.1 mg/kg - Plasma - agg. (n=6)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 12.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Johnston 1981, Verapamil 0.1mg/kg iv (5min) SD, R-Vera|Application_1|ProtocolSchemaItem|Infusion time", "Value": 5.0, "Unit": "min" }, { "Path": "Applications|Johnston 1981, Verapamil 0.1mg/kg iv (5min) SD, S-Vera|Application_1|ProtocolSchemaItem|Infusion time", "Value": 5.0, "Unit": "min" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "iv_Verapamil 0.1 mg/kg SD (5min), Johnston 1981, n=6|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Johnston 1981 - Verapamil IV - Verapamil - IV - 0.1 mg/kg - Plasma - agg. (n=6)" } ], "Individual": "Johnston 1981, n=6", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Johnston 1981, Verapamil 0.1mg/kg iv (5min) SD, R-Vera" } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Johnston 1981, Verapamil 0.1mg/kg iv (5min) SD, S-Vera" } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "Min": -0.2207407, "Max": 4.791111, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "Min": 3.441529, "Max": 110.7411, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "iv_Verapamil 0.1 mg/kg SD (5min), Johnston 1981, n=6|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "iv_Verapamil 0.1 mg/kg SD (5min), Johnston 1981, n=6|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Johnston 1981 - Verapamil IV - Verapamil - IV - 0.1 mg/kg - Plasma - agg. (n=6)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Johnston 1981 - Verapamil IV - Verapamil - IV - 0.1 mg/kg - Plasma - agg. (n=6)|Time", "Y": "Johnston 1981 - Verapamil IV - Verapamil - IV - 0.1 mg/kg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "LegendIndex": 18, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\niv_Verapamil 0.1 mg/kg SD (5min), Johnston 1981, n=6\n2022-01-18 17:00" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 120 mg SD, Johnston 1981, n=6", "Model": "4Comp", "ObservedData": [ "Johnston 1981 - Verapamil PO - Verapamil - PO - 120 mg - Plasma - agg. (n=6)", "Johnston 1981 - Verapamil PO - Norverapamil - PO - 120 mg - Plasma - agg. (n=6)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 12.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Johnston 1981, Verapamil 120mg po SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Johnston 1981, Verapamil 120mg po SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 120 mg SD, Johnston 1981, n=6|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Johnston 1981 - Verapamil PO - Norverapamil - PO - 120 mg - Plasma - agg. (n=6)" }, { "Scaling": "Log", "Path": "po_Verapamil 120 mg SD, Johnston 1981, n=6|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Johnston 1981 - Verapamil PO - Verapamil - PO - 120 mg - Plasma - agg. (n=6)" } ], "Individual": "Johnston 1981, n=6", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Johnston 1981, Verapamil 120mg po SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Johnston 1981, Verapamil 120mg po SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg SD, Johnston 1981, n=6|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg SD, Johnston 1981, n=6|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Johnston 1981 - Verapamil PO - Verapamil - PO - 120 mg - Plasma - agg. (n=6)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Johnston 1981 - Verapamil PO - Verapamil - PO - 120 mg - Plasma - agg. (n=6)|Time", "Y": "Johnston 1981 - Verapamil PO - Verapamil - PO - 120 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 18, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Johnston 1981 - Verapamil PO - Norverapamil - PO - 120 mg - Plasma - agg. (n=6)-Norverapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Johnston 1981 - Verapamil PO - Norverapamil - PO - 120 mg - Plasma - agg. (n=6)|Time", "Y": "Johnston 1981 - Verapamil PO - Norverapamil - PO - 120 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean", "CurveOptions": { "Color": "#008000", "LegendIndex": 17, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 120 mg SD, Johnston 1981, n=6\n2022-01-18 17:33" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "iv_Verapamil 10mg SD (10min), Abernethy 1985, n=1", "Model": "4Comp", "ObservedData": [ "Abernethy et al. 1985 - 10mg Verapamil without cimetidine, IV - Verapamil - IV - 10 mg - Plasma - indiv." ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 24.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Abernethy 1985, Verapamil 10mg iv (10min) SD, R-Vera|Application_1|ProtocolSchemaItem|Infusion time", "Value": 10.0, "Unit": "min" }, { "Path": "Applications|Abernethy 1985, Verapamil 10mg iv (10min) SD, S-Vera|Application_1|ProtocolSchemaItem|Infusion time", "Value": 10.0, "Unit": "min" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "iv_Verapamil 10mg SD (10min), Abernethy 1985, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Abernethy et al. 1985 - 10mg Verapamil without cimetidine, IV - Verapamil - IV - 10 mg - Plasma - indiv." } ], "Individual": "Abernethy 1985, n=1", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Abernethy 1985, Verapamil 10mg iv (10min) SD, R-Vera" } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Abernethy 1985, Verapamil 10mg iv (10min) SD, S-Vera" } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "iv_Verapamil 10mg SD (10min), Abernethy 1985, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 9 } }, { "Name": "Abernethy et al. 1985 - 10mg Verapamil without cimetidine, IV - Verapamil - IV - 10 mg - Plasma - indiv.-Verapamil-Peripheral Venous Blood-Plasma-Individual", "X": "Abernethy et al. 1985 - 10mg Verapamil without cimetidine, IV - Verapamil - IV - 10 mg - Plasma - indiv.|Time", "Y": "Abernethy et al. 1985 - 10mg Verapamil without cimetidine, IV - Verapamil - IV - 10 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|Individual", "CurveOptions": { "LegendIndex": 16, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\niv_Verapamil 10mg SD (10min), Abernethy 1985, n=1\n2022-01-18 15:53" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 120mg SD, Abernethy 1985, n=1", "Model": "4Comp", "ObservedData": [ "Abernethy et al. 1985 - 120mg Verapamil without cimetidine, PO - Verapamil - PO - 120 mg - Plasma - indiv." ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 28.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Abernethy 1985, Verapamil 120mg po SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Abernethy 1985, Verapamil 120mg po SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 120mg SD, Abernethy 1985, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Abernethy et al. 1985 - 120mg Verapamil without cimetidine, PO - Verapamil - PO - 120 mg - Plasma - indiv." } ], "Individual": "Abernethy 1985, n=1", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Abernethy 1985, Verapamil 120mg po SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Abernethy 1985, Verapamil 120mg po SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 120mg SD, Abernethy 1985, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 9 } }, { "Name": "Abernethy et al. 1985 - 120mg Verapamil without cimetidine, PO - Verapamil - PO - 120 mg - Plasma - indiv.-Verapamil-Peripheral Venous Blood-Plasma-Individual", "X": "Abernethy et al. 1985 - 120mg Verapamil without cimetidine, PO - Verapamil - PO - 120 mg - Plasma - indiv.|Time", "Y": "Abernethy et al. 1985 - 120mg Verapamil without cimetidine, PO - Verapamil - PO - 120 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|Individual", "CurveOptions": { "LegendIndex": 11, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 120mg SD, Abernethy 1985, n=1\n2022-01-18 15:50" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "iv_Verapamil 10mg SD (10min), Barbarash 1988, n=6", "Model": "4Comp", "ObservedData": [ "Barbarash 1988 - Verapamil IV control - Verapamil - IV - 10 mg - Serum - agg. (n=6)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 24.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Barbarash 1988, Verapamil 10mg iv (10min) SD, R-Vera|Application_1|ProtocolSchemaItem|Infusion time", "Value": 10.0, "Unit": "min" }, { "Path": "Applications|Barbarash 1988, Verapamil 10mg iv (10min) SD, S-Vera|Application_1|ProtocolSchemaItem|Infusion time", "Value": 10.0, "Unit": "min" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "iv_Verapamil 10mg SD (10min), Barbarash 1988, n=6|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Barbarash 1988 - Verapamil IV control - Verapamil - IV - 10 mg - Serum - agg. (n=6)" } ], "Individual": "Barbarash 1988, n=6", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Barbarash 1988, Verapamil 10mg iv (10min) SD, R-Vera" } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Barbarash 1988, Verapamil 10mg iv (10min) SD, S-Vera" } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "iv_Verapamil 10mg SD (10min), Barbarash 1988, n=6|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 9 } }, { "Name": "Barbarash 1988 - Verapamil IV control - Verapamil - IV - 10 mg - Serum - agg. (n=6)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Barbarash 1988 - Verapamil IV control - Verapamil - IV - 10 mg - Serum - agg. (n=6)|Time", "Y": "Barbarash 1988 - Verapamil IV control - Verapamil - IV - 10 mg - Serum - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "LegendIndex": 11, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\niv_Verapamil 10mg SD (10min), Barbarash 1988, n=6\n2022-01-18 15:40" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 120 mg SD, Barbarash 1988, n=6", "Model": "4Comp", "ObservedData": [ "Barbarash 1988 - Verapamil PO control - Verapamil - PO - 120 mg - Serum - agg. (n=6)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 14.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Barbarash 1988, Verapamil 120mg po SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Barbarash 1988, Verapamil 120mg po SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 120 mg SD, Barbarash 1988, n=6|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Barbarash 1988 - Verapamil PO control - Verapamil - PO - 120 mg - Serum - agg. (n=6)" } ], "Individual": "Barbarash 1988, n=6", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Barbarash 1988, Verapamil 120mg po SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Barbarash 1988, Verapamil 120mg po SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg SD, Barbarash 1988, n=6|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg SD, Barbarash 1988, n=6|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Barbarash 1988 - Verapamil PO control - Verapamil - PO - 120 mg - Serum - agg. (n=6)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Barbarash 1988 - Verapamil PO control - Verapamil - PO - 120 mg - Serum - agg. (n=6)|Time", "Y": "Barbarash 1988 - Verapamil PO control - Verapamil - PO - 120 mg - Serum - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 16, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 120 mg SD, Barbarash 1988, n=6\n2024-08-19 19:05" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "iv_Verapamil 10mg SD (5min), McAllister, Kirsten 1982, n=20", "Model": "4Comp", "ObservedData": [ "McAllister 1982 - Verapamil 10 mg IV - Verapamil - IV - 10 mg - Plasma - agg. (n=20)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 24.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|McAllister, Kirsten 1982, Verapamil 10mg iv (5min) SD, R-Vera|Application_1|ProtocolSchemaItem|Infusion time", "Value": 5.0, "Unit": "min" }, { "Path": "Applications|McAllister, Kirsten 1982, Verapamil 10mg iv (5min) SD, S-Vera|Application_1|ProtocolSchemaItem|Infusion time", "Value": 5.0, "Unit": "min" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "iv_Verapamil 10mg SD (5min), McAllister, Kirsten 1982, n=20|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "McAllister 1982 - Verapamil 10 mg IV - Verapamil - IV - 10 mg - Plasma - agg. (n=20)" } ], "Individual": "McAllister, Kirsten 1982, n=20", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "McAllister, Kirsten 1982, Verapamil 10mg iv (5min) SD, R-Vera" } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "McAllister, Kirsten 1982, Verapamil 10mg iv (5min) SD, S-Vera" } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "iv_Verapamil 10mg SD (5min), McAllister, Kirsten 1982, n=20|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 9 } }, { "Name": "McAllister 1982 - Verapamil 10 mg IV - Verapamil - IV - 10 mg - Plasma - agg. (n=20)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "McAllister 1982 - Verapamil 10 mg IV - Verapamil - IV - 10 mg - Plasma - agg. (n=20)|Time", "Y": "McAllister 1982 - Verapamil 10 mg IV - Verapamil - IV - 10 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "LegendIndex": 11, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\niv_Verapamil 10mg SD (5min), McAllister, Kirsten 1982, n=20\n2022-01-07 18:32" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "iv_Verapamil 13.1 mg SD (13min), Freedman 1981, n=1", "Model": "4Comp", "ObservedData": [ "Freedman et al. 1981 - Control Subject (Subject number 4) - Verapamil - IV - 13.1 mg - Plasma - indiv." ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 20.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 14.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Applications|Freedman 1981, Verapamil 13.1mg iv (13min) SD, R-Vera|Application_1|ProtocolSchemaItem|Infusion time", "Value": 13.0, "Unit": "min" }, { "Path": "Applications|Freedman 1981, Verapamil 13.1mg iv (13min) SD, S-Vera|Application_1|ProtocolSchemaItem|Infusion time", "Value": 13.0, "Unit": "min" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "iv_Verapamil 13.1 mg SD (13min), Freedman 1981, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Freedman et al. 1981 - Control Subject (Subject number 4) - Verapamil - IV - 13.1 mg - Plasma - indiv." } ], "Individual": "Freedman 1981, n=1", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Freedman 1981, Verapamil 13.1mg iv (13min) SD, R-Vera" } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Freedman 1981, Verapamil 13.1mg iv (13min) SD, S-Vera" } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "iv_Verapamil 13.1 mg SD (13min), Freedman 1981, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "iv_Verapamil 13.1 mg SD (13min), Freedman 1981, n=1|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Freedman et al. 1981 - Control Subject (Subject number 4) - Verapamil - IV - 13.1 mg - Plasma - indiv.-Verapamil-Peripheral Venous Blood-Plasma-Individual", "X": "Freedman et al. 1981 - Control Subject (Subject number 4) - Verapamil - IV - 13.1 mg - Plasma - indiv.|Time", "Y": "Freedman et al. 1981 - Control Subject (Subject number 4) - Verapamil - IV - 13.1 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|Individual", "CurveOptions": { "LegendIndex": 16, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\niv_Verapamil 13.1 mg SD (13min), Freedman 1981, n=1\n2022-01-11 18:31" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "iv_Verapamil 20mg SD (30min), Abernethy 1993, n=1", "Model": "4Comp", "ObservedData": [ "Abernethy et al. 1993 - Representative younger subject - R-Verapamil - IV - 20 mg - Plasma - indiv.", "Abernethy et al. 1993 - Representative younger subject - S-Verapamil - IV - 20 mg - Plasma - indiv.", "Abernethy et al. 1993 - Representative younger subject - Verapamil - IV - 20 mg - Plasma - indiv." ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 20.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 14.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Applications|Abernethy 1993, Verapamil 20mg iv (30min) SD, R-Vera|Application_1|ProtocolSchemaItem|Infusion time", "Value": 30.0, "Unit": "min" }, { "Path": "Applications|Abernethy 1993, Verapamil 20mg iv (30min) SD, S-Vera|Application_1|ProtocolSchemaItem|Infusion time", "Value": 30.0, "Unit": "min" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "iv_Verapamil 20mg SD (30min), Abernethy 1993, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Abernethy et al. 1993 - Representative younger subject - R-Verapamil - IV - 20 mg - Plasma - indiv." }, { "Scaling": "Log", "Path": "iv_Verapamil 20mg SD (30min), Abernethy 1993, n=1|Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Abernethy et al. 1993 - Representative younger subject - S-Verapamil - IV - 20 mg - Plasma - indiv." }, { "Scaling": "Log", "Path": "iv_Verapamil 20mg SD (30min), Abernethy 1993, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Abernethy et al. 1993 - Representative younger subject - Verapamil - IV - 20 mg - Plasma - indiv." } ], "Individual": "Abernethy 1993, n=1", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Abernethy 1993, Verapamil 20mg iv (30min) SD, R-Vera" } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Abernethy 1993, Verapamil 20mg iv (30min) SD, S-Vera" } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "iv_Verapamil 20mg SD (30min), Abernethy 1993, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9 } }, { "Name": "S-Verapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "iv_Verapamil 20mg SD (30min), Abernethy 1993, n=1|Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#008000", "LegendIndex": 16 } }, { "Name": "R-Verapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "iv_Verapamil 20mg SD (30min), Abernethy 1993, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 15 } }, { "Name": "Abernethy et al. 1993 - Representative younger subject - R-Verapamil - IV - 20 mg - Plasma - indiv.-R-Verapamil-Peripheral Venous Blood-Plasma-Individual", "X": "Abernethy et al. 1993 - Representative younger subject - R-Verapamil - IV - 20 mg - Plasma - indiv.|Time", "Y": "Abernethy et al. 1993 - Representative younger subject - R-Verapamil - IV - 20 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|Individual", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 20, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Abernethy et al. 1993 - Representative younger subject - S-Verapamil - IV - 20 mg - Plasma - indiv.-S-Verapamil-Peripheral Venous Blood-Plasma-Individual", "X": "Abernethy et al. 1993 - Representative younger subject - S-Verapamil - IV - 20 mg - Plasma - indiv.|Time", "Y": "Abernethy et al. 1993 - Representative younger subject - S-Verapamil - IV - 20 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|S-Verapamil|Individual", "CurveOptions": { "Color": "#008000", "LegendIndex": 21, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Abernethy et al. 1993 - Representative younger subject - Verapamil - IV - 20 mg - Plasma - indiv.-Verapamil-Peripheral Venous Blood-Plasma-Individual", "X": "Abernethy et al. 1993 - Representative younger subject - Verapamil - IV - 20 mg - Plasma - indiv.|Time", "Y": "Abernethy et al. 1993 - Representative younger subject - Verapamil - IV - 20 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|Individual", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 22, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\niv_Verapamil 20mg SD (30min), Abernethy 1993, n=1\n2022-01-12 15:14" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_R-Verapamil 250mg SD, Vogelgesang 1984, n=1", "Model": "4Comp", "ObservedData": [ "Vogelgesang et al. 1984 - Healthy volunteers - R-Verapamil - PO - 250 mg - Plasma - indiv." ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 36.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Vogelgesang 1984, R-Verapamil 250mg po SD|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_R-Verapamil 250mg SD, Vogelgesang 1984, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Vogelgesang et al. 1984 - Healthy volunteers - R-Verapamil - PO - 250 mg - Plasma - indiv." } ], "Individual": "Vogelgesang 1984, n=1", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Vogelgesang 1984, R-Verapamil 250mg po SD", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "µmol/l", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "po_R-Verapamil 250mg SD, Vogelgesang 1984, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 1 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "po_R-Verapamil 250mg SD, Vogelgesang 1984, n=1|Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#0000FF", "LegendIndex": 2 } }, { "Name": "Vogelgesang et al. 1984 - Healthy volunteers - R-Verapamil - PO - 250 mg - Plasma - indiv.-R-Verapamil-Peripheral Venous Blood-Plasma-Individual", "X": "Vogelgesang et al. 1984 - Healthy volunteers - R-Verapamil - PO - 250 mg - Plasma - indiv.|Time", "Y": "Vogelgesang et al. 1984 - Healthy volunteers - R-Verapamil - PO - 250 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|Individual", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 4, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_R-Verapamil 250mg SD, Vogelgesang 1984, n=1\n2022-01-12 16:52" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" } ] }, { "Name": "po_Verapamil 0.1 mg SD (sol), Maeda 2011, n=8", "Model": "4Comp", "ObservedData": [ "Maeda 2011 - Verapamil 0.1 mg - Norverapamil - Norverapamil - PO - 0.1 mg - Plasma - agg. (n=8)", "Maeda 2011 - Verapamil 0.1 mg - Verapamil - PO - 0.1 mg - Plasma - agg. (n=8)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 25.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "End time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 100.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Maeda 2011, Verapamil 0.1 mg po SD (sol), R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" }, { "Path": "Applications|Maeda 2011, Verapamil 0.1 mg po SD (sol), S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 0.1 mg SD (sol), Maeda 2011, n=8|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Maeda 2011 - Verapamil 0.1 mg - Norverapamil - Norverapamil - PO - 0.1 mg - Plasma - agg. (n=8)" }, { "Scaling": "Log", "Path": "po_Verapamil 0.1 mg SD (sol), Maeda 2011, n=8|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Maeda 2011 - Verapamil 0.1 mg - Verapamil - PO - 0.1 mg - Plasma - agg. (n=8)" } ], "Individual": "Maeda 2011, n=8", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Maeda 2011, Verapamil 0.1 mg po SD (sol), R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Maeda 2011, Verapamil 0.1 mg po SD (sol), S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "Min": -0.5144222, "Max": 16.44616, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "Min": 7.696127E-05, "Max": 0.1620699, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "po_Verapamil 0.1 mg SD (sol), Maeda 2011, n=8-R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 0.1 mg SD (sol), Maeda 2011, n=8|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#008000", "LegendIndex": 6 } }, { "Name": "po_Verapamil 0.1 mg SD (sol), Maeda 2011, n=8-R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 0.1 mg SD (sol), Maeda 2011, n=8|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 5 } }, { "Name": "Maeda 2011 - Verapamil 0.1 mg - Norverapamil - Norverapamil - PO - 0.1 mg - Plasma - agg. (n=8)-Norverapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Maeda 2011 - Verapamil 0.1 mg - Norverapamil - Norverapamil - PO - 0.1 mg - Plasma - agg. (n=8)|Time", "Y": "Maeda 2011 - Verapamil 0.1 mg - Norverapamil - Norverapamil - PO - 0.1 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean", "CurveOptions": { "Color": "#008000", "LegendIndex": 10, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Maeda 2011 - Verapamil 0.1 mg - Verapamil - PO - 0.1 mg - Plasma - agg. (n=8)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Maeda 2011 - Verapamil 0.1 mg - Verapamil - PO - 0.1 mg - Plasma - agg. (n=8)|Time", "Y": "Maeda 2011 - Verapamil 0.1 mg - Verapamil - PO - 0.1 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 11, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 0.1 mg SD (sol), Maeda 2011, n=8\n2022-01-12 17:47" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 3 mg SD (sol), Maeda 2011, n=8", "Model": "4Comp", "ObservedData": [ "Maeda 2011 - Verapamil 3 mg - Verapamil - PO - 3 mg - Plasma - agg. (n=8)", "Maeda 2011 - Verapamil 3 mg - Norverapamil - Norverapamil - PO - 3 mg - Plasma - agg. (n=8)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 25.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "End time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 100.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Maeda 2011, Verapamil 3 mg po SD (sol), R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" }, { "Path": "Applications|Maeda 2011, Verapamil 3 mg po SD (sol), S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 3 mg SD (sol), Maeda 2011, n=8|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Maeda 2011 - Verapamil 3 mg - Verapamil - PO - 3 mg - Plasma - agg. (n=8)" }, { "Scaling": "Log", "Path": "po_Verapamil 3 mg SD (sol), Maeda 2011, n=8|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Maeda 2011 - Verapamil 3 mg - Norverapamil - Norverapamil - PO - 3 mg - Plasma - agg. (n=8)" } ], "Individual": "Maeda 2011, n=8", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Maeda 2011, Verapamil 3 mg po SD (sol), R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Maeda 2011, Verapamil 3 mg po SD (sol), S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "Min": 0.0, "Max": 18.0, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "po_Verapamil 3 mg SD (sol), Maeda 2011, n=8-R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 3 mg SD (sol), Maeda 2011, n=8|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#008000", "LegendIndex": 6 } }, { "Name": "po_Verapamil 3 mg SD (sol), Maeda 2011, n=8-R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 3 mg SD (sol), Maeda 2011, n=8|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 5 } }, { "Name": "Maeda 2011 - Verapamil 3 mg - Verapamil - PO - 3 mg - Plasma - agg. (n=8)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Maeda 2011 - Verapamil 3 mg - Verapamil - PO - 3 mg - Plasma - agg. (n=8)|Time", "Y": "Maeda 2011 - Verapamil 3 mg - Verapamil - PO - 3 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 10, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Maeda 2011 - Verapamil 3 mg - Norverapamil - Norverapamil - PO - 3 mg - Plasma - agg. (n=8)-Norverapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Maeda 2011 - Verapamil 3 mg - Norverapamil - Norverapamil - PO - 3 mg - Plasma - agg. (n=8)|Time", "Y": "Maeda 2011 - Verapamil 3 mg - Norverapamil - Norverapamil - PO - 3 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean", "CurveOptions": { "Color": "#008000", "LegendIndex": 11, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 3 mg SD (sol), Maeda 2011, n=8\n2022-01-12 18:00" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 80 mg SD (sol), Maeda 2011, n=8", "Model": "4Comp", "ObservedData": [ "Maeda 2011 - Verapamil 80 mg - Verapamil - PO - 80 mg - Plasma - agg. (n=8)", "Maeda 2011 - Verapamil 80 mg - Norverapamil - Norverapamil - PO - 80 mg - Plasma - agg. (n=8)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 25.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "End time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 100.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Maeda 2011, Verapamil 80 mg po SD (sol), R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" }, { "Path": "Applications|Maeda 2011, Verapamil 80 mg po SD (sol), S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 80 mg SD (sol), Maeda 2011, n=8|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Maeda 2011 - Verapamil 80 mg - Verapamil - PO - 80 mg - Plasma - agg. (n=8)" }, { "Scaling": "Log", "Path": "po_Verapamil 80 mg SD (sol), Maeda 2011, n=8|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Maeda 2011 - Verapamil 80 mg - Norverapamil - Norverapamil - PO - 80 mg - Plasma - agg. (n=8)" } ], "Individual": "Maeda 2011, n=8", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Maeda 2011, Verapamil 80 mg po SD (sol), R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Maeda 2011, Verapamil 80 mg po SD (sol), S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "Min": 0.0, "Max": 18.0, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "po_Verapamil 80 mg SD (sol), Maeda 2011, n=8-R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 80 mg SD (sol), Maeda 2011, n=8|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#008000", "LegendIndex": 6 } }, { "Name": "po_Verapamil 80 mg SD (sol), Maeda 2011, n=8-R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 80 mg SD (sol), Maeda 2011, n=8|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 5 } }, { "Name": "Maeda 2011 - Verapamil 80 mg - Verapamil - PO - 80 mg - Plasma - agg. (n=8)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Maeda 2011 - Verapamil 80 mg - Verapamil - PO - 80 mg - Plasma - agg. (n=8)|Time", "Y": "Maeda 2011 - Verapamil 80 mg - Verapamil - PO - 80 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 10, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Maeda 2011 - Verapamil 80 mg - Norverapamil - Norverapamil - PO - 80 mg - Plasma - agg. (n=8)-Norverapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Maeda 2011 - Verapamil 80 mg - Norverapamil - Norverapamil - PO - 80 mg - Plasma - agg. (n=8)|Time", "Y": "Maeda 2011 - Verapamil 80 mg - Norverapamil - Norverapamil - PO - 80 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean", "CurveOptions": { "Color": "#008000", "LegendIndex": 11, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 80 mg SD (sol), Maeda 2011, n=8\n2022-01-12 18:03" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 40 mg SD, John 1992, n=6", "Model": "4Comp", "ObservedData": [ "John et al. 1992 - Healthy volunteers - Verapamil - PO - 40 mg - Plasma - agg. (n=6)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 12.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|John 1992, Verapamil 40mg po (tab) SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|John 1992, Verapamil 40mg po (tab) SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 40 mg SD, John 1992, n=6|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "John et al. 1992 - Healthy volunteers - Verapamil - PO - 40 mg - Plasma - agg. (n=6)" } ], "Individual": "John 1992, n=6", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "John 1992, Verapamil 40mg po (tab) SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "John 1992, Verapamil 40mg po (tab) SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 40 mg SD, John 1992, n=6|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 40 mg SD, John 1992, n=6|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#008000", "LegendIndex": 14 } }, { "Name": "John et al. 1992 - Healthy volunteers - Verapamil - PO - 40 mg - Plasma - agg. (n=6)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "John et al. 1992 - Healthy volunteers - Verapamil - PO - 40 mg - Plasma - agg. (n=6)|Time", "Y": "John et al. 1992 - Healthy volunteers - Verapamil - PO - 40 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 18, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 40 mg SD, John 1992, n=6\n2022-01-12 18:53" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 40 mg SD, Sawicki, Janicki 2002, n=12", "Model": "4Comp", "ObservedData": [ "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Norverapamil - PO - 40 mg - Plasma - agg. (n=12)", "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Verapamil - PO - 40 mg - Plasma - agg. (n=12)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 24.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Sawicki, Janicki 2002, Verapamil 40mg po (tab) SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Sawicki, Janicki 2002, Verapamil 40mg po (tab) SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 40 mg SD, Sawicki, Janicki 2002, n=12|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Norverapamil - PO - 40 mg - Plasma - agg. (n=12)" }, { "Scaling": "Log", "Path": "po_Verapamil 40 mg SD, Sawicki, Janicki 2002, n=12|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Verapamil - PO - 40 mg - Plasma - agg. (n=12)" } ], "Individual": "Sawicki, Janicki 2002, n=12", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Sawicki, Janicki 2002, Verapamil 40mg po (tab) SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Sawicki, Janicki 2002, Verapamil 40mg po (tab) SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 40 mg SD, Sawicki, Janicki 2002, n=12|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 40 mg SD, Sawicki, Janicki 2002, n=12|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Norverapamil - PO - 40 mg - Plasma - agg. (n=12)-Norverapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Norverapamil - PO - 40 mg - Plasma - agg. (n=12)|Time", "Y": "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Norverapamil - PO - 40 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean", "CurveOptions": { "Color": "#008000", "LegendIndex": 19, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Verapamil - PO - 40 mg - Plasma - agg. (n=12)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Verapamil - PO - 40 mg - Plasma - agg. (n=12)|Time", "Y": "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Verapamil - PO - 40 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 20, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 40 mg SD, Sawicki, Janicki 2002, n=12\n2022-01-12 19:21" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 60 mg SD, Choi 2008, n=12", "Model": "4Comp", "ObservedData": [ "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Verapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)", "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Norverapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 24.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Choi 2008, Verapamil 60 mg po (caps) SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Choi 2008, Verapamil 60 mg po (caps) SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 60 mg SD, Choi 2008, n=12|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Norverapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)" }, { "Scaling": "Log", "Path": "po_Verapamil 60 mg SD, Choi 2008, n=12|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Verapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)" } ], "Individual": "Choi 2008, n=12", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Choi 2008, Verapamil 60 mg po (caps) SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Choi 2008, Verapamil 60 mg po (caps) SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 60 mg SD, Choi 2008, n=12|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 60 mg SD, Choi 2008, n=12|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Verapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)-Verapamil-Arterial Blood-Plasma-ArithmeticMean", "X": "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Verapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)|Time", "Y": "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Verapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)|ObservedData|Arterial Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 17, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Norverapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)-Norverapamil-Arterial Blood-Plasma-ArithmeticMean", "X": "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Norverapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)|Time", "Y": "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Norverapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)|ObservedData|Arterial Blood|Plasma|Norverapamil|ArithmeticMean", "CurveOptions": { "Color": "#008000", "LegendIndex": 18, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 60 mg SD, Choi 2008, n=12\n2022-01-13 14:07" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 80 mg SD, Ratiopharm 1988, n=16", "Model": "4Comp", "ObservedData": [ "Ratiopharm 1988 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)", "Ratiopharm 1988 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 30.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Ratiopharm 1988, Verapamil 80mg po SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Ratiopharm 1988, Verapamil 80mg po SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 80 mg SD, Ratiopharm 1988, n=16|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Ratiopharm 1988 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)" }, { "Scaling": "Log", "Path": "po_Verapamil 80 mg SD, Ratiopharm 1988, n=16|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Ratiopharm 1988 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)" } ], "Individual": "Ratiopharm 1988, n=16", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Ratiopharm 1988, Verapamil 80mg po SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Ratiopharm 1988, Verapamil 80mg po SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 80 mg SD, Ratiopharm 1988, n=16|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 80 mg SD, Ratiopharm 1988, n=16|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Ratiopharm 1988 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Ratiopharm 1988 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)|Time", "Y": "Ratiopharm 1988 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 17, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Ratiopharm 1988 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)-Norverapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Ratiopharm 1988 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)|Time", "Y": "Ratiopharm 1988 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean", "CurveOptions": { "Color": "#008000", "LegendIndex": 18, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 80 mg SD, Ratiopharm 1988, n=16\n2022-01-13 15:33" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 80 mg (2 40mg tab) SD, Ratiopharm 1989, n=16", "Model": "4Comp", "ObservedData": [ "Ratiopharm 1989 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)", "Ratiopharm 1989 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 30.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Ratiopharm 1989, Verapamil 80mg (2 40mg tabs) po SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Ratiopharm 1989, Verapamil 80mg (2 40mg tabs) po SD, R-Vera|Solution|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Ratiopharm 1989, Verapamil 80mg (2 40mg tabs) po SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Ratiopharm 1989, Verapamil 80mg (2 40mg tabs) po SD, S-Vera|Solution|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 80 mg (2 40mg tab) SD, Ratiopharm 1989, n=16|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Ratiopharm 1989 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)" }, { "Scaling": "Log", "Path": "po_Verapamil 80 mg (2 40mg tab) SD, Ratiopharm 1989, n=16|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Ratiopharm 1989 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)" } ], "Individual": "Ratiopharm 1989, n=16", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Ratiopharm 1989, Verapamil 80mg (2 40mg tabs) po SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Ratiopharm 1989, Verapamil 80mg (2 40mg tabs) po SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 80 mg (2 40mg tab) SD, Ratiopharm 1989, n=16|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 80 mg (2 40mg tab) SD, Ratiopharm 1989, n=16|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Ratiopharm 1989 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)-Norverapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Ratiopharm 1989 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)|Time", "Y": "Ratiopharm 1989 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean", "CurveOptions": { "Color": "#008000", "LegendIndex": 17, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Ratiopharm 1989 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Ratiopharm 1989 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)|Time", "Y": "Ratiopharm 1989 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 18, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 80 mg (2 40mg tab) SD, Ratiopharm 1989, n=16\n2022-01-13 15:37" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 80 mg tid 7rep, Johnson 2001, n=12", "Model": "4Comp", "ObservedData": [ "Johnson 2001 - Verapamil Steady State - Verapamil - PO - 80 mg - Plasma - agg. (n=12)", "Johnson 2001 - Verapamil Steady State - Norverapamil - PO - 80 mg - Plasma - agg. (n=12)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 72.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Johnson 2001, Verapamil 80mg po tid 7rep, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Johnson 2001, Verapamil 80mg po tid 7rep, R-Vera|Solution|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Johnson 2001, Verapamil 80mg po tid 7rep, R-Vera|Solution|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Johnson 2001, Verapamil 80mg po tid 7rep, R-Vera|Solution|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Johnson 2001, Verapamil 80mg po tid 7rep, R-Vera|Solution|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Johnson 2001, Verapamil 80mg po tid 7rep, R-Vera|Solution|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Johnson 2001, Verapamil 80mg po tid 7rep, R-Vera|Solution|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Johnson 2001, Verapamil 80mg po tid 7rep, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Johnson 2001, Verapamil 80mg po tid 7rep, S-Vera|Solution|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Johnson 2001, Verapamil 80mg po tid 7rep, S-Vera|Solution|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Johnson 2001, Verapamil 80mg po tid 7rep, S-Vera|Solution|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Johnson 2001, Verapamil 80mg po tid 7rep, S-Vera|Solution|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Johnson 2001, Verapamil 80mg po tid 7rep, S-Vera|Solution|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Johnson 2001, Verapamil 80mg po tid 7rep, S-Vera|Solution|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 80 mg tid 7rep, Johnson 2001, n=12|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Johnson 2001 - Verapamil Steady State - Norverapamil - PO - 80 mg - Plasma - agg. (n=12)" }, { "Scaling": "Log", "Path": "po_Verapamil 80 mg tid 7rep, Johnson 2001, n=12|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Johnson 2001 - Verapamil Steady State - Verapamil - PO - 80 mg - Plasma - agg. (n=12)" } ], "Individual": "Johnson 2001, n=12", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Johnson 2001, Verapamil 80mg po tid 7rep, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Johnson 2001, Verapamil 80mg po tid 7rep, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 80 mg tid 7rep, Johnson 2001, n=12|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 80 mg tid 7rep, Johnson 2001, n=12|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Johnson 2001 - Verapamil Steady State - Verapamil - PO - 80 mg - Plasma - agg. (n=12)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Johnson 2001 - Verapamil Steady State - Verapamil - PO - 80 mg - Plasma - agg. (n=12)|Time", "Y": "Johnson 2001 - Verapamil Steady State - Verapamil - PO - 80 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 17, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Johnson 2001 - Verapamil Steady State - Norverapamil - PO - 80 mg - Plasma - agg. (n=12)-Norverapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Johnson 2001 - Verapamil Steady State - Norverapamil - PO - 80 mg - Plasma - agg. (n=12)|Time", "Y": "Johnson 2001 - Verapamil Steady State - Norverapamil - PO - 80 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean", "CurveOptions": { "Color": "#008000", "LegendIndex": 19, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 80 mg tid 7rep, Johnson 2001, n=12\n2022-01-13 17:36" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 120 mg (IR tab) SD, Boehringer 2018, n=12", "Model": "4Comp", "ObservedData": [ "Boehringer 2018 - Unknown - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)", "Boehringer 2018 - Unknown - R-Verapamil - PO - 120 mg - Plasma - agg. (n=12)", "Boehringer 2018 - Unknown - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)", "Boehringer 2018 - Unknown - S-Verapamil - PO - 120 mg - Plasma - agg. (n=12)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 30.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Boehringer 2018, Verapamil 120mg po (IR tab) SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Boehringer 2018, Verapamil 120mg po (IR tab) SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 120 mg (IR tab) SD, Boehringer 2018, n=12|Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Boehringer 2018 - Unknown - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)" }, { "Scaling": "Log", "Path": "po_Verapamil 120 mg (IR tab) SD, Boehringer 2018, n=12|Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Boehringer 2018 - Unknown - R-Verapamil - PO - 120 mg - Plasma - agg. (n=12)" }, { "Scaling": "Log", "Path": "po_Verapamil 120 mg (IR tab) SD, Boehringer 2018, n=12|Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Boehringer 2018 - Unknown - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)" }, { "Scaling": "Log", "Path": "po_Verapamil 120 mg (IR tab) SD, Boehringer 2018, n=12|Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Boehringer 2018 - Unknown - S-Verapamil - PO - 120 mg - Plasma - agg. (n=12)" } ], "Individual": "Boehringer 2018, n=12", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Boehringer 2018, Verapamil 120mg po (IR tab) SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Boehringer 2018, Verapamil 120mg po (IR tab) SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "µmol/l", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "S-Norverapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg (IR tab) SD, Boehringer 2018, n=12|Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#4BACC6", "LegendIndex": 4 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg (IR tab) SD, Boehringer 2018, n=12|Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 2 } }, { "Name": "R-Verapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg (IR tab) SD, Boehringer 2018, n=12|Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 1 } }, { "Name": "S-Verapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg (IR tab) SD, Boehringer 2018, n=12|Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#008000", "LegendIndex": 3 } }, { "Name": "Boehringer 2018 - Unknown - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)-R-Norverapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Boehringer 2018 - Unknown - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)|Time", "Y": "Boehringer 2018 - Unknown - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|R-Norverapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Boehringer 2018 - Unknown - R-Verapamil - PO - 120 mg - Plasma - agg. (n=12)-R-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Boehringer 2018 - Unknown - R-Verapamil - PO - 120 mg - Plasma - agg. (n=12)|Time", "Y": "Boehringer 2018 - Unknown - R-Verapamil - PO - 120 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 10, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Boehringer 2018 - Unknown - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)-S-Norverapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Boehringer 2018 - Unknown - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)|Time", "Y": "Boehringer 2018 - Unknown - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|S-Norverapamil|ArithmeticMean", "CurveOptions": { "Color": "#4BACC6", "LegendIndex": 11, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Boehringer 2018 - Unknown - S-Verapamil - PO - 120 mg - Plasma - agg. (n=12)-S-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Boehringer 2018 - Unknown - S-Verapamil - PO - 120 mg - Plasma - agg. (n=12)|Time", "Y": "Boehringer 2018 - Unknown - S-Verapamil - PO - 120 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|S-Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#008000", "LegendIndex": 12, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 120 mg (IR tab) SD, Boehringer 2018, n=12\n2022-01-13 18:23" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 120 mg (IR) bid 3days, Haertter 2012, n=20", "Model": "4Comp", "ObservedData": [ "Härtter et al. 2012 - 120mg po bid - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)", "Härtter et al. 2012 - 120mg po bid - R-Verapamil - PO - 120 mg - Plasma - agg. (n=20)", "Härtter et al. 2012 - 120mg po bid - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)", "Härtter et al. 2012 - 120mg po bid - S-Verapamil - PO - 120 mg - Plasma - agg. (n=20)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 84.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "End time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 100.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Härtter 2012, Verapamil 120 mg bid, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Härtter 2012, Verapamil 120 mg bid, R-Vera|Solution|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Härtter 2012, Verapamil 120 mg bid, R-Vera|Solution|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Härtter 2012, Verapamil 120 mg bid, R-Vera|Solution|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Härtter 2012, Verapamil 120 mg bid, R-Vera|Solution|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Härtter 2012, Verapamil 120 mg bid, R-Vera|Solution|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Härtter 2012, Verapamil 120 mg bid, R-Vera|Solution|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Härtter 2012, Verapamil 120 mg bid, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Härtter 2012, Verapamil 120 mg bid, S-Vera|Solution|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Härtter 2012, Verapamil 120 mg bid, S-Vera|Solution|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Härtter 2012, Verapamil 120 mg bid, S-Vera|Solution|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Härtter 2012, Verapamil 120 mg bid, S-Vera|Solution|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Härtter 2012, Verapamil 120 mg bid, S-Vera|Solution|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Härtter 2012, Verapamil 120 mg bid, S-Vera|Solution|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil|Fraction excreted to urine", "Organism|Kidney|Urine|S-Verapamil|Fraction excreted to urine", "Organism|Lumen|Feces|R-Verapamil|Fraction excreted to feces", "Organism|Lumen|Feces|S-Verapamil|Fraction excreted to feces" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 120 mg (IR) bid 3days, Härtter 2012, n=20|Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Härtter et al. 2012 - 120mg po bid - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)" }, { "Scaling": "Log", "Path": "po_Verapamil 120 mg (IR) bid 3days, Härtter 2012, n=20|Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Härtter et al. 2012 - 120mg po bid - R-Verapamil - PO - 120 mg - Plasma - agg. (n=20)" }, { "Scaling": "Log", "Path": "po_Verapamil 120 mg (IR) bid 3days, Härtter 2012, n=20|Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Härtter et al. 2012 - 120mg po bid - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)" }, { "Scaling": "Log", "Path": "po_Verapamil 120 mg (IR) bid 3days, Härtter 2012, n=20|Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Härtter et al. 2012 - 120mg po bid - S-Verapamil - PO - 120 mg - Plasma - agg. (n=20)" } ], "Individual": "Härtter 2012 MD, n=20", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Härtter 2012, Verapamil 120 mg bid, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Härtter 2012, Verapamil 120 mg bid, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "Min": 43.9881, "Max": 79.02281, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "Min": 0.04790001, "Max": 817.8182, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "po_Verapamil 120 mg (IR) bid 3days, Haertter 2012, n=20-R-Verapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg (IR) bid 3days, Haertter 2012, n=20|Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#FF8000", "LegendIndex": 1 } }, { "Name": "po_Verapamil 120 mg (IR) bid 3days, Haertter 2012, n=20-R-Norverapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg (IR) bid 3days, Haertter 2012, n=20|Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#ECD33A", "LegendIndex": 5 } }, { "Name": "po_Verapamil 120 mg (IR) bid 3days, Haertter 2012, n=20-S-Verapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg (IR) bid 3days, Haertter 2012, n=20|Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#76923C", "LegendIndex": 7 } }, { "Name": "po_Verapamil 120 mg (IR) bid 3days, Haertter 2012, n=20-S-Norverapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg (IR) bid 3days, Haertter 2012, n=20|Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000C0", "LegendIndex": 8 } }, { "Name": "Härtter et al. 2012 - 120mg po bid - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)-R-Norverapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Härtter et al. 2012 - 120mg po bid - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)|Time", "Y": "Härtter et al. 2012 - 120mg po bid - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|R-Norverapamil|ArithmeticMean", "CurveOptions": { "Color": "#ECD33A", "LegendIndex": 13, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Härtter et al. 2012 - 120mg po bid - R-Verapamil - PO - 120 mg - Plasma - agg. (n=20)-R-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Härtter et al. 2012 - 120mg po bid - R-Verapamil - PO - 120 mg - Plasma - agg. (n=20)|Time", "Y": "Härtter et al. 2012 - 120mg po bid - R-Verapamil - PO - 120 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#FF8000", "LegendIndex": 14, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Härtter et al. 2012 - 120mg po bid - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)-S-Norverapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Härtter et al. 2012 - 120mg po bid - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)|Time", "Y": "Härtter et al. 2012 - 120mg po bid - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|S-Norverapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000C0", "LegendIndex": 15, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Härtter et al. 2012 - 120mg po bid - S-Verapamil - PO - 120 mg - Plasma - agg. (n=20)-S-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Härtter et al. 2012 - 120mg po bid - S-Verapamil - PO - 120 mg - Plasma - agg. (n=20)|Time", "Y": "Härtter et al. 2012 - 120mg po bid - S-Verapamil - PO - 120 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|S-Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#76923C", "LegendIndex": 16, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 120 mg (IR) bid 3days, Härtter 2012, n=20\n2022-01-14 13:42" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 120 mg SD, Hla 1987, n=10", "Model": "4Comp", "ObservedData": [ "Hla 1987 - conventional Verapamil 120mg once daily (day 1) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 24.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "End time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 100.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 120 mg SD, Hla 1987, n=10|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Hla 1987 - conventional Verapamil 120mg once daily (day 1) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)" } ], "Individual": "Hla 1987, n=10", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Hla 1987, Verapamil 120mg po (tab) SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Hla 1987, Verapamil 120mg po (tab) SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "Min": -0.7847412, "Max": 24.71063, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "Min": 0.02978219, "Max": 286.7691, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "po_Verapamil 120 mg SD, Hla 1987, n=10-R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg SD, Hla 1987, n=10|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 1 } }, { "Name": "Hla 1987 - conventional Verapamil 120mg once daily (day 1) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Hla 1987 - conventional Verapamil 120mg once daily (day 1) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)|Time", "Y": "Hla 1987 - conventional Verapamil 120mg once daily (day 1) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "LegendIndex": 3, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 120 mg SD, Hla 1987, n=10\n2022-01-14 14:01" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 120 mg MD, Hla 1987, n=10", "Model": "4Comp", "ObservedData": [ "Hla 1987 - conventional Verapamil 120mg twice daily (day 10) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 250.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "End time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 100.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, R-Vera|Solution|Application_10|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, R-Vera|Solution|Application_11|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, R-Vera|Solution|Application_12|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, R-Vera|Solution|Application_13|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, R-Vera|Solution|Application_14|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, R-Vera|Solution|Application_15|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, R-Vera|Solution|Application_16|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, R-Vera|Solution|Application_17|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, R-Vera|Solution|Application_18|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, R-Vera|Solution|Application_19|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, R-Vera|Solution|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, R-Vera|Solution|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, R-Vera|Solution|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, R-Vera|Solution|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, R-Vera|Solution|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, R-Vera|Solution|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, R-Vera|Solution|Application_8|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, R-Vera|Solution|Application_9|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, S-Vera|Solution|Application_10|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, S-Vera|Solution|Application_11|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, S-Vera|Solution|Application_12|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, S-Vera|Solution|Application_13|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, S-Vera|Solution|Application_14|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, S-Vera|Solution|Application_15|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, S-Vera|Solution|Application_16|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, S-Vera|Solution|Application_17|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, S-Vera|Solution|Application_18|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, S-Vera|Solution|Application_19|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, S-Vera|Solution|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, S-Vera|Solution|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, S-Vera|Solution|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, S-Vera|Solution|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, S-Vera|Solution|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, S-Vera|Solution|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, S-Vera|Solution|Application_8|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Hla 1987, Verapamil 120mg po (tab) MD, S-Vera|Solution|Application_9|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 120 mg MD, Hla 1987, n=10|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Hla 1987 - conventional Verapamil 120mg twice daily (day 10) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)" } ], "Individual": "Hla 1987, n=10", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Hla 1987, Verapamil 120mg po (tab) MD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Hla 1987, Verapamil 120mg po (tab) MD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "Min": -6.980024, "Max": 268.7246, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "Min": 7.966473, "Max": 291.7579, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "po_Verapamil 120 mg MD, Hla 1987, n=10-R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg MD, Hla 1987, n=10|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 1 } }, { "Name": "Hla 1987 - conventional Verapamil 120mg twice daily (day 10) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Hla 1987 - conventional Verapamil 120mg twice daily (day 10) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)|Time", "Y": "Hla 1987 - conventional Verapamil 120mg twice daily (day 10) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "LegendIndex": 3, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 120 mg MD, Hla 1987, n=10\n2022-01-14 18:30" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 180mg PO BID 3days,van Haarst 2009, n=10", "Model": "4Comp", "ObservedData": [ "van Haarst et al. 2009 - Verapamil only - Norverapamil - PO - 180 mg - Plasma - agg. (n=10)", "van Haarst et al. 2009 - Verapamil only - Verapamil - PO - 180 mg - Plasma - agg. (n=10)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 12.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 12.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 84.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Applications|van Haarst 2009, Verapamil 180mg PO BID 3days, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|van Haarst 2009, Verapamil 180mg PO BID 3days, R-Vera|Solution|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|van Haarst 2009, Verapamil 180mg PO BID 3days, R-Vera|Solution|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|van Haarst 2009, Verapamil 180mg PO BID 3days, R-Vera|Solution|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|van Haarst 2009, Verapamil 180mg PO BID 3days, R-Vera|Solution|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|van Haarst 2009, Verapamil 180mg PO BID 3days, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|van Haarst 2009, Verapamil 180mg PO BID 3days, S-Vera|Solution|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|van Haarst 2009, Verapamil 180mg PO BID 3days, S-Vera|Solution|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|van Haarst 2009, Verapamil 180mg PO BID 3days, S-Vera|Solution|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|van Haarst 2009, Verapamil 180mg PO BID 3days, S-Vera|Solution|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 180mg PO BID 3days,van Haarst 2009, n=10|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "ObservedData": "van Haarst et al. 2009 - Verapamil only - Norverapamil - PO - 180 mg - Plasma - agg. (n=10)" }, { "Scaling": "Log", "Path": "po_Verapamil 180mg PO BID 3days,van Haarst 2009, n=10|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "van Haarst et al. 2009 - Verapamil only - Verapamil - PO - 180 mg - Plasma - agg. (n=10)" } ], "Individual": "van Haarst 2009, n=10", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "van Haarst 2009, Verapamil 180mg PO BID 3days, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "van Haarst 2009, Verapamil 180mg PO BID 3days, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "Min": 41.0736, "Max": 86.4388, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "Min": 1.412678, "Max": 457.3296, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "Min": 0.003650297, "Max": 1.207099, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 180mg PO BID 3days,van Haarst 2009, n=10|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 180mg PO BID 3days,van Haarst 2009, n=10|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#008000", "LegendIndex": 14 } }, { "Name": "van Haarst et al. 2009 - Verapamil only - Norverapamil - PO - 180 mg - Plasma - agg. (n=10)-Norverapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "van Haarst et al. 2009 - Verapamil only - Norverapamil - PO - 180 mg - Plasma - agg. (n=10)|Time", "Y": "van Haarst et al. 2009 - Verapamil only - Norverapamil - PO - 180 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean", "CurveOptions": { "Color": "#008000", "LegendIndex": 17, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "van Haarst et al. 2009 - Verapamil only - Verapamil - PO - 180 mg - Plasma - agg. (n=10)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "van Haarst et al. 2009 - Verapamil only - Verapamil - PO - 180 mg - Plasma - agg. (n=10)|Time", "Y": "van Haarst et al. 2009 - Verapamil only - Verapamil - PO - 180 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 18, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 180mg PO BID 3days,van Haarst 2009, n=10\n2022-01-17 17:06" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 80 mg SD, Blume, Mutschler 1989, n=18", "Model": "4Comp", "ObservedData": [ "Blume, Mutschler 1989 - Verapamil - Verapamil - PO - 80 mg - Plasma - agg. (n=18)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 30.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Blume, Mutschler 1989, Verapamil 80mg po SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" }, { "Path": "Applications|Blume, Mutschler 1989, Verapamil 80mg po SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 80 mg SD, Blume, Mutschler 1989, n=18|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Blume, Mutschler 1989 - Verapamil - Verapamil - PO - 80 mg - Plasma - agg. (n=18)" } ], "Individual": "Blume, Mutschler 1989, n=18", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Blume, Mutschler 1989, Verapamil 80mg po SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Blume, Mutschler 1989, Verapamil 80mg po SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 80 mg SD, Blume, Mutschler 1989, n=18|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 80 mg SD, Blume, Mutschler 1989, n=18|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Blume, Mutschler 1989 - Verapamil - Verapamil - PO - 80 mg - Plasma - agg. (n=18)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Blume, Mutschler 1989 - Verapamil - Verapamil - PO - 80 mg - Plasma - agg. (n=18)|Time", "Y": "Blume, Mutschler 1989 - Verapamil - Verapamil - PO - 80 mg - Plasma - agg. (n=18)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 16, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 80 mg SD, Blume, Mutschler 1989, n=18\n2022-01-18 14:42" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 120 mg SD, Blume, Mutschler 1987, n=12", "Model": "4Comp", "ObservedData": [ "Blume, Mutschler 1987 - Verapamil - Verapamil - PO - 120 mg - Plasma - agg. (n=12)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 24.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Blume, Mutschler 1987, Verapamil 120mg po SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Blume, Mutschler 1987, Verapamil 120mg po SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 120 mg SD, Blume, Mutschler 1987, n=12|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Blume, Mutschler 1987 - Verapamil - Verapamil - PO - 120 mg - Plasma - agg. (n=12)" } ], "Individual": "Blume, Mutschler 1987, n=12", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Blume, Mutschler 1987, Verapamil 120mg po SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Blume, Mutschler 1987, Verapamil 120mg po SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg SD, Blume, Mutschler 1987, n=12|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg SD, Blume, Mutschler 1987, n=12|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Blume, Mutschler 1987 - Verapamil - Verapamil - PO - 120 mg - Plasma - agg. (n=12)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Blume, Mutschler 1987 - Verapamil - Verapamil - PO - 120 mg - Plasma - agg. (n=12)|Time", "Y": "Blume, Mutschler 1987 - Verapamil - Verapamil - PO - 120 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 16, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 120 mg SD, Blume, Mutschler 1987, n=12\n2022-01-18 14:54" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 40 mg SD, Blume, Mutschler 1990, n=24", "Model": "4Comp", "ObservedData": [ "Blume, Mutschler 1990 - Verapamil - Verapamil - PO - 40 mg - Plasma - agg. (n=24)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 30.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Blume, Mutschler 1990, Verapamil 40mg po SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Blume, Mutschler 1990, Verapamil 40mg po SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 40 mg SD, Blume, Mutschler 1990, n=24|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Blume, Mutschler 1990 - Verapamil - Verapamil - PO - 40 mg - Plasma - agg. (n=24)" } ], "Individual": "Blume, Mutschler 1990, n=24", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Blume, Mutschler 1990, Verapamil 40mg po SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Blume, Mutschler 1990, Verapamil 40mg po SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 40 mg SD, Blume, Mutschler 1990, n=24|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 40 mg SD, Blume, Mutschler 1990, n=24|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Blume, Mutschler 1990 - Verapamil - Verapamil - PO - 40 mg - Plasma - agg. (n=24)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Blume, Mutschler 1990 - Verapamil - Verapamil - PO - 40 mg - Plasma - agg. (n=24)|Time", "Y": "Blume, Mutschler 1990 - Verapamil - Verapamil - PO - 40 mg - Plasma - agg. (n=24)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 16, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 40 mg SD, Blume, Mutschler 1990, n=24\n2022-01-18 15:07" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 40 mg SD, Blume, Mutschler 1983, n=12", "Model": "4Comp", "ObservedData": [ "Blume, Mutschler 1983 - Verapamil - Verapamil - PO - 40 mg - Plasma - agg. (n=12)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 30.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Blume, Mutschler 1983, Verapamil 40mg po SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Blume, Mutschler 1983, Verapamil 40mg po SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 40 mg SD, Blume, Mutschler 1983, n=12|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Blume, Mutschler 1983 - Verapamil - Verapamil - PO - 40 mg - Plasma - agg. (n=12)" } ], "Individual": "Blume, Mutschler 1983, n=12", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Blume, Mutschler 1983, Verapamil 40mg po SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Blume, Mutschler 1983, Verapamil 40mg po SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 40 mg SD, Blume, Mutschler 1983, n=12|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 40 mg SD, Blume, Mutschler 1983, n=12|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Blume, Mutschler 1983 - Verapamil - Verapamil - PO - 40 mg - Plasma - agg. (n=12)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Blume, Mutschler 1983 - Verapamil - Verapamil - PO - 40 mg - Plasma - agg. (n=12)|Time", "Y": "Blume, Mutschler 1983 - Verapamil - Verapamil - PO - 40 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 16, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 40 mg SD, Blume, Mutschler 1983, n=12\n2022-01-18 15:14" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "iv_R-Verapamil 5 mg (5 min), Eichelbaum 1984, n=1", "Model": "4Comp", "ObservedData": [ "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 5 mg - Plasma - indiv." ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 25.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 100.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Eichelbaum 1984, R-Verapamil 5 mg iv (5 min)|Application_1|ProtocolSchemaItem|Infusion time", "Value": 5.0, "Unit": "min" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil|Fraction excreted to urine", "Organism|Lumen|Feces|R-Verapamil|Fraction excreted to feces" ], "OutputMappings": [ { "Scaling": "Log", "Path": "iv_R-Verapamil 5 mg (5 min), Eichelbaum 1984, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 5 mg - Plasma - indiv." } ], "Individual": "Eichelbaum 1984, n=1\u001f", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Eichelbaum 1984, R-Verapamil 5 mg iv (5 min)" } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "Min": 1.0, "Max": 1200.0, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "iv_R-Verapamil 5 mg (5 min), Eichelbaum 1984, n=1-R-Verapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "iv_R-Verapamil 5 mg (5 min), Eichelbaum 1984, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 1 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "iv_R-Verapamil 5 mg (5 min), Eichelbaum 1984, n=1|Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#FF8000", "LegendIndex": 3 } }, { "Name": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 5 mg - Plasma - indiv.-R-Verapamil-Peripheral Venous Blood-Plasma-Individual", "X": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 5 mg - Plasma - indiv.|Time", "Y": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|Individual", "CurveOptions": { "LegendIndex": 5, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\niv_R-Verapamil 5 mg (5 min), Eichelbaum 1984, n=1\n2022-01-18 18:26" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" } ] }, { "Name": "iv_R-Verapamil 25 mg (5 min), Eichelbaum 1984, n=1", "Model": "4Comp", "ObservedData": [ "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 25 mg - Plasma - indiv." ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 25.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 1.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 100.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Eichelbaum 1984, R-Verapamil 25 mg iv (5 min)|Application_1|ProtocolSchemaItem|Infusion time", "Value": 5.0, "Unit": "min" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil|Fraction excreted to urine", "Organism|Lumen|Feces|R-Verapamil|Fraction excreted to feces" ], "OutputMappings": [ { "Scaling": "Log", "Path": "iv_R-Verapamil 25 mg (5 min), Eichelbaum 1984, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 25 mg - Plasma - indiv." } ], "Individual": "Eichelbaum 1984, n=1\u001f", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Eichelbaum 1984, R-Verapamil 25 mg iv (5 min)" } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "Min": 1.0, "Max": 1200.0, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "iv_R-Verapamil 25 mg (5 min), Eichelbaum 1984, n=1-R-Verapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "iv_R-Verapamil 25 mg (5 min), Eichelbaum 1984, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 1 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "iv_R-Verapamil 25 mg (5 min), Eichelbaum 1984, n=1|Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#FF8000", "LegendIndex": 3 } }, { "Name": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 25 mg - Plasma - indiv.-R-Verapamil-Peripheral Venous Blood-Plasma-Individual", "X": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 25 mg - Plasma - indiv.|Time", "Y": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 25 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|Individual", "CurveOptions": { "LegendIndex": 5, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\niv_R-Verapamil 25 mg (5 min), Eichelbaum 1984, n=1\n2022-01-18 20:08" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" } ] }, { "Name": "iv_S-Verapamil 5 mg SD (5min), Eichelbaum 1984, n=1", "Model": "4Comp", "ObservedData": [ "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 5 mg - Plasma - indiv." ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 20.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 14.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Applications|Eichelbaum 1984, S-Verapamil 5 mg iv (5 min)|Application_1|ProtocolSchemaItem|Infusion time", "Value": 5.0, "Unit": "min" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "iv_S-Verapamil 5 mg SD (5min), Eichelbaum 1984, n=1|Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 5 mg - Plasma - indiv." } ], "Individual": "Eichelbaum 1984, n=1\u001f", "Compounds": [ { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Eichelbaum 1984, S-Verapamil 5 mg iv (5 min)" } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "µmol/l", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "S-Verapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "iv_S-Verapamil 5 mg SD (5min), Eichelbaum 1984, n=1|Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 1 } }, { "Name": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 5 mg - Plasma - indiv.-S-Verapamil-Peripheral Venous Blood-Plasma-Individual", "X": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 5 mg - Plasma - indiv.|Time", "Y": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|S-Verapamil|Individual", "CurveOptions": { "LegendIndex": 3, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\niv_S-Verapamil 5 mg SD (5min), Eichelbaum 1984, n=1\n2022-01-18 18:29" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "iv_S-Verapamil 7.5 mg SD (5min), Eichelbaum 1984, n=1", "Model": "4Comp", "ObservedData": [ "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 7.5 mg - Plasma - indiv." ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 20.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 14.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Applications|Eichelbaum 1984, S-Verapamil 7.5 mg iv (5 min)|Application_1|ProtocolSchemaItem|Infusion time", "Value": 5.0, "Unit": "min" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "iv_S-Verapamil 7.5 mg SD (5min), Eichelbaum 1984, n=1|Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 7.5 mg - Plasma - indiv." } ], "Individual": "Eichelbaum 1984, n=1\u001f", "Compounds": [ { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Eichelbaum 1984, S-Verapamil 7.5 mg iv (5 min)" } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "µmol/l", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "S-Verapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "iv_S-Verapamil 7.5 mg SD (5min), Eichelbaum 1984, n=1|Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 1 } }, { "Name": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 7.5 mg - Plasma - indiv.-S-Verapamil-Peripheral Venous Blood-Plasma-Individual", "X": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 7.5 mg - Plasma - indiv.|Time", "Y": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 7.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|S-Verapamil|Individual", "CurveOptions": { "LegendIndex": 3, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\niv_S-Verapamil 7.5 mg SD (5min), Eichelbaum 1984, n=1\n2022-01-18 18:30" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "iv_S-Verapamil 10 mg SD (5min), Eichelbaum 1984, n=1", "Model": "4Comp", "ObservedData": [ "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 10 mg - Plasma - indiv." ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 20.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 2.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 14.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Applications|Eichelbaum 1984, S-Verapamil 10 mg iv (5 min)|Application_1|ProtocolSchemaItem|Infusion time", "Value": 5.0, "Unit": "min" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "iv_S-Verapamil 10 mg SD (5min), Eichelbaum 1984, n=1|Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 10 mg - Plasma - indiv." } ], "Individual": "Eichelbaum 1984, n=1\u001f", "Compounds": [ { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Eichelbaum 1984, S-Verapamil 10 mg iv (5 min)" } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "µmol/l", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "S-Verapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "iv_S-Verapamil 10 mg SD (5min), Eichelbaum 1984, n=1|Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 1 } }, { "Name": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 10 mg - Plasma - indiv.-S-Verapamil-Peripheral Venous Blood-Plasma-Individual", "X": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 10 mg - Plasma - indiv.|Time", "Y": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 10 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|S-Verapamil|Individual", "CurveOptions": { "LegendIndex": 3, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\niv_S-Verapamil 10 mg SD (5min), Eichelbaum 1984, n=1\n2022-01-18 18:31" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 80mg PO TID 5rep, Backman 1994, n=9", "Model": "4Comp", "ObservedData": [ "Backman 1994 - Verapamil - Verapamil - PO - 80 mg - Plasma - agg. (n=9)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 12.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 12.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 84.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Applications|Backman 1994, Verapamil 80mg po TID, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" }, { "Path": "Applications|Backman 1994, Verapamil 80mg po TID, R-Vera|Solution|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" }, { "Path": "Applications|Backman 1994, Verapamil 80mg po TID, R-Vera|Solution|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" }, { "Path": "Applications|Backman 1994, Verapamil 80mg po TID, R-Vera|Solution|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" }, { "Path": "Applications|Backman 1994, Verapamil 80mg po TID, R-Vera|Solution|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" }, { "Path": "Applications|Backman 1994, Verapamil 80mg po TID, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" }, { "Path": "Applications|Backman 1994, Verapamil 80mg po TID, S-Vera|Solution|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" }, { "Path": "Applications|Backman 1994, Verapamil 80mg po TID, S-Vera|Solution|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" }, { "Path": "Applications|Backman 1994, Verapamil 80mg po TID, S-Vera|Solution|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" }, { "Path": "Applications|Backman 1994, Verapamil 80mg po TID, S-Vera|Solution|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 2.0, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 80mg PO TID 5rep, Backman 1994, n=9|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Backman 1994 - Verapamil - Verapamil - PO - 80 mg - Plasma - agg. (n=9)" } ], "Individual": "Backman 1994", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Backman 1994, Verapamil 80mg po TID, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Backman 1994, Verapamil 80mg po TID, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "Min": -1.578743, "Max": 48.9321, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "Min": 9.302593, "Max": 208.9095, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 80mg PO TID 5rep, Backman 1994, n=9|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 80mg PO TID 5rep, Backman 1994, n=9|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Backman 1994 - Verapamil - Verapamil - PO - 80 mg - Plasma - agg. (n=9)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Backman 1994 - Verapamil - Verapamil - PO - 80 mg - Plasma - agg. (n=9)|Time", "Y": "Backman 1994 - Verapamil - Verapamil - PO - 80 mg - Plasma - agg. (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 15, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 80mg PO TID 2days, Backman 1994, n=9\n2024-08-20 16:17" } ], "Interactions": [ { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 80mg SD, McAllister, Kirsten 1982, n=20", "Model": "4Comp", "ObservedData": [ "McAllister 1982 - Verapamil 80 mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=20)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 30.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|McAllister 1982, Verapamil 80mg po SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|McAllister 1982, Verapamil 80mg po SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 80mg SD, McAllister, Kirsten 1982, n=20|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "McAllister 1982 - Verapamil 80 mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=20)" } ], "Individual": "McAllister, Kirsten 1982, n=20", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "McAllister 1982, Verapamil 80mg po SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "McAllister 1982, Verapamil 80mg po SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "µmol/l", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 80mg SD, McAllister, Kirsten 1982, n=20|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#0000FF", "LegendIndex": 2 } }, { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 80mg SD, McAllister, Kirsten 1982, n=20|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 1 } }, { "Name": "McAllister 1982 - Verapamil 80 mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=20)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "McAllister 1982 - Verapamil 80 mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=20)|Time", "Y": "McAllister 1982 - Verapamil 80 mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 3, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 80mg SD, McAllister, Kirsten 1982, n=20\n2024-08-23 17:18" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 120mg SD, McAllister, Kirsten 1982, n=20", "Model": "4Comp", "ObservedData": [ "McAllister 1982 - Verapamil 120 mg PO - Verapamil - PO - 120 mg - Plasma - agg. (n=20)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 30.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|McAllister 1982, Verapamil 120 mg SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|McAllister 1982, Verapamil 120 mg SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 120mg SD, McAllister, Kirsten 1982, n=20|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "McAllister 1982 - Verapamil 120 mg PO - Verapamil - PO - 120 mg - Plasma - agg. (n=20)" } ], "Individual": "McAllister, Kirsten 1982, n=20", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "McAllister 1982, Verapamil 120 mg SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "McAllister 1982, Verapamil 120 mg SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "Min": -0.5232525, "Max": 17.51615, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "µmol/l", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "Min": 0.000863475, "Max": 0.3557204, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 120mg SD, McAllister, Kirsten 1982, n=20|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#0000FF", "LegendIndex": 2 } }, { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 120mg SD, McAllister, Kirsten 1982, n=20|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 1 } }, { "Name": "McAllister 1982 - Verapamil 120 mg PO - Verapamil - PO - 120 mg - Plasma - agg. (n=20)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "McAllister 1982 - Verapamil 120 mg PO - Verapamil - PO - 120 mg - Plasma - agg. (n=20)|Time", "Y": "McAllister 1982 - Verapamil 120 mg PO - Verapamil - PO - 120 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "LegendIndex": 3, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 120mg SD, McAllister, Kirsten 1982, n=20\n2024-08-23 17:20" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 160mg SD, McAllister, Kirsten 1982, n=20", "Model": "4Comp", "ObservedData": [ "McAllister 1982 - Verapamil 160 mg PO - Verapamil - PO - 160 mg - Plasma - agg. (n=20)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 30.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|McAllister 1982, Verapamil 160mg po SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|McAllister 1982, Verapamil 160mg po SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 160mg SD, McAllister, Kirsten 1982, n=20|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "McAllister 1982 - Verapamil 160 mg PO - Verapamil - PO - 160 mg - Plasma - agg. (n=20)" } ], "Individual": "McAllister, Kirsten 1982, n=20", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "McAllister 1982, Verapamil 160mg po SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "McAllister 1982, Verapamil 160mg po SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "Min": -1.025615, "Max": 16.78544, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "µmol/l", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "Min": 0.0009898053, "Max": 0.5579191, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 160mg SD, McAllister, Kirsten 1982, n=20|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#0000FF", "LegendIndex": 2 } }, { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 160mg SD, McAllister, Kirsten 1982, n=20|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 1 } }, { "Name": "McAllister 1982 - Verapamil 160 mg PO - Verapamil - PO - 160 mg - Plasma - agg. (n=20)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "McAllister 1982 - Verapamil 160 mg PO - Verapamil - PO - 160 mg - Plasma - agg. (n=20)|Time", "Y": "McAllister 1982 - Verapamil 160 mg PO - Verapamil - PO - 160 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 3, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 160mg SD, McAllister, Kirsten 1982, n=20\n2024-08-23 17:26" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 120mg PO BID 8days, Jorgensen 1988, n=12", "Model": "4Comp", "ObservedData": [ "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)", "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 1 - 5 and 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 12.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 12.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 200.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, R-Vera|Solution|Application_10|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, R-Vera|Solution|Application_11|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, R-Vera|Solution|Application_12|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, R-Vera|Solution|Application_13|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, R-Vera|Solution|Application_14|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, R-Vera|Solution|Application_15|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, R-Vera|Solution|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, R-Vera|Solution|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, R-Vera|Solution|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, R-Vera|Solution|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, R-Vera|Solution|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, R-Vera|Solution|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, R-Vera|Solution|Application_8|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, R-Vera|Solution|Application_9|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, S-Vera|Solution|Application_10|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, S-Vera|Solution|Application_11|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, S-Vera|Solution|Application_12|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, S-Vera|Solution|Application_13|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, S-Vera|Solution|Application_14|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, S-Vera|Solution|Application_15|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, S-Vera|Solution|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, S-Vera|Solution|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, S-Vera|Solution|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, S-Vera|Solution|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, S-Vera|Solution|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, S-Vera|Solution|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, S-Vera|Solution|Application_8|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 120mg PO BID, S-Vera|Solution|Application_9|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 120mg PO BID 8days, Jorgensen 1988, n=12|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 1 - 5 and 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)" }, { "Scaling": "Log", "Path": "po_Verapamil 120mg PO BID 8days, Jorgensen 1988, n=12|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)" } ], "Individual": "Jorgensen 1988, n = 12", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Jorgensen 1988, Verapamil 120mg PO BID, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Jorgensen 1988, Verapamil 120mg PO BID, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 120mg PO BID 8days, Jorgensen 1988, n=12|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 120mg PO BID 8days, Jorgensen 1988, n=12|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)|Time", "Y": "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "LegendIndex": 16, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 1 - 5 and 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 1 - 5 and 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)|Time", "Y": "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 1 - 5 and 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "LegendIndex": 15, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 120mg PO BID 8days, Jorgensen 1988, n=12\n2024-08-26 15:14" } ], "Interactions": [ { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 240mg PO OD 8days sustained realese, Jorgensen 1988, n=12", "Model": "4Comp", "ObservedData": [ "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)", "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 1 - 5 and 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 12.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 12.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 200.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Applications|Jorgensen 1988, Verapamil 240mg PO MD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 240mg PO MD, R-Vera|Solution|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 240mg PO MD, R-Vera|Solution|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 240mg PO MD, R-Vera|Solution|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 240mg PO MD, R-Vera|Solution|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 240mg PO MD, R-Vera|Solution|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 240mg PO MD, R-Vera|Solution|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 240mg PO MD, R-Vera|Solution|Application_8|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 240mg PO MD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 240mg PO MD, S-Vera|Solution|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 240mg PO MD, S-Vera|Solution|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 240mg PO MD, S-Vera|Solution|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 240mg PO MD, S-Vera|Solution|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 240mg PO MD, S-Vera|Solution|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 240mg PO MD, S-Vera|Solution|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Jorgensen 1988, Verapamil 240mg PO MD, S-Vera|Solution|Application_8|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 240mg PO OD 8days sustained realese, Jorgensen 1988, n=12|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 1 - 5 and 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)" }, { "Scaling": "Log", "Path": "po_Verapamil 240mg PO OD 8days sustained realese, Jorgensen 1988, n=12|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)" } ], "Individual": "Jorgensen 1988, n = 12", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Jorgensen 1988, Verapamil 240mg PO MD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Jorgensen 1988, Verapamil 240mg PO MD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 240mg PO OD 8days sustained realese, Jorgensen 1988, n=12|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 240mg PO OD 8days sustained realese, Jorgensen 1988, n=12|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)|Time", "Y": "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 16, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 1 - 5 and 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 1 - 5 and 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)|Time", "Y": "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 1 - 5 and 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 15, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 240mg PO OD 8days sustained realese, Jorgensen 1988, n=12\n2024-08-26 16:11" } ], "Interactions": [ { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 240 mg SD, Karim 1995, n=12", "Model": "4Comp", "ObservedData": [ "Karim 1995 - Verapamil total IR fasting - Verapamil - PO - 240 mg - Plasma - agg. (n=12)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 24.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Karim 1995, Verapamil 240mg PO SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Karim 1995, Verapamil 240mg PO SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 240 mg SD, Karim 1995, n=12|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Karim 1995 - Verapamil total IR fasting - Verapamil - PO - 240 mg - Plasma - agg. (n=12)" } ], "Individual": "Karim 1995, n = 12", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Karim 1995, Verapamil 240mg PO SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Karim 1995, Verapamil 240mg PO SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 240 mg SD, Karim 1995, n=12|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 240 mg SD, Karim 1995, n=12|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Karim 1995 - Verapamil total IR fasting - Verapamil - PO - 240 mg - Plasma - agg. (n=12)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Karim 1995 - Verapamil total IR fasting - Verapamil - PO - 240 mg - Plasma - agg. (n=12)|Time", "Y": "Karim 1995 - Verapamil total IR fasting - Verapamil - PO - 240 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "Color": "#0000FF", "LegendIndex": 15, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 240 mg SD, Karim 1995, n=12\n2024-08-26 16:26" } ], "Interactions": [ { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 120mg PO TID 7rep, Shand 1981, n=6", "Model": "4Comp", "ObservedData": [ "Shand 1981 - Verapamil day 1 - Verapamil - PO - 120 mg - Plasma - agg. (n=6)", "Shand 1981 - Verapamil day 3 (after 7th dose) - Verapamil - PO - 120 mg - Plasma - agg. (n=6)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 12.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] }, { "Parameters": [ { "Name": "Start time", "Value": 12.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 84.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 4.0, "Unit": "pts/h" } ] } ], "Parameters": [ { "Path": "Applications|Shand 1981, Verapamil 120 mg TID, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Shand 1981, Verapamil 120 mg TID, R-Vera|Solution|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Shand 1981, Verapamil 120 mg TID, R-Vera|Solution|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Shand 1981, Verapamil 120 mg TID, R-Vera|Solution|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Shand 1981, Verapamil 120 mg TID, R-Vera|Solution|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Shand 1981, Verapamil 120 mg TID, R-Vera|Solution|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Shand 1981, Verapamil 120 mg TID, R-Vera|Solution|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Shand 1981, Verapamil 120 mg TID, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Shand 1981, Verapamil 120 mg TID, S-Vera|Solution|Application_2|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Shand 1981, Verapamil 120 mg TID, S-Vera|Solution|Application_3|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Shand 1981, Verapamil 120 mg TID, S-Vera|Solution|Application_4|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Shand 1981, Verapamil 120 mg TID, S-Vera|Solution|Application_5|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Shand 1981, Verapamil 120 mg TID, S-Vera|Solution|Application_6|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Shand 1981, Verapamil 120 mg TID, S-Vera|Solution|Application_7|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 120mg PO TID 7rep, Shand 1981, n=6|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Shand 1981 - Verapamil day 1 - Verapamil - PO - 120 mg - Plasma - agg. (n=6)" }, { "Scaling": "Log", "Path": "po_Verapamil 120mg PO TID 7rep, Shand 1981, n=6|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Shand 1981 - Verapamil day 3 (after 7th dose) - Verapamil - PO - 120 mg - Plasma - agg. (n=6)" } ], "Individual": "Shand 1981, n = 6", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Shand 1981, Verapamil 120 mg TID, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Shand 1981, Verapamil 120 mg TID, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "Min": -2.689169, "Max": 64.61078, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "Min": 14.6489, "Max": 695.0531, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 120mg PO TID 7rep, Shand 1981, n=6|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 9 } }, { "Name": "R-Norverapamil-Peripheral Venous Blood-Sum-Norverapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 120mg PO TID 7rep, Shand 1981, n=6|Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "Visible": false, "Color": "#008000", "LegendIndex": 14 } }, { "Name": "Shand 1981 - Verapamil day 1 - Verapamil - PO - 120 mg - Plasma - agg. (n=6)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Shand 1981 - Verapamil day 1 - Verapamil - PO - 120 mg - Plasma - agg. (n=6)|Time", "Y": "Shand 1981 - Verapamil day 1 - Verapamil - PO - 120 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "LegendIndex": 15, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Shand 1981 - Verapamil day 3 (after 7th dose) - Verapamil - PO - 120 mg - Plasma - agg. (n=6)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Shand 1981 - Verapamil day 3 (after 7th dose) - Verapamil - PO - 120 mg - Plasma - agg. (n=6)|Time", "Y": "Shand 1981 - Verapamil day 3 (after 7th dose) - Verapamil - PO - 120 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "LegendIndex": 16, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 120mg PO TID 7rep, Shand 1981, n=6\n2024-08-26 17:01" } ], "Interactions": [ { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" } ] }, { "Name": "iv_Verapamil 10 mg (bol), Smith 1984, n=8", "Model": "4Comp", "ObservedData": [ "Smith 1984 - IV 10 mg Verapamil control - Verapamil - IV - 10 mg - Plasma - agg. (n=8)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "End time", "Value": 8.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 20.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)" ], "OutputMappings": [ { "Scaling": "Log", "Path": "iv_Verapamil 10 mg (bol), Smith 1984, n=8|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Smith 1984 - IV 10 mg Verapamil control - Verapamil - IV - 10 mg - Plasma - agg. (n=8)" } ], "Individual": "Smith 1984, n=8", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "MoleculeName": "AADAC" }, { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "MoleculeName": "OATP1B1" }, { "MoleculeName": "MATE1" }, { "MoleculeName": "OCT1" }, { "MoleculeName": "OAT3" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Smith 1984, Verapamil 10 mg iv (bol), R-Vera" } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "MoleculeName": "AADAC" }, { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "MoleculeName": "OATP1B1" }, { "MoleculeName": "MATE1" }, { "MoleculeName": "OCT1" }, { "MoleculeName": "OAT3" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "MoleculeName": "AADAC" }, { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "MoleculeName": "OATP1B1" }, { "MoleculeName": "MATE1" }, { "MoleculeName": "OCT1" }, { "MoleculeName": "OAT3" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Smith 1984, Verapamil 10 mg iv (bol), S-Vera" } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "MoleculeName": "AADAC" }, { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "MoleculeName": "OATP1B1" }, { "MoleculeName": "MATE1" }, { "MoleculeName": "OCT1" }, { "MoleculeName": "OAT3" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "iv_Verapamil 10 mg (bol), Smith 1984, n=8-R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "iv_Verapamil 10 mg (bol), Smith 1984, n=8|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 1 } }, { "Name": "Smith 1984 - IV 10 mg Verapamil control - Verapamil - IV - 10 mg - Plasma - agg. (n=8)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Smith 1984 - IV 10 mg Verapamil control - Verapamil - IV - 10 mg - Plasma - agg. (n=8)|Time", "Y": "Smith 1984 - IV 10 mg Verapamil control - Verapamil - IV - 10 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "LegendIndex": 5, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\niv_Verapamil 10 mg (bol), Smith 1984, n=8\n2024-09-04 09:41" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 120 mg SD, Smith 1984, n=8", "Model": "4Comp", "ObservedData": [ "Smith 1984 - PO 120 mg Verapamil control - Verapamil - PO - 120 mg - Plasma - agg. (n=8)" ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h" }, { "Name": "End time", "Value": 8.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Smith 1984, Verapamil 120mg po SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Smith 1984, Verapamil 120mg po SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 120 mg SD, Smith 1984, n=8|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Smith 1984 - PO 120 mg Verapamil control - Verapamil - PO - 120 mg - Plasma - agg. (n=8)" } ], "Individual": "Smith 1984, n=8", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "MoleculeName": "AADAC" }, { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "MoleculeName": "OATP1B1" }, { "MoleculeName": "MATE1" }, { "MoleculeName": "OCT1" }, { "MoleculeName": "OAT3" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Smith 1984, Verapamil 120mg po SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "MoleculeName": "AADAC" }, { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "MoleculeName": "OATP1B1" }, { "MoleculeName": "MATE1" }, { "MoleculeName": "OCT1" }, { "MoleculeName": "OAT3" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "MoleculeName": "AADAC" }, { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "MoleculeName": "OATP1B1" }, { "MoleculeName": "MATE1" }, { "MoleculeName": "OCT1" }, { "MoleculeName": "OAT3" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Smith 1984, Verapamil 120mg po SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "MoleculeName": "AADAC" }, { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "MoleculeName": "OATP1B1" }, { "MoleculeName": "MATE1" }, { "MoleculeName": "OCT1" }, { "MoleculeName": "OAT3" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "po_Verapamil 120 mg SD, Smith 1984, n=8-R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 120 mg SD, Smith 1984, n=8|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 1 } }, { "Name": "Smith 1984 - PO 120 mg Verapamil control - Verapamil - PO - 120 mg - Plasma - agg. (n=8)-Verapamil-Peripheral Venous Blood-Plasma-ArithmeticMean", "X": "Smith 1984 - PO 120 mg Verapamil control - Verapamil - PO - 120 mg - Plasma - agg. (n=8)|Time", "Y": "Smith 1984 - PO 120 mg Verapamil control - Verapamil - PO - 120 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean", "CurveOptions": { "LegendIndex": 5, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 120 mg SD, Smith 1984, n=8\n2024-09-04 09:47" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "iv_Verapamil 10mg SD (10min), Wing 1985, n=1", "Model": "4Comp", "ObservedData": [ "Wing et al. 1985 - 10mg Verapamil without cimetidine, IV - Verapamil - IV - 10 mg - Plasma - indiv." ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 12.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Wing 1985, Verapamil 10mg iv (10min) SD, R-Vera|Application_1|ProtocolSchemaItem|Infusion time", "Value": 10.0, "Unit": "min" }, { "Path": "Applications|Wing 1985, Verapamil 10mg iv (10min) SD, S-Vera|Application_1|ProtocolSchemaItem|Infusion time", "Value": 10.0, "Unit": "min" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "iv_Verapamil 10mg SD (10min), Wing 1985, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Wing et al. 1985 - 10mg Verapamil without cimetidine, IV - Verapamil - IV - 10 mg - Plasma - indiv." } ], "Individual": "Wing 1985, n=1", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Wing 1985, Verapamil 10mg iv (10min) SD, R-Vera" } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Wing 1985, Verapamil 10mg iv (10min) SD, S-Vera" } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "iv_Verapamil 10mg SD (10min), Wing 1985, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 9 } }, { "Name": "Wing et al. 1985 - 10mg Verapamil without cimetidine, IV - Verapamil - IV - 10 mg - Plasma - indiv.-Verapamil-Peripheral Venous Blood-Plasma-Individual", "X": "Wing et al. 1985 - 10mg Verapamil without cimetidine, IV - Verapamil - IV - 10 mg - Plasma - indiv.|Time", "Y": "Wing et al. 1985 - 10mg Verapamil without cimetidine, IV - Verapamil - IV - 10 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|Individual", "CurveOptions": { "LegendIndex": 10, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\niv_Verapamil 10mg SD (10min), Wing 1985, n=1\n2024-09-04 12:58" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 80mg SD, Wing 1985, n=1", "Model": "4Comp", "ObservedData": [ "Wing et al. 1985 - 80mg Verapamil without cimetidine, PO - Verapamil - PO - 80 mg - Plasma - indiv." ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 10.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Wing 1985, Verapamil 80mg po SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Wing 1985, Verapamil 80mg po SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 80mg SD, Wing 1985, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "ObservedData": "Wing et al. 1985 - 80mg Verapamil without cimetidine, PO - Verapamil - PO - 80 mg - Plasma - indiv." } ], "Individual": "Wing 1985, n=1", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Wing 1985, Verapamil 80mg po SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Wing 1985, Verapamil 80mg po SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "R-Verapamil-Peripheral Venous Blood-Sum-Verapamil Plasma (Peripheral Venous Blood)-Concentration", "X": "Time", "Y": "po_Verapamil 80mg SD, Wing 1985, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "CurveOptions": { "LegendIndex": 9 } }, { "Name": "Wing et al. 1985 - 80mg Verapamil without cimetidine, PO - Verapamil - PO - 80 mg - Plasma - indiv.-Verapamil-Peripheral Venous Blood-Plasma-Individual", "X": "Wing et al. 1985 - 80mg Verapamil without cimetidine, PO - Verapamil - PO - 80 mg - Plasma - indiv.|Time", "Y": "Wing et al. 1985 - 80mg Verapamil without cimetidine, PO - Verapamil - PO - 80 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|Individual", "CurveOptions": { "LegendIndex": 12, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 80mg SD, Wing 1985, n=1\n2024-09-04 13:02" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] }, { "Name": "po_Verapamil 160 mg SD, Mikus 1990, n=1", "Model": "4Comp", "ObservedData": [ "Mikus et al. 1990 - 160mg verapamil without cimetidine, PO - R-Verapamil - PO - 160 mg - Plasma - indiv.", "Mikus et al. 1990 - 160mg verapamil without cimetidine, PO - S-Verapamil - PO - 160 mg - Plasma - indiv." ], "Solver": {}, "OutputSchema": [ { "Parameters": [ { "Name": "Start time", "Value": 0.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "End time", "Value": 16.0, "Unit": "h", "ValueOrigin": { "Source": "Unknown" } }, { "Name": "Resolution", "Value": 10.0, "Unit": "pts/h", "ValueOrigin": { "Source": "Unknown" } } ] } ], "Parameters": [ { "Path": "Applications|Mikus 1990, Verapamil 160mg po (sol) SD, R-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" }, { "Path": "Applications|Mikus 1990, Verapamil 160mg po (sol) SD, S-Vera|Solution|Application_1|ProtocolSchemaItem|Volume of water/body weight", "Value": 3.5, "Unit": "ml/kg" } ], "OutputSelections": [ "Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|S-Norverapamil|Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Verapamil|Sum-Verapamil Plasma (Peripheral Venous Blood)", "Organism|PeripheralVenousBlood|R-Norverapamil|Sum-Norverapamil Plasma (Peripheral Venous Blood)", "Organism|Kidney|Urine|R-Verapamil", "Organism|Kidney|Urine|R-Norverapamil", "Organism|Kidney|Urine|S-Verapamil", "Organism|Kidney|Urine|S-Norverapamil" ], "OutputMappings": [ { "Scaling": "Log", "Path": "po_Verapamil 160 mg SD, Mikus 1990, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Mikus et al. 1990 - 160mg verapamil without cimetidine, PO - R-Verapamil - PO - 160 mg - Plasma - indiv." }, { "Scaling": "Log", "Path": "po_Verapamil 160 mg SD, Mikus 1990, n=1|Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "ObservedData": "Mikus et al. 1990 - 160mg verapamil without cimetidine, PO - S-Verapamil - PO - 160 mg - Plasma - indiv." } ], "Individual": "Mikus 1990, n=1", "Compounds": [ { "Name": "R-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "R-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Mikus 1990, Verapamil 160mg po (sol) SD, R-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "R-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] }, { "Name": "S-Verapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-Norverapamil", "MoleculeName": "CYP3A4", "MetaboliteName": "S-Norverapamil" }, { "Name": "CYP3A4-D617", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ], "Protocol": { "Name": "Mikus 1990, Verapamil 160mg po (sol) SD, S-Vera", "Formulations": [ { "Name": "Solution", "Key": "Formulation" } ] } }, { "Name": "S-Norverapamil", "CalculationMethods": [ "Cellular partition coefficient method - Rodgers and Rowland", "Cellular permeability - PK-Sim Standard" ], "Alternatives": [ { "AlternativeName": "Fitted", "GroupName": "COMPOUND_PERMEABILITY" }, { "AlternativeName": "Fitted", "GroupName": "COMPOUND_INTESTINAL_PERMEABILITY" } ], "Processes": [ { "Name": "CYP3A4-D620", "MoleculeName": "CYP3A4" }, { "Name": "P-gp-Paper", "MoleculeName": "P-gp" }, { "Name": "Glomerular Filtration-GFR", "SystemicProcessType": "GFR" } ] } ], "ObserverSets": [ { "Name": "Sum-Verapamil" }, { "Name": "Sum-Norverapamil" } ], "HasResults": true, "IndividualAnalyses": [ { "Axes": [ { "Unit": "h", "Dimension": "Time", "Type": "X", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "None", "Scaling": "Linear", "NumberMode": "Normal" }, { "Unit": "ng/ml", "Dimension": "Concentration (molar)", "Type": "Y", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Solid", "Scaling": "Log", "NumberMode": "Normal" }, { "Unit": "", "Type": "Y2", "GridLines": false, "Visible": true, "DefaultColor": "#FFFFFF", "DefaultLineStyle": "Dash", "Scaling": "Log", "NumberMode": "Normal" } ], "Curves": [ { "Name": "S-Verapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "po_Verapamil 160 mg SD, Mikus 1990, n=1|Organism|PeripheralVenousBlood|S-Verapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#008000", "LegendIndex": 18 } }, { "Name": "R-Verapamil-Peripheral Venous Blood-Plasma-Concentration", "X": "Time", "Y": "po_Verapamil 160 mg SD, Mikus 1990, n=1|Organism|PeripheralVenousBlood|R-Verapamil|Plasma (Peripheral Venous Blood)", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 17 } }, { "Name": "Mikus et al. 1990 - 160mg verapamil without cimetidine, PO - R-Verapamil - PO - 160 mg - Plasma - indiv.-R-Verapamil-Peripheral Venous Blood-Plasma-Individual", "X": "Mikus et al. 1990 - 160mg verapamil without cimetidine, PO - R-Verapamil - PO - 160 mg - Plasma - indiv.|Time", "Y": "Mikus et al. 1990 - 160mg verapamil without cimetidine, PO - R-Verapamil - PO - 160 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|Individual", "CurveOptions": { "Color": "#FF0000", "LegendIndex": 21, "LineStyle": "None", "Symbol": "Circle" } }, { "Name": "Mikus et al. 1990 - 160mg verapamil without cimetidine, PO - S-Verapamil - PO - 160 mg - Plasma - indiv.-S-Verapamil-Peripheral Venous Blood-Plasma-Individual", "X": "Mikus et al. 1990 - 160mg verapamil without cimetidine, PO - S-Verapamil - PO - 160 mg - Plasma - indiv.|Time", "Y": "Mikus et al. 1990 - 160mg verapamil without cimetidine, PO - S-Verapamil - PO - 160 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|S-Verapamil|Individual", "CurveOptions": { "Color": "#008000", "LegendIndex": 22, "LineStyle": "None", "Symbol": "Circle" } } ], "Name": "Time Profile Analysis", "FontAndSize": { "Fonts": { "AxisSize": 10, "LegendSize": 8, "TitleSize": 16, "DescriptionSize": 12, "OriginSize": 8, "FontFamilyName": "Microsoft Sans Serif", "WatermarkSize": 32 } }, "Settings": { "SideMarginsEnabled": true, "LegendPosition": "None", "BackColor": "#00FFFFFF", "DiagramBackColor": "#FFFFFF" }, "OriginText": "Verapamil-Model\npo_Verapamil 160 mg SD, Mikus 1990, n=1\n2024-09-04 13:07" } ], "Interactions": [ { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "R-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "R-Norverapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Verapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Verapamil" }, { "Name": "P-gp-Non-competitive", "MoleculeName": "P-gp", "CompoundName": "S-Norverapamil" }, { "Name": "CYP3A4-MBI", "MoleculeName": "CYP3A4", "CompoundName": "S-Norverapamil" } ] } ], "ObservedData": [ { "Name": "Backman 1994 - Verapamil - Verapamil - PO - 80 mg - Plasma - agg. (n=9)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 1109.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Backman 1994", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/8198928", "Type": "String" }, { "Name": "Source", "Value": "Fig. 1", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 9.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "80 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": "S0-T8-R5", "Type": "String" }, { "Name": "Formulation", "Value": "2x Verpamil 40 mg tabl., Orion Pharmaceutical Company Ltd)", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Backman 1994 - Verapamil - Verapamil - PO - 80 mg - Plasma - agg. (n=9)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 54.50104, 85.15022, 74.92451, 67.37442, 60.55465, 51.29431, 41.79105, 35.69412, 29.5972, 26.4196, 28.9531 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Backman 1994 - Verapamil - Verapamil - PO - 80 mg - Plasma - agg. (n=9)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 25.0, 25.5, 26.0, 26.5, 27.0, 28.0, 29.0, 30.0, 31.0, 32.0, 42.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Barbarash 1988 - Verapamil IV control - Verapamil - IV - 10 mg - Serum - agg. (n=6)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2055.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Barbarash 1988", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/3180898", "Type": "String" }, { "Name": "Source", "Value": "Fig. 1", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil IV control", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 6.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "IV", "Type": "String" }, { "Name": "Dose", "Value": "10 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "iv infusion", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Barbarash 1988 - Verapamil IV control - Verapamil - IV - 10 mg - Serum - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.02099905, 0.01059613, 0.009422718, 0.007053406, 0.000872921, 0.003680323, 0.003393995, 0.002371463, 0.002323616, 0.002676879, 0.00258626021, 0.001896646, 0.000941767648 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Barbarash 1988 - Verapamil IV control - Verapamil - IV - 10 mg - Serum - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 101.7524, 56.98735, 45.66609, 34.18352, 25.15546, 25.17352, 16.44588, 12.75172, 10.23046, 6.584702, 5.112801, 4.955398, 4.563397 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Barbarash 1988 - Verapamil IV control - Verapamil - IV - 10 mg - Serum - agg. (n=6)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.17, 0.33, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 10.0, 12.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Barbarash 1988 - Verapamil PO control - Verapamil - PO - 120 mg - Serum - agg. (n=6)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2057.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Barbarash 1988", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/3180898", "Type": "String" }, { "Name": "Source", "Value": "Fig. 2", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil PO control", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 6.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Barbarash 1988 - Verapamil PO control - Verapamil - PO - 120 mg - Serum - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.003041857, 0.1168914, 0.1220741, 0.0722194239, 0.1145825, 0.07463083, 0.0426439568, 0.01793789, 0.01045367, 0.00545695331, 0.004473727, 0.004476229, 0.00355196884 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Barbarash 1988 - Verapamil PO control - Verapamil - PO - 120 mg - Serum - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 1.273073, 54.42658, 88.13258, 93.31271, 168.8972, 140.8194, 101.2364, 60.69596, 38.46138, 21.94651, 13.99261, 9.43155, 7.93594 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Barbarash 1988 - Verapamil PO control - Verapamil - PO - 120 mg - Serum - agg. (n=6)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.17, 0.33, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 10.0, 12.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "McAllister 1982 - Verapamil 10 mg IV - Verapamil - IV - 10 mg - Plasma - agg. (n=20)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2061.0, "Type": "Double" }, { "Name": "Study Id", "Value": "McAllister 1982", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/7060323", "Type": "String" }, { "Name": "Source", "Value": "Table 1", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil 10 mg IV", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 20.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "IV", "Type": "String" }, { "Name": "Dose", "Value": "10 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "iv infusion", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": "Arith. SEM converted to arith. SD", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "McAllister 1982 - Verapamil 10 mg IV - Verapamil - IV - 10 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.010285913, 0.04968543, 0.0143108349, 0.0138636213, 0.008049845, 0.01118034, 0.00760263158, 0.008049845, 0.008049845, 0.009838699, 0.008497058, 0.006708204, 0.00357770873, 0.00357770873, 0.00357770873 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "McAllister 1982 - Verapamil 10 mg IV - Verapamil - IV - 10 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 16.6, 69.9, 46.7, 42.3, 35.5, 30.8, 28.4, 29.6, 24.6, 21.1, 19.7, 14.5, 8.25, 5.8, 3.4 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "McAllister 1982 - Verapamil 10 mg IV - Verapamil - IV - 10 mg - Plasma - agg. (n=20)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.03, 0.08, 0.17, 0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 10.0, 12.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "McAllister 1982 - Verapamil 80 mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=20)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2062.0, "Type": "Double" }, { "Name": "Study Id", "Value": "McAllister 1982", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/7060323", "Type": "String" }, { "Name": "Source", "Value": "Table 1", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil 80 mg PO", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 20.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "80 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": "Arith. SEM converted to arith. SD", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "McAllister 1982 - Verapamil 80 mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.006708204, 0.00760263158, 0.00715541746, 0.0134164076, 0.0196773987, 0.01878297, 0.0232551079, 0.0178885441, 0.01118034, 0.00715541746, 0.00491934968, 0.00491934968 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "McAllister 1982 - Verapamil 80 mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 0.0046, 0.0079, 0.0125, 0.0226, 0.0330999978, 0.0354000032, 0.0384, 0.0321999975, 0.0228, 0.0158999991, 0.0087, 0.00424999977 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "McAllister 1982 - Verapamil 80 mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=20)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 10.0, 12.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "McAllister 1982 - Verapamil 120 mg PO - Verapamil - PO - 120 mg - Plasma - agg. (n=20)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2063.0, "Type": "Double" }, { "Name": "Study Id", "Value": "McAllister 1982", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/7060323", "Type": "String" }, { "Name": "Source", "Value": "Table 1", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil 120 mg PO", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 20.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": "Arith. SEM converted to arith. SD", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "McAllister 1982 - Verapamil 120 mg PO - Verapamil - PO - 120 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.00760263158, 0.0219134651, 0.0339882337, 0.03756594, 0.0429325067, 0.0509823523, 0.0442741476, 0.0339882337, 0.0272800289, 0.0107331267, 0.005813777, 0.004472136 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "McAllister 1982 - Verapamil 120 mg PO - Verapamil - PO - 120 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 0.0039, 0.0183, 0.0308, 0.0472, 0.0652, 0.0683, 0.0611999966, 0.0478, 0.0323, 0.0221, 0.0125, 0.0072 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "McAllister 1982 - Verapamil 120 mg PO - Verapamil - PO - 120 mg - Plasma - agg. (n=20)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 10.0, 12.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "McAllister 1982 - Verapamil 160 mg PO - Verapamil - PO - 160 mg - Plasma - agg. (n=20)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2064.0, "Type": "Double" }, { "Name": "Study Id", "Value": "McAllister 1982", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/7060323", "Type": "String" }, { "Name": "Source", "Value": "Table 1", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil 160 mg PO", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 20.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "160 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": "Arith. SEM converted to arith. SD", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "McAllister 1982 - Verapamil 160 mg PO - Verapamil - PO - 160 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.006708204, 0.008944272, 0.0134164076, 0.05634891, 0.04740464, 0.04516857, 0.03711873, 0.0254911762, 0.0143108349, 0.0134164076, 0.010285913, 0.008944272 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "McAllister 1982 - Verapamil 160 mg PO - Verapamil - PO - 160 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 0.0026, 0.0087, 0.0169999991, 0.0471, 0.0781, 0.0902, 0.0878, 0.0678, 0.0418, 0.0316, 0.0178, 0.0109 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "McAllister 1982 - Verapamil 160 mg PO - Verapamil - PO - 160 mg - Plasma - agg. (n=20)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 10.0, 12.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Hla 1987 - conventional Verapamil 120mg once daily (day 1) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2069.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Hla 1987", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/3435694", "Type": "String" }, { "Name": "Source", "Value": "Fig. 1", "Type": "String" }, { "Name": "Grouping", "Value": "conventional Verapamil 120mg once daily (day 1)", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 10.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "conventional tablet, Securon®", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Hla 1987 - conventional Verapamil 120mg once daily (day 1) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 0.983644366, 34.94037, 118.6365, 93.50379, 81.18125, 68.8551, 52.58839, 39.75183, 22.9459, 13.03149, 10.01218, 7.484094, 5.940852, 2.166417 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Hla 1987 - conventional Verapamil 120mg once daily (day 1) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.0, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 6.0, 8.0, 10.0, 12.0, 14.0, 24.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Hla 1987 - conventional Verapamil 120mg twice daily (day 10) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2070.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Hla 1987", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/3435694", "Type": "String" }, { "Name": "Source", "Value": "Fig. 1", "Type": "String" }, { "Name": "Grouping", "Value": "conventional Verapamil 120mg twice daily (day 10)", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 10.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": "0-(S24-T12-R18)", "Type": "String" }, { "Name": "Formulation", "Value": "conventional tablet, Securon®", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Hla 1987 - conventional Verapamil 120mg twice daily (day 10) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 41.10572, 153.9867, 259.4429, 229.2031, 188.5799, 159.8367, 140.4937, 110.2412, 74.48297, 45.65612, 35.65336, 30.113121, 82.99883, 45.85372, 21.29115 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Hla 1987 - conventional Verapamil 120mg twice daily (day 10) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 216.0, 216.5, 217.0, 217.5, 218.0, 218.5, 219.0, 220.0, 222.0, 224.0, 226.0, 228.0, 230.0, 240.0, 246.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 1 - 5 and 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2071.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Jorgensen 1988", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/3186615", "Type": "String" }, { "Name": "Source", "Value": "Fig. 1", "Type": "String" }, { "Name": "Grouping", "Value": "Conventional Verapamil 120 mg BID (day 1 - 5 and 8)", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 12.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": "S0-T12-R15", "Type": "String" }, { "Name": "Formulation", "Value": "conventional tablets", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 1 - 5 and 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 0.1420959, 24.2984, 37.37123, 41.6341, 46.18117, 46.03908 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 1 - 5 and 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.0, 24.0, 48.0, 72.0, 96.0, 168.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2072.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Jorgensen 1988", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/3186615", "Type": "String" }, { "Name": "Source", "Value": "Fig. 2", "Type": "String" }, { "Name": "Grouping", "Value": "Conventional Verapamil 120 mg BID (day 8)", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 12.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": "S0-T12-R15", "Type": "String" }, { "Name": "Formulation", "Value": "conventional tablets", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.03169399, 0.0540983677, 0.0901639462, 0.04480878, 0.04480872, 3.051758E-08, 0.0459016, 0.04590165, 0.03224044, 0.03934427, 0.02349726, 0.03005464, 0.01423358, 0.006021898 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 48.63388, 274.8634, 289.6175, 236.612, 179.235, 151.9126, 117.4863, 91.80328, 81.42077, 61.2021942, 42.0765, 36.61202, 17.51825, 6.569343 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 168.0, 168.5, 169.0, 169.5, 170.0, 171.0, 172.0, 173.0, 174.0, 176.0, 178.0, 180.0, 192.0, 200.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 1 - 5 and 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2073.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Jorgensen 1988", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/3186615", "Type": "String" }, { "Name": "Source", "Value": "Fig. 1", "Type": "String" }, { "Name": "Grouping", "Value": "Sustained release Verapamil 240 mg OD (day 1 - 5 and 8)", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 12.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "240 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": "S0-T24-R8", "Type": "String" }, { "Name": "Formulation", "Value": "sustained release tablets", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 1 - 5 and 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ "NaN", 0.01207815, 0.0242984015, 0.0152042592, 0.02387211, 0.029413851 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 1 - 5 and 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 0.1420959, 21.45648, 38.93428, 40.07105, 36.23446, 44.47602 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 1 - 5 and 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.0, 24.0, 48.0, 72.0, 96.0, 168.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2074.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Jorgensen 1988", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/3186615", "Type": "String" }, { "Name": "Source", "Value": "Fig. 2", "Type": "String" }, { "Name": "Grouping", "Value": "Sustained release Verapamil 240 mg OD (day 8)", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 12.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "240 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": "S0-T24-R8", "Type": "String" }, { "Name": "Formulation", "Value": "sustained release tablets", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.02349727, "NaN", "NaN", "NaN", "NaN", 0.03825142, 0.02404372, 0.02622955, 0.03497272, 0.03606559, "NaN", "NaN", "NaN", "NaN" ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 40.43716, 77.04918, 121.3115, 139.8907, 146.4481, 156.2841, 144.2623, 157.377, 145.9016, 122.9508, 101.0929, 78.14207, 21.89781, 6.569343 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 168.0, 168.5, 169.0, 169.5, 170.0, 171.0, 172.0, 173.0, 174.0, 176.0, 178.0, 180.0, 192.0, 200.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Karim 1995 - Verapamil total IR fasting - Verapamil - PO - 240 mg - Plasma - agg. (n=12)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2075.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Karim 1995", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/7648767", "Type": "String" }, { "Name": "Source", "Value": "Fig. 3", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil total IR fasting", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 12.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "240 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "2x 120 mg Calan immediate-release tablet (lot 2N298)", "Type": "String" }, { "Name": "Food state", "Value": "Fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Karim 1995 - Verapamil total IR fasting - Verapamil - PO - 240 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 5.691057, 105.2846, 232.7642, 280.5691, 303.9024, 285.1219, 267.4797, 243.577209, 171.8699, 95.04065, 71.70731, 54.06504, 33.00813, 27.31707, 22.76423, 18.78049, 13.65854, 6.260163 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Karim 1995 - Verapamil total IR fasting - Verapamil - PO - 240 mg - Plasma - agg. (n=12)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 6.0, 7.0, 8.0, 10.0, 11.0, 12.0, 14.0, 16.0, 24.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Karim 1995 - Verapamil total SR fed - Verapamil - PO - 240 mg - Plasma - agg. (n=12)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2076.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Karim 1995", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/7648767", "Type": "String" }, { "Name": "Source", "Value": "Fig. 3", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil total SR fed", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 12.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "240 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "240 mg Calan sustained-release tablet (lot 2J066K)", "Type": "String" }, { "Name": "Food state", "Value": "Fed", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Karim 1995 - Verapamil total SR fed - Verapamil - PO - 240 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 3.414634, 6.260163, 10.81301, 14.79675, 23.90244, 53.49593, 50.0813, 44.95935, 39.26829, 43.25203, 47.23577, 44.95935, 34.14634, 32.43903 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Karim 1995 - Verapamil total SR fed - Verapamil - PO - 240 mg - Plasma - agg. (n=12)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 1.5, 2.0, 2.5, 3.0, 4.0, 6.0, 7.0, 8.0, 10.0, 11.0, 12.0, 14.0, 16.0, 24.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Shand 1981 - Verapamil day 1 - Verapamil - PO - 120 mg - Plasma - agg. (n=6)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2077.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Shand 1981", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/7297027", "Type": "String" }, { "Name": "Source", "Value": "Fig. 1", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil day 1", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 6.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral (Isoptin, 120 mg)", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Shand 1981 - Verapamil day 1 - Verapamil - PO - 120 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 352.8735, 134.6641, 84.83429, 62.01789, 43.9397, 32.37458, 21.71374 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Shand 1981 - Verapamil day 1 - Verapamil - PO - 120 mg - Plasma - agg. (n=6)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 1.0, 2.0, 3.0, 4.0, 5.0, 6.0, 8.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Shand 1981 - Verapamil day 3 (after 7th dose) - Verapamil - PO - 120 mg - Plasma - agg. (n=6)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2078.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Shand 1981", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/7297027", "Type": "String" }, { "Name": "Source", "Value": "Fig. 1", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil day 3 (after 7th dose)", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 6.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": "S0-T8-R7", "Type": "String" }, { "Name": "Formulation", "Value": "oral (Isoptin, 120 mg)", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Shand 1981 - Verapamil day 3 (after 7th dose) - Verapamil - PO - 120 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 159.9859, 522.0199, 355.648, 276.8069, 232.9952, 200.7803, 146.7799, 145.6348, 130.5107 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Shand 1981 - Verapamil day 3 (after 7th dose) - Verapamil - PO - 120 mg - Plasma - agg. (n=6)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 48.0, 49.0, 50.0, 51.0, 52.0, 53.0, 54.0, 55.0, 56.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Johnson 2001 - Verapamil Steady State - Verapamil - PO - 80 mg - Plasma - agg. (n=12)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2079.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Johnson 2001", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/11697758", "Type": "String" }, { "Name": "Source", "Value": "Table 1", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil Steady State", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 12.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "80 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": "S0-T8-R7", "Type": "String" }, { "Name": "Formulation", "Value": "standard release capsules", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Johnson 2001 - Verapamil Steady State - Verapamil - PO - 80 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.0478, 0.0927, 0.116000004, 0.0978999957, 0.0920999944, 0.177, 0.1231, 0.0792, 0.0647, 0.0458, 0.0399, 0.0276, 0.0155 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Johnson 2001 - Verapamil Steady State - Verapamil - PO - 80 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 61.0999947, 70.9, 199.2, 179.4, 155.0, 175.0, 142.4, 88.3, 65.0, 47.9, 39.4, 26.3, 15.9 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Johnson 2001 - Verapamil Steady State - Verapamil - PO - 80 mg - Plasma - agg. (n=12)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 48.0, 48.5, 49.0, 49.5, 50.0, 51.0, 52.0, 54.0, 56.0, 58.0, 60.0, 64.0, 72.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Streit 2005 - intravenous verapamil during normoxia (5 mg) - Verapamil - IV - 5 mg - Plasma - agg. (n=10)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2080.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Streit 2005", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/15692829", "Type": "String" }, { "Name": "Source", "Value": "Fig. 2", "Type": "String" }, { "Name": "Grouping", "Value": "intravenous verapamil during normoxia (5 mg)", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 10.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "IV", "Type": "String" }, { "Name": "Dose", "Value": "5 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "iv infusion, Isoptin, Knoll Deutschland GmbH, Ludwigshafen, Germany)", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Streit 2005 - intravenous verapamil during normoxia (5 mg) - Verapamil - IV - 5 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.0453592278, 0.00481552863, 0.00326213287, 0.003106797, 0.00248543313, 0.00233009621, "NaN", "NaN", "NaN", "NaN", "NaN", "NaN", "NaN" ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Streit 2005 - intravenous verapamil during normoxia (5 mg) - Verapamil - IV - 5 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 72.54369, 27.33981, 19.1068, 15.2233, 11.18447, 8.54369, 5.592233, 4.194175, 2.485437, 2.019418, 1.553398, 1.242718, 0.9320388 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Streit 2005 - intravenous verapamil during normoxia (5 mg) - Verapamil - IV - 5 mg - Plasma - agg. (n=10)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.33, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 10.0, 12.0, 14.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 5 mg - Plasma - indiv.", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16080.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Eichelbaum 1984", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/6721991/", "Type": "String" }, { "Name": "Source", "Value": "Fig.1 & Tab. 2", "Type": "String" }, { "Name": "Grouping", "Value": "Subject 4", "Type": "String" }, { "Name": "Data type", "Value": "individual", "Type": "String" }, { "Name": "N", "Value": 1.0, "Type": "Double" }, { "Name": "Molecule", "Value": "R-Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "IV", "Type": "String" }, { "Name": "Dose", "Value": "5 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "i.v. infusion", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|Individual" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.611, "LLOQ": 2E-10 }, "Values": [ 144.198, 58.2668, 34.9588966, 31.9694, 20.8664989, 18.270401, 16.1952, 14.8416, 11.8613, 7.39132071, 5.97313, 3.65998983, 2.22002983, 1.71185 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 5 mg - Plasma - indiv.|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.08333334, 0.1666667, 0.25, 0.3333333, 0.5833333, 0.8333333, 1.08333313, 1.58333313, 2.083333, 3.083333, 4.083333, 7.083333, 9.083333, 11.08333 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 25 mg - Plasma - indiv.", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16081.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Eichelbaum 1984", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/6721991/", "Type": "String" }, { "Name": "Source", "Value": "Fig.1 & Tab. 2", "Type": "String" }, { "Name": "Grouping", "Value": "Subject 4", "Type": "String" }, { "Name": "Data type", "Value": "individual", "Type": "String" }, { "Name": "N", "Value": 1.0, "Type": "Double" }, { "Name": "Molecule", "Value": "R-Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "IV", "Type": "String" }, { "Name": "Dose", "Value": "25 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "i.v. infusion", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 25 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|Individual" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.611, "LLOQ": 2E-10 }, "Values": [ 522.503, 265.499, 149.35, 127.242004, 96.5589, 82.8747, 74.6002, 58.3488, 56.1692, 42.5531, 26.2323, 16.7413, 14.1033993, 10.0393, 8.156641, 6.80772972 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 25 mg - Plasma - indiv.|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.08333334, 0.1666667, 0.25, 0.3333333, 0.5833333, 0.8333333, 1.08333313, 1.58333313, 2.083333, 3.083333, 4.083333, 6.083333, 7.083333, 9.083333, 11.08333, 12.08333 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 50 mg - Plasma - indiv.", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16082.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Eichelbaum 1984", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/6721991/", "Type": "String" }, { "Name": "Source", "Value": "Fig.1 & Tab. 2", "Type": "String" }, { "Name": "Grouping", "Value": "Subject 4", "Type": "String" }, { "Name": "Data type", "Value": "individual", "Type": "String" }, { "Name": "N", "Value": 1.0, "Type": "Double" }, { "Name": "Molecule", "Value": "R-Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "IV", "Type": "String" }, { "Name": "Dose", "Value": "50 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "i.v. infusion", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 50 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|Individual" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.611, "LLOQ": 2E-10 }, "Values": [ 1169.86, 575.615, 306.802, 257.382, 194.124, 169.455, 125.468, 109.458992, 99.2346039, 72.7886047, 46.7758, 28.0273, 23.8658, 19.1246, 15.7066, 12.8897991 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 50 mg - Plasma - indiv.|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.08333334, 0.1666667, 0.25, 0.3333333, 0.5833333, 0.8333333, 1.08333313, 1.58333313, 2.083333, 3.083333, 4.083333, 6.083333, 7.083333, 9.083333, 11.08333, 12.08333 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 5 mg - Plasma - indiv.", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16083.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Eichelbaum 1984", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/6721991/", "Type": "String" }, { "Name": "Source", "Value": "Fig.1 & Tab. 2", "Type": "String" }, { "Name": "Grouping", "Value": "Subject 4", "Type": "String" }, { "Name": "Data type", "Value": "individual", "Type": "String" }, { "Name": "N", "Value": 1.0, "Type": "Double" }, { "Name": "Molecule", "Value": "S-Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "IV", "Type": "String" }, { "Name": "Dose", "Value": "5 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "i.v. infusion", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|S-Verapamil|Individual" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.611, "LLOQ": 2E-10 }, "Values": [ 0.0365668, 0.0218736, 0.0176064, 0.0147932, 0.010589, 0.00915864, 0.00652535, 0.00612903, 0.00577428, 0.00436106, 0.00242533, 0.00208439, 0.00145879 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 5 mg - Plasma - indiv.|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.08333334, 0.1666667, 0.25, 0.3333333, 0.5833333, 0.8333333, 1.08333313, 1.58333313, 2.083333, 3.083333, 6.083333, 7.083333, 9.083333 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 7.5 mg - Plasma - indiv.", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16084.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Eichelbaum 1984", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/6721991/", "Type": "String" }, { "Name": "Source", "Value": "Fig.1 & Tab. 2", "Type": "String" }, { "Name": "Grouping", "Value": "Subject 4", "Type": "String" }, { "Name": "Data type", "Value": "individual", "Type": "String" }, { "Name": "N", "Value": 1.0, "Type": "Double" }, { "Name": "Molecule", "Value": "S-Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "IV", "Type": "String" }, { "Name": "Dose", "Value": "7.5 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "i.v. infusion", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 7.5 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|S-Verapamil|Individual" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.611, "LLOQ": 2E-10 }, "Values": [ 0.0450771, 0.0302597973, 0.0269569, 0.0207825, 0.0156267, 0.0127801, 0.0101196, 0.00892402, 0.00632805, 0.00551413, 0.00377127971, 0.00196907, 0.00155615, 0.0011953 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 7.5 mg - Plasma - indiv.|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.08333334, 0.1666667, 0.25, 0.3333333, 0.5833333, 1.08333313, 1.58333313, 2.083333, 3.083333, 4.083333, 6.083333, 9.083333, 11.08333, 12.08333 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 10 mg - Plasma - indiv.", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16085.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Eichelbaum 1984", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/6721991/", "Type": "String" }, { "Name": "Source", "Value": "Fig.1 & Tab. 2", "Type": "String" }, { "Name": "Grouping", "Value": "Subject 4", "Type": "String" }, { "Name": "Data type", "Value": "individual", "Type": "String" }, { "Name": "N", "Value": 1.0, "Type": "Double" }, { "Name": "Molecule", "Value": "S-Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "IV", "Type": "String" }, { "Name": "Dose", "Value": "10 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "i.v. infusion", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 10 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|S-Verapamil|Individual" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.611, "LLOQ": 2E-10 }, "Values": [ 0.07488351, 0.0650928, 0.0421136, 0.0353312, 0.0268954, 0.0207908, 0.0170919, 0.0134298, 0.0110003, 0.00930979, 0.00580134, 0.00424881, 0.00299661, 0.00199957, 0.00160353 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 10 mg - Plasma - indiv.|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.08333334, 0.1666667, 0.25, 0.3333333, 0.5833333, 0.8333333, 1.08333313, 1.58333313, 2.083333, 3.083333, 6.083333, 7.083333, 9.083333, 11.08333, 12.08333 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Streit et al. 2005 - intravenous verapamil during normoxia (5 mg) - Norverapamil - IV - 5 mg - Plasma - agg. (n=10)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16108.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Streit et al. 2005", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/15692829/", "Type": "String" }, { "Name": "Source", "Value": "Table 5", "Type": "String" }, { "Name": "Grouping", "Value": "intravenous verapamil during normoxia (5 mg)", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 10.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Norverapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "IV", "Type": "String" }, { "Name": "Dose", "Value": "5 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "iv infusion, Isoptin, Knoll Deutschland GmbH, Ludwigshafen, Germany)", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Streit et al. 2005 - intravenous verapamil during normoxia (5 mg) - Norverapamil - IV - 5 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 440.584, "LLOQ": 1E-10 }, "Values": [ 1.79000008 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Streit et al. 2005 - intravenous verapamil during normoxia (5 mg) - Norverapamil - IV - 5 mg - Plasma - agg. (n=10)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 1.6 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Abernethy et al. 1985 - 10mg Verapamil without cimetidine, IV - Verapamil - IV - 10 mg - Plasma - indiv.", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16109.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Abernethy et al. 1985", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/4028631/", "Type": "String" }, { "Name": "Source", "Value": "Figure 1", "Type": "String" }, { "Name": "Grouping", "Value": "10mg Verapamil without cimetidine, IV", "Type": "String" }, { "Name": "Data type", "Value": "individual", "Type": "String" }, { "Name": "N", "Value": 1.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "IV", "Type": "String" }, { "Name": "Dose", "Value": "10 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 12.0, "Type": "Double" }, { "Name": "Formulation", "Value": "i.v. infusion", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Abernethy et al. 1985 - 10mg Verapamil without cimetidine, IV - Verapamil - IV - 10 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|Individual" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 114.61, 47.022, 32.713, 28.953001, 26.908, 25.587, 20.555, 20.08, 17.44, 8.86899948, 7.62900066 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Abernethy et al. 1985 - 10mg Verapamil without cimetidine, IV - Verapamil - IV - 10 mg - Plasma - indiv.|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 12.1670008, 12.25, 12.4170008, 12.6670008, 12.9170008, 13.1670008, 13.6670008, 14.1670008, 14.6670008, 16.167, 18.167 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Abernethy et al. 1985 - 120mg Verapamil without cimetidine, PO - Verapamil - PO - 120 mg - Plasma - indiv.", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16110.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Abernethy et al. 1985", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/4028631/", "Type": "String" }, { "Name": "Source", "Value": "Figure 1", "Type": "String" }, { "Name": "Grouping", "Value": "120mg Verapamil without cimetidine, PO", "Type": "String" }, { "Name": "Data type", "Value": "individual", "Type": "String" }, { "Name": "N", "Value": 1.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 12.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Abernethy et al. 1985 - 120mg Verapamil without cimetidine, PO - Verapamil - PO - 120 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|Individual" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 66.545, 162.72, 208.23999, 164.91, 148.93, 135.11, 97.324, 94.658, 66.097, 40.994, 26.145, 13.6240005, 9.2107 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Abernethy et al. 1985 - 120mg Verapamil without cimetidine, PO - Verapamil - PO - 120 mg - Plasma - indiv.|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 13.0, 13.0457, 13.2802, 13.5698, 13.6845, 14.1118, 14.5918, 15.1227, 16.0452, 18.0964, 20.0589, 24.2404, 26.9161 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Wing et al. 1985 - 80mg Verapamil without cimetidine, PO - Verapamil - PO - 80 mg - Plasma - indiv.", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16112.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Wing et al. 1985", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/3986090/", "Type": "String" }, { "Name": "Source", "Value": "Figure 1", "Type": "String" }, { "Name": "Grouping", "Value": "80mg Verapamil without cimetidine, PO", "Type": "String" }, { "Name": "Data type", "Value": "individual", "Type": "String" }, { "Name": "N", "Value": 1.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "80 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Wing et al. 1985 - 80mg Verapamil without cimetidine, PO - Verapamil - PO - 80 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|Individual" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 57.3830032, 78.984, 66.459, 50.127, 30.4569988, 19.768, 10.7450008 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Wing et al. 1985 - 80mg Verapamil without cimetidine, PO - Verapamil - PO - 80 mg - Plasma - indiv.|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Mikus et al. 1990 - 160mg verapamil without cimetidine, PO - R-Verapamil - PO - 160 mg - Plasma - indiv.", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16140.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Mikus et al. 1990", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/2359015/", "Type": "String" }, { "Name": "Source", "Value": "Figure 3", "Type": "String" }, { "Name": "Grouping", "Value": "160mg verapamil without cimetidine, PO", "Type": "String" }, { "Name": "Data type", "Value": "individual", "Type": "String" }, { "Name": "N", "Value": 1.0, "Type": "Double" }, { "Name": "Molecule", "Value": "R-Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "160 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral solution", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Mikus et al. 1990 - 160mg verapamil without cimetidine, PO - R-Verapamil - PO - 160 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|Individual" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.611 }, "Values": [ 0.21163, 0.21421, 0.18168, 0.15642, 0.13446, 0.11582, 0.10029, 0.08028, 0.07285, 0.05393, 0.03843, 0.03339, 0.02744, 0.02148, 0.01517, 0.01252 ], "Dimension": "Concentration (molar)", "Unit": "µmol/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Mikus et al. 1990 - 160mg verapamil without cimetidine, PO - R-Verapamil - PO - 160 mg - Plasma - indiv.|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.75, 1.0, 1.25, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0, 6.0, 8.0, 9.0, 11.0, 12.0, 14.0, 15.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Freedman et al. 1981 - Control Subject (Subject number 4) - Verapamil - IV - 13.1 mg - Plasma - indiv.", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16113.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Freedman et al. 1981", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/7297023/", "Type": "String" }, { "Name": "Source", "Value": "Figure 1", "Type": "String" }, { "Name": "Grouping", "Value": "Control Subject (Subject number 4)", "Type": "String" }, { "Name": "Data type", "Value": "individual", "Type": "String" }, { "Name": "N", "Value": 1.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "IV", "Type": "String" }, { "Name": "Dose", "Value": "13.1 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "i.v. infusion", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Freedman et al. 1981 - Control Subject (Subject number 4) - Verapamil - IV - 13.1 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|Individual" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 204.097, 111.115, 83.0373, 76.5629959, 65.92349, 49.9759026, 45.1357, 39.4870033, 30.6092014, 28.1778, 22.0171986, 20.8241024, 16.0143013, 11.4824991, 9.21809, 6.23147, 5.64588976, 4.49658, 3.72068, 2.88876, 2.88417 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Freedman et al. 1981 - Control Subject (Subject number 4) - Verapamil - IV - 13.1 mg - Plasma - indiv.|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.2166667, 0.3, 0.3416667, 0.3833333, 0.4666667, 0.7166666, 0.9666666, 1.216667, 1.716667, 2.216667, 2.716667, 3.216667, 4.216667, 5.216667, 6.216667, 8.216666, 9.216666, 10.21667, 11.21667, 13.21667, 14.21667 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Abernethy et al. 1993 - Representative younger subject - Verapamil - IV - 20 mg - Plasma - indiv.", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16114.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Abernethy et al. 1993", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/8355215/", "Type": "String" }, { "Name": "Source", "Value": "Figure 1", "Type": "String" }, { "Name": "Grouping", "Value": "Representative younger subject", "Type": "String" }, { "Name": "Data type", "Value": "individual", "Type": "String" }, { "Name": "N", "Value": 1.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "IV", "Type": "String" }, { "Name": "Dose", "Value": "20 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "i.v. infusion", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Abernethy et al. 1993 - Representative younger subject - Verapamil - IV - 20 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|Individual" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 146.3804, 106.390793, 75.73051, 62.0765038, 51.1132, 39.8836975, 36.2110977, 30.2319984, 27.7147, 24.0478115, 18.02734, 13.05137, 8.384951, 4.4396 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Abernethy et al. 1993 - Representative younger subject - Verapamil - IV - 20 mg - Plasma - indiv.|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5, 0.5833333, 0.75, 1.0, 1.25, 1.5, 1.75, 2.0, 2.5, 3.0, 3.5, 4.5, 6.5, 8.5 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Abernethy et al. 1993 - Representative younger subject - R-Verapamil - IV - 20 mg - Plasma - indiv.", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16115.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Abernethy et al. 1993", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/8355215/", "Type": "String" }, { "Name": "Source", "Value": "Figure 1", "Type": "String" }, { "Name": "Grouping", "Value": "Representative younger subject", "Type": "String" }, { "Name": "Data type", "Value": "individual", "Type": "String" }, { "Name": "N", "Value": 1.0, "Type": "Double" }, { "Name": "Molecule", "Value": "R-Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "IV", "Type": "String" }, { "Name": "Dose", "Value": "20 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "i.v. infusion", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Abernethy et al. 1993 - Representative younger subject - R-Verapamil - IV - 20 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|Individual" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.611 }, "Values": [ 83.4114, 60.4906, 44.5114, 37.6331, 31.4987011, 25.522, 23.0773, 19.1866, 17.5457, 15.1547, 11.3164005, 8.40459, 5.64557, 3.13499975, 2.20881 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Abernethy et al. 1993 - Representative younger subject - R-Verapamil - IV - 20 mg - Plasma - indiv.|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.501391, 0.629438, 0.757373, 1.00983, 1.26236, 1.52691, 1.75137, 2.05105, 2.53444, 3.0379, 3.54247, 4.55726, 6.53823, 8.54029, 12.5381 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Abernethy et al. 1993 - Representative younger subject - S-Verapamil - IV - 20 mg - Plasma - indiv.", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16116.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Abernethy et al. 1993", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/8355215/", "Type": "String" }, { "Name": "Source", "Value": "Figure 1", "Type": "String" }, { "Name": "Grouping", "Value": "Representative younger subject", "Type": "String" }, { "Name": "Data type", "Value": "individual", "Type": "String" }, { "Name": "N", "Value": 1.0, "Type": "Double" }, { "Name": "Molecule", "Value": "S-Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "IV", "Type": "String" }, { "Name": "Dose", "Value": "20 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "i.v. infusion", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Abernethy et al. 1993 - Representative younger subject - S-Verapamil - IV - 20 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|S-Verapamil|Individual" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.611 }, "Values": [ 62.969, 45.9002, 37.2046, 31.2191029, 24.4433975, 19.6145, 14.3617, 13.1338, 11.0454006, 10.1690006, 8.89311, 6.71094036, 4.64678, 2.73938012, 1.3046 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Abernethy et al. 1993 - Representative younger subject - S-Verapamil - IV - 20 mg - Plasma - indiv.|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.499621, 0.576952, 0.712594, 0.769131, 1.02724, 1.26544, 1.5083, 1.76127, 2.06612, 2.54372, 3.04536986, 3.53633, 4.54434, 6.52328, 8.53934 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Vogelgesang et al. 1984 - Healthy volunteers - R-Verapamil - PO - 250 mg - Plasma - indiv.", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16117.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Vogelgesang et al. 1984", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/6508982/", "Type": "String" }, { "Name": "Source", "Value": "Figure 1", "Type": "String" }, { "Name": "Grouping", "Value": "Healthy volunteers", "Type": "String" }, { "Name": "Data type", "Value": "individual", "Type": "String" }, { "Name": "N", "Value": 1.0, "Type": "Double" }, { "Name": "Molecule", "Value": "R-Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "250 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral solution", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Vogelgesang et al. 1984 - Healthy volunteers - R-Verapamil - PO - 250 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|Individual" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.611 }, "Values": [ 0.4293597, 0.4158913, 0.3392883, 0.2757995, 0.24269408, 0.2378966, 0.2087913, 0.2162071, 0.1515976, 0.1317532, 0.1252465, 0.1088576, 0.06680758, 0.05413678, 0.0459572, 0.04037307, 0.03340418, 0.02719752, 0.01435707 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Vogelgesang et al. 1984 - Healthy volunteers - R-Verapamil - PO - 250 mg - Plasma - indiv.|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 1.75, 2.0, 2.5, 3.0, 5.0, 6.0, 8.0, 9.0, 11.0, 12.0, 14.0, 15.0, 24.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Verapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16121.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Choi et al. 2008", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/18193210/", "Type": "String" }, { "Name": "Source", "Value": "Figure 1", "Type": "String" }, { "Name": "Grouping", "Value": "60mg Verapamil in absence of oral atorvastatin", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 12.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Arterial Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "60 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral capsule", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Verapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)|ObservedData|Arterial Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.00387966982, 0.0080394, 0.0187749, 0.0158024, 0.0146195, 0.0090615, 0.0065833, 0.00379761029, 0.00256986, 0.00160073 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Verapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)|ObservedData|Arterial Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6, "LLOQ": 2E-09 }, "Values": [ 9.05037, 27.1293, 55.4861, 48.433, 40.9202042, 29.6901, 22.2158012, 10.9535007, 6.0536, 3.17629 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Verapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.25, 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 8.0, 12.0, 24.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Norverapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16122.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Choi et al. 2008", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/18193210/", "Type": "String" }, { "Name": "Source", "Value": "Figure 1", "Type": "String" }, { "Name": "Grouping", "Value": "60mg Verapamil in absence of oral atorvastatin", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 12.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Norverapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Arterial Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "60 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral capsule", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Norverapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)|ObservedData|Arterial Blood|Plasma|Norverapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 440.584 }, "Values": [ 0.00234969, 0.0079886, 0.0052048, 0.0053342, 0.0058298, 0.0042542, 0.0046069, 0.00295028, 0.00091494 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Norverapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)|ObservedData|Arterial Blood|Plasma|Norverapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 440.584, "LLOQ": 2E-09 }, "Values": [ 5.61906, 29.6349983, 30.6736012, 28.2336, 23.1139, 18.2515, 12.6441, 8.04676, 2.48 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Norverapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 8.0, 12.0, 24.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Ratiopharm 1988 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16123.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Ratiopharm 1988", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ratiopharm.de/assets/products/de/label/Verapamil-ratiopharm%20N%20-%205.pdf?pzn=3634082", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/)", "Type": "String" }, { "Name": "Grouping", "Value": "Unknown", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 16.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "80 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Ratiopharm 1988 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.027803, 0.026595, 0.021628, 0.01903, 0.017664, 0.016094, 0.014191, 0.011003, 0.006691, 0.004637, 0.002749 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Ratiopharm 1988 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 28.782999, 43.95, 43.1130028, 41.857, 37.420002, 34.029, 31.71, 24.619, 14.076, 8.51, 5.21699953 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Ratiopharm 1988 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.4974, 0.75, 0.9988, 1.5013, 2.0011, 2.5016, 3.0011, 4.0011, 6.0001, 8.001901, 11.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Ratiopharm 1988 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16124.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Ratiopharm 1988", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ratiopharm.de/assets/products/de/label/Verapamil-ratiopharm%20N%20-%205.pdf?pzn=3634082", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/)", "Type": "String" }, { "Name": "Grouping", "Value": "Unknown", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 16.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Norverapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "80 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Ratiopharm 1988 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 440.584 }, "Values": [ 0.020441, 0.023884, 0.017949, 0.013174, 0.011752, 0.009922, 0.010578, 0.009839999, 0.009713001, 0.008631, 0.006519, 0.004171, 0.002197 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Ratiopharm 1988 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 440.584 }, "Values": [ 23.0659981, 43.848, 45.3630028, 45.572998, 44.11, 43.684, 43.605, 39.802, 32.2399979, 26.036, 20.0159988, 12.96, 4.63499975 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Ratiopharm 1988 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5022, 0.7433, 1.002, 1.4948, 1.9987, 2.4957, 2.9995, 3.995, 5.9956, 8.0044, 10.9989, 15.0038, 30.0041 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Ratiopharm 1989 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16125.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Ratiopharm 1989", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ratiopharm.de/assets/products/de/label/Verapamil-ratiopharm%20N%20-%205.pdf?pzn=3634082", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/)", "Type": "String" }, { "Name": "Grouping", "Value": "Unknown", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 16.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "80 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Ratiopharm 1989 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ "NaN", 0.039666, 0.035484, 0.027342, 0.021729, 0.019833, 0.016688, 0.013559, 0.009288, 0.00658, 0.003773 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Ratiopharm 1989 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 41.2640038, 55.567997, 54.045, 49.9950027, 41.204998, 36.7279968, 31.6190033, 24.765, 14.885, 9.486, 5.44699955 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Ratiopharm 1989 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5018, 0.7512, 1.0053, 1.5051, 1.9984, 2.5066, 3.0017, 4.0013, 6.0005, 7.9997, 10.9985 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Ratiopharm 1989 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16126.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Ratiopharm 1989", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ratiopharm.de/assets/products/de/label/Verapamil-ratiopharm%20N%20-%205.pdf?pzn=3634082", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/)", "Type": "String" }, { "Name": "Grouping", "Value": "Unknown", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 16.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Norverapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "80 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Ratiopharm 1989 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 440.584 }, "Values": [ 0.0196976, 0.0189048, 0.016237, 0.0143509, 0.0137446, 0.013686, 0.0128686, 0.0125523, 0.0127268, 0.0091453, 0.0064272, 0.0046155, 0.0027831, 0.0024258 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Ratiopharm 1989 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 440.584 }, "Values": [ 23.0742989, 35.8503036, 36.9120026, 39.2883034, 37.452198, 36.3906975, 33.9167023, 31.6227016, 27.9346, 20.7196, 14.7734995, 9.7184, 5.6457, 2.96130013 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Ratiopharm 1989 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.4897, 0.7355, 0.9997, 1.4983, 2.0029, 2.5092, 3.006, 3.9871, 5.9965, 8.0027, 10.9962988, 14.9995, 23.9968, 29.9936 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Boehringer 2018 - Unknown - R-Verapamil - PO - 120 mg - Plasma - agg. (n=12)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16128.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Boehringer 2018", "Type": "String" }, { "Name": "Reference", "Value": "https://clinicaltrials.gov/ct2/show/record/NCT03307252", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/ ; https://github.com/Clinical-Pharmacy-Saarland-University/Verapamil-Norverapamil-Model)", "Type": "String" }, { "Name": "Grouping", "Value": "Unknown", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 12.0, "Type": "Double" }, { "Name": "Molecule", "Value": "R-Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Boehringer 2018 - Unknown - R-Verapamil - PO - 120 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.611 }, "Values": [ 0.03646559, 0.03003475, 0.02718648, 0.02039836, 0.01770662, 0.01582147, 0.01488254, 0.01039907, 0.00763581274, 0.006471827, 0.005094588, 0.004042694, 0.002783686 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Boehringer 2018 - Unknown - R-Verapamil - PO - 120 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.611 }, "Values": [ 0.08544167, 0.07869167, 0.07450834, 0.058225, 0.05275, 0.04686667, 0.04080833, 0.03216667, 0.02328182, 0.02066364, 0.01504454, 0.01035818, 0.007050909 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Boehringer 2018 - Unknown - R-Verapamil - PO - 120 mg - Plasma - agg. (n=12)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 1.333, 1.667, 2.0, 2.5, 3.0, 3.5, 4.0, 5.0, 6.0, 7.0, 9.0, 11.0, 13.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Boehringer 2018 - Unknown - S-Verapamil - PO - 120 mg - Plasma - agg. (n=12)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16129.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Boehringer 2018", "Type": "String" }, { "Name": "Reference", "Value": "https://clinicaltrials.gov/ct2/show/record/NCT03307252", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/ ; https://github.com/Clinical-Pharmacy-Saarland-University/Verapamil-Norverapamil-Model)", "Type": "String" }, { "Name": "Grouping", "Value": "Unknown", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 12.0, "Type": "Double" }, { "Name": "Molecule", "Value": "S-Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Boehringer 2018 - Unknown - S-Verapamil - PO - 120 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|S-Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.611 }, "Values": [ 0.01127755, 0.009811355, 0.008347172, 0.00581324, 0.005204772, 0.00373777887, 0.004048229, 0.003234755, 0.001714177, 0.001523305 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Boehringer 2018 - Unknown - S-Verapamil - PO - 120 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|S-Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.611 }, "Values": [ 0.01679417, 0.0152608287, 0.0146, 0.01141083, 0.01026167, 0.008804168, 0.008108333, 0.0068525, 0.004924, 0.004975 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Boehringer 2018 - Unknown - S-Verapamil - PO - 120 mg - Plasma - agg. (n=12)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 1.333, 1.667, 2.0, 2.5, 3.0, 3.5, 4.0, 5.0, 6.0, 7.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Boehringer 2018 - Unknown - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16130.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Boehringer 2018", "Type": "String" }, { "Name": "Reference", "Value": "https://clinicaltrials.gov/ct2/show/record/NCT03307252", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/ ; https://github.com/Clinical-Pharmacy-Saarland-University/Verapamil-Norverapamil-Model)", "Type": "String" }, { "Name": "Grouping", "Value": "Unknown", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 12.0, "Type": "Double" }, { "Name": "Molecule", "Value": "R-Norverapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Boehringer 2018 - Unknown - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|R-Norverapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 440.584 }, "Values": [ 0.01387929, 0.01283285, 0.01319351, 0.01288112, 0.01243871, 0.01151294, 0.01165734, 0.01093178, 0.009337299, 0.00936128, 0.008875515, 0.006048867, 0.004894454, 0.002532625 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Boehringer 2018 - Unknown - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|R-Norverapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 440.584 }, "Values": [ 0.0512, 0.050625, 0.05038333, 0.04818333, 0.04601667, 0.04306667, 0.04205, 0.038525, 0.03368333, 0.03210833, 0.027075, 0.02101667, 0.01712273, 0.007685833 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Boehringer 2018 - Unknown - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 1.333, 1.667, 2.0, 2.5, 3.0, 3.5, 4.0, 5.0, 6.0, 7.0, 9.0, 11.0, 13.0, 25.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Boehringer 2018 - Unknown - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16131.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Boehringer 2018", "Type": "String" }, { "Name": "Reference", "Value": "https://clinicaltrials.gov/ct2/show/record/NCT03307252", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/ ; https://github.com/Clinical-Pharmacy-Saarland-University/Verapamil-Norverapamil-Model)", "Type": "String" }, { "Name": "Grouping", "Value": "Unknown", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 12.0, "Type": "Double" }, { "Name": "Molecule", "Value": "S-Norverapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Boehringer 2018 - Unknown - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|S-Norverapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 440.584 }, "Values": [ 0.006391685, 0.006111756, 0.004995868, 0.0048587, 0.004189778, 0.004181273, 0.004382957, 0.004300265, 0.00321675, 0.003194303, 0.002911752, 0.002202375, 0.001578958 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Boehringer 2018 - Unknown - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|S-Norverapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 440.584 }, "Values": [ 0.01915, 0.01855833, 0.017465, 0.01828333, 0.01661667, 0.01583583, 0.01599667, 0.01445083, 0.01267083, 0.01188333, 0.010315, 0.0081125, 0.006785455 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Boehringer 2018 - Unknown - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 1.333, 1.667, 2.0, 2.5, 3.0, 3.5, 4.0, 5.0, 6.0, 7.0, 9.0, 11.0, 13.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Härtter et al. 2012 - 120mg po SD - R-Verapamil - PO - 120 mg - Plasma - agg. (n=19)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16132.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Härtter et al. 2012", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/22946890/", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/)", "Type": "String" }, { "Name": "Grouping", "Value": "120mg po SD", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 19.0, "Type": "Double" }, { "Name": "Molecule", "Value": "R-Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po SD - R-Verapamil - PO - 120 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.611 }, "Values": [ 0.0605313927, 0.03813069, 0.03248391, 0.02624686, 0.020693, 0.01447668, 0.007267228, 0.00526886, 0.0037686578, 0.002960451, 0.001277819 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po SD - R-Verapamil - PO - 120 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.611, "LLOQ": 3E-09 }, "Values": [ 95.0879, 91.43684, 73.7105255, 61.9894829, 45.68421, 33.9894676, 18.77316, 12.83842, 9.580525, 6.951579, 4.337273 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po SD - R-Verapamil - PO - 120 mg - Plasma - agg. (n=19)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 10.0, 12.0, 24.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Härtter et al. 2012 - 120mg po SD - S-Verapamil - PO - 120 mg - Plasma - agg. (n=19)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16133.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Härtter et al. 2012", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/22946890/", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/)", "Type": "String" }, { "Name": "Grouping", "Value": "120mg po SD", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 19.0, "Type": "Double" }, { "Name": "Molecule", "Value": "S-Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po SD - S-Verapamil - PO - 120 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|S-Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.611 }, "Values": [ 0.01292794, 0.008632543, 0.007078778, 0.005928245, 0.004875413, 0.003379943, 0.001636056, 0.00124526, 0.000646475, 0.000489524 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po SD - S-Verapamil - PO - 120 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|S-Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.611, "LLOQ": 3E-09 }, "Values": [ 16.94945, 16.87474, 13.5636806, 12.205, 9.455, 7.415556, 4.86066675, 4.09500027, 3.84399986, 3.45666718 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po SD - S-Verapamil - PO - 120 mg - Plasma - agg. (n=19)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 10.0, 12.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Härtter et al. 2012 - 120mg po SD - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16134.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Härtter et al. 2012", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/22946890/", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/)", "Type": "String" }, { "Name": "Grouping", "Value": "120mg po SD", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 19.0, "Type": "Double" }, { "Name": "Molecule", "Value": "R-Norverapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po SD - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|R-Norverapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 440.584 }, "Values": [ 0.0300500989, 0.02149376, 0.01715297, 0.01583427, 0.0151127912, 0.0129838, 0.00973111, 0.008534073, 0.006670271, 0.005613101, 0.002520232 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po SD - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|R-Norverapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 440.584, "LLOQ": 3E-09 }, "Values": [ 55.37368, 65.99474, 60.7736855, 59.32105, 52.1736832, 45.56842, 36.43158, 29.547369, 23.38421, 18.56316, 8.458421 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po SD - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 10.0, 12.0, 24.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Härtter et al. 2012 - 120mg po SD - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16135.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Härtter et al. 2012", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/22946890/", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/)", "Type": "String" }, { "Name": "Grouping", "Value": "120mg po SD", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 19.0, "Type": "Double" }, { "Name": "Molecule", "Value": "S-Norverapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po SD - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|S-Norverapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 440.584 }, "Values": [ 0.01490597, 0.01058219, 0.00761853345, 0.007189808, 0.007109165, 0.00573318, 0.004231615, 0.003988479, 0.003039367, 0.002533801, 0.001027234 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po SD - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)|ObservedData|Peripheral Venous Blood|Plasma|S-Norverapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 440.584, "LLOQ": 3E-09 }, "Values": [ 20.0, 26.280529, 24.37368, 23.8000011, 21.06737, 18.30842, 14.53105, 11.8931589, 9.912631, 8.14842, 4.392778 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po SD - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 10.0, 12.0, 24.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Härtter et al. 2012 - 120mg po bid - R-Verapamil - PO - 120 mg - Plasma - agg. (n=20)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16136.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Härtter et al. 2012", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/22946890/", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/)", "Type": "String" }, { "Name": "Grouping", "Value": "120mg po bid", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 20.0, "Type": "Double" }, { "Name": "Molecule", "Value": "R-Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": "S0-T12-R7", "Type": "String" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po bid - R-Verapamil - PO - 120 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.611 }, "Values": [ 0.01318024, 0.1131304, 0.07263353, 0.05522054, 0.04283873, 0.03247001, 0.02145565, 0.0180828, 0.01480833, 0.01156116, 0.01628138, 0.1115721, 0.07878675 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po bid - R-Verapamil - PO - 120 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|R-Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.611, "LLOQ": 3E-09 }, "Values": [ 28.5250015, 190.31, 186.05, 140.265, 108.094994, 87.534996, 55.4899979, 42.1649971, 31.785, 25.3049984, 33.77, 204.359985, 197.31 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po bid - R-Verapamil - PO - 120 mg - Plasma - agg. (n=20)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 47.917, 48.5, 49.0, 50.0, 51.0, 52.0, 54.0, 56.0, 58.0, 59.917, 71.917, 72.5, 72.917 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Härtter et al. 2012 - 120mg po bid - S-Verapamil - PO - 120 mg - Plasma - agg. (n=20)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16137.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Härtter et al. 2012", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/22946890/", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/)", "Type": "String" }, { "Name": "Grouping", "Value": "120mg po bid", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 20.0, "Type": "Double" }, { "Name": "Molecule", "Value": "S-Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": "S0-T12-R7", "Type": "String" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po bid - S-Verapamil - PO - 120 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|S-Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.611 }, "Values": [ 0.002776269, 0.02984358, 0.02179003, 0.01652403, 0.01268069, 0.009408585, 0.005413748, 0.004212506, 0.003449929, 0.002166901, 0.003716047, 0.0305428114, 0.02127266 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po bid - S-Verapamil - PO - 120 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|S-Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.611, "LLOQ": 3E-09 }, "Values": [ 6.67578936, 39.498, 44.3850021, 33.515, 25.775, 20.74, 12.7809992, 9.617499, 7.47750044, 6.17611074, 7.885001, 45.2725, 47.09 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po bid - S-Verapamil - PO - 120 mg - Plasma - agg. (n=20)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 47.917, 48.5, 49.0, 50.0, 51.0, 52.0, 54.0, 56.0, 58.0, 59.917, 71.917, 72.5, 72.917 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Härtter et al. 2012 - 120mg po bid - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16138.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Härtter et al. 2012", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/22946890/", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/)", "Type": "String" }, { "Name": "Grouping", "Value": "120mg po bid", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 20.0, "Type": "Double" }, { "Name": "Molecule", "Value": "R-Norverapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": "S0-T12-R7", "Type": "String" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po bid - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|R-Norverapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 440.584 }, "Values": [ 0.01409507, 0.03499649, 0.02635395, 0.0268462, 0.02681347, 0.02590106, 0.02133565, 0.0209093, 0.01816506, 0.0152790686, 0.0171868, 0.03685284, 0.03092768 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po bid - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|R-Norverapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 440.584, "LLOQ": 3E-09 }, "Values": [ 46.04, 98.75, 110.134995, 105.140007, 97.135, 91.08, 76.01501, 65.69, 53.39, 44.755, 51.975, 107.0, 118.44 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po bid - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 47.917, 48.5, 49.0, 50.0, 51.0, 52.0, 54.0, 56.0, 58.0, 59.917, 71.917, 72.5, 72.917 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Härtter et al. 2012 - 120mg po bid - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16139.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Härtter et al. 2012", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/22946890/", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/)", "Type": "String" }, { "Name": "Grouping", "Value": "120mg po bid", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 20.0, "Type": "Double" }, { "Name": "Molecule", "Value": "S-Norverapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": "S0-T12-R7", "Type": "String" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po bid - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|S-Norverapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 440.584 }, "Values": [ 0.004976627, 0.01839953, 0.01362114, 0.01097202, 0.01118504, 0.01050479, 0.008150975, 0.00763984676, 0.006773874, 0.005358561, 0.005618438, 0.01959424, 0.01437352 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po bid - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)|ObservedData|Peripheral Venous Blood|Plasma|S-Norverapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 440.584, "LLOQ": 3E-09 }, "Values": [ 19.5050011, 42.555, 52.98, 50.2, 45.31, 41.7, 33.805, 28.79, 23.67, 19.6950016, 21.65, 46.96, 56.0650024 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Härtter et al. 2012 - 120mg po bid - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 47.917, 48.5, 49.0, 50.0, 51.0, 52.0, 54.0, 56.0, 58.0, 59.917, 71.917, 72.5, 72.917 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "van Haarst et al. 2009 - Verapamil only - Verapamil - PO - 180 mg - Plasma - agg. (n=10)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16142.0, "Type": "Double" }, { "Name": "Study Id", "Value": "van Haarst et al. 2009", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/19299533/", "Type": "String" }, { "Name": "Source", "Value": "Figure 1", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil only", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 10.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "180 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": "S0-T12-R5", "Type": "String" }, { "Name": "Formulation", "Value": "oral", "Type": "String" }, { "Name": "Food state", "Value": "fed", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "van Haarst et al. 2009 - Verapamil only - Verapamil - PO - 180 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.0312956, 0.0297309, 0.0381421, 0.125575, 0.137897, 0.112274, 0.06356899, 0.0451834, 0.025232, 0.0189731, 0.0154522, 0.0103668 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "van Haarst et al. 2009 - Verapamil only - Verapamil - PO - 180 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6, "LLOQ": 2.1E-09 }, "Values": [ 77.4464, 68.8373, 82.3309, 191.665, 240.951, 204.955, 137.463, 76.8106, 63.2983, 49.0030975, 29.5901, 19.3862019 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "van Haarst et al. 2009 - Verapamil only - Verapamil - PO - 180 mg - Plasma - agg. (n=10)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 48.0, 48.5, 49.0, 50.0, 51.0, 52.0, 54.0, 57.0, 60.0, 63.0, 72.0, 78.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "van Haarst et al. 2009 - Verapamil only - Norverapamil - PO - 180 mg - Plasma - agg. (n=10)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16143.0, "Type": "Double" }, { "Name": "Study Id", "Value": "van Haarst et al. 2009", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/19299533/", "Type": "String" }, { "Name": "Source", "Value": "Table 1", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil only", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 10.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Norverapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "180 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": "S0-T12-R5", "Type": "String" }, { "Name": "Formulation", "Value": "oral", "Type": "String" }, { "Name": "Food state", "Value": "fed", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "van Haarst et al. 2009 - Verapamil only - Norverapamil - PO - 180 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 440.584 }, "Values": [ 0.036, 0.049 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "van Haarst et al. 2009 - Verapamil only - Norverapamil - PO - 180 mg - Plasma - agg. (n=10)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 440.584, "LLOQ": 2.5E-09 }, "Values": [ 115.0, 182.0 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "van Haarst et al. 2009 - Verapamil only - Norverapamil - PO - 180 mg - Plasma - agg. (n=10)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 48.0, 51.4 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Blume, Mutschler 1983 - Verapamil - Verapamil - PO - 40 mg - Plasma - agg. (n=12)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16144.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Blume, Mutschler 1983", "Type": "String" }, { "Name": "Reference", "Value": "Blume H, Mutschler E (1989) Bioäquivalenz: Qualitätsbewertung wirkstoffgleicher Fertigarzneimittel: Anleitung, Methoden, Materialien. Govi-Verlag", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/)", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 12.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "40 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral dragee", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Blume, Mutschler 1983 - Verapamil - Verapamil - PO - 40 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 31.2640018, 46.7740021, 39.998, 29.474, 16.784, 15.454, 11.688, 4.399 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Blume, Mutschler 1983 - Verapamil - Verapamil - PO - 40 mg - Plasma - agg. (n=12)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5144, 1.0195, 1.5283, 2.0238, 3.00909972, 3.5193, 4.0307, 7.9766 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Blume, Mutschler 1990 - Verapamil - Verapamil - PO - 40 mg - Plasma - agg. (n=24)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16145.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Blume, Mutschler 1990", "Type": "String" }, { "Name": "Reference", "Value": "Blume H, Mutschler E (1989) Bioäquivalenz: Qualitätsbewertung wirkstoffgleicher Fertigarzneimittel: Anleitung, Methoden, Materialien. Govi-Verlag", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/)", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 24.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "40 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Blume, Mutschler 1990 - Verapamil - Verapamil - PO - 40 mg - Plasma - agg. (n=24)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 24.545, 35.8389969, 45.87, 48.0920029, 41.769, 32.031, 25.189, 19.5560017, 14.441, 9.499, 6.525, 4.081 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Blume, Mutschler 1990 - Verapamil - Verapamil - PO - 40 mg - Plasma - agg. (n=24)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.4867, 0.7286001, 1.0271, 1.33289993, 1.6577, 2.0185, 2.4687, 3.0056, 3.989, 5.9969, 8.058001, 10.0416 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Blume, Mutschler 1989 - Verapamil - Verapamil - PO - 80 mg - Plasma - agg. (n=18)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16146.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Blume, Mutschler 1989", "Type": "String" }, { "Name": "Reference", "Value": "Blume H, Mutschler E (1989) Bioäquivalenz: Qualitätsbewertung wirkstoffgleicher Fertigarzneimittel: Anleitung, Methoden, Materialien. Govi-Verlag", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/)", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 18.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "80 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Blume, Mutschler 1989 - Verapamil - Verapamil - PO - 80 mg - Plasma - agg. (n=18)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 25.4900017, 57.399, 49.293, 38.977, 28.831, 21.734, 11.558, 7.803, 5.24, 3.302, 2.65099978, 1.99900007 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Blume, Mutschler 1989 - Verapamil - Verapamil - PO - 80 mg - Plasma - agg. (n=18)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.4994, 0.9626, 1.54490006, 1.9956, 3.0359, 4.0598, 5.9954, 8.035399, 10.0128, 12.0663, 15.0309, 24.0606 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Blume, Mutschler 1987 - Verapamil - Verapamil - PO - 120 mg - Plasma - agg. (n=12)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16147.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Blume, Mutschler 1987", "Type": "String" }, { "Name": "Reference", "Value": "Blume H, Mutschler E (1989) Bioäquivalenz: Qualitätsbewertung wirkstoffgleicher Fertigarzneimittel: Anleitung, Methoden, Materialien. Govi-Verlag", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/)", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 12.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Blume, Mutschler 1987 - Verapamil - Verapamil - PO - 120 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 35.158, 97.051, 105.852005, 103.297005, 106.325005, 95.915, 76.32601, 56.736, 48.314, 23.709, 11.9740009, 6.7699995 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Blume, Mutschler 1987 - Verapamil - Verapamil - PO - 120 mg - Plasma - agg. (n=12)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.3433, 0.6822, 0.8204, 1.1132, 1.3445, 1.7822, 2.27029967, 3.015, 4.0139, 6.0254, 9.0144, 12.0102 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Johnson 2001 - Verapamil Steady State - Norverapamil - PO - 80 mg - Plasma - agg. (n=12)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16127.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Johnson 2001", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/11697758", "Type": "String" }, { "Name": "Source", "Value": "Table 1", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil Steady State", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 12.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Norverapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "80 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": "S0-T8-R7", "Type": "String" }, { "Name": "Formulation", "Value": "standard release capsules", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Johnson 2001 - Verapamil Steady State - Norverapamil - PO - 80 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 440.584 }, "Values": [ 0.041, 0.0474, 0.0544, 0.0558, 0.0489, 0.0739, 0.0695, 0.0629, 0.0581, 0.0486, 0.0435, 0.0358, 0.0208 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Johnson 2001 - Verapamil Steady State - Norverapamil - PO - 80 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 440.584 }, "Values": [ 99.1, 90.8, 145.1, 157.1, 150.6, 158.3, 151.3, 133.6, 106.9, 85.2, 71.0, 49.4, 28.8 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Johnson 2001 - Verapamil Steady State - Norverapamil - PO - 80 mg - Plasma - agg. (n=12)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 48.0, 48.5, 49.0, 49.5, 50.0, 51.0, 52.0, 54.0, 56.0, 58.0, 60.0, 64.0, 72.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Blume, Mutschler 1994 - Verapamil - Verapamil - PO - 240 mg - Plasma - agg. (n=24)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16148.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Blume, Mutschler 1994", "Type": "String" }, { "Name": "Reference", "Value": "Blume H, Mutschler E (1989) Bioäquivalenz: Qualitätsbewertung wirkstoffgleicher Fertigarzneimittel: Anleitung, Methoden, Materialien. Govi-Verlag", "Type": "String" }, { "Name": "Source", "Value": "Hanke et al 2020 (https://pubmed.ncbi.nlm.nih.gov/32560124/)", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 24.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "240 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": "S0-T24-R6", "Type": "String" }, { "Name": "Formulation", "Value": "oral retard formulation", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Blume, Mutschler 1994 - Verapamil - Verapamil - PO - 240 mg - Plasma - agg. (n=24)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 45.91055, 67.34232, 128.138, 188.939, 225.1454, 253.0764, 248.22168, 233.5418, 213.9335, 191.1256, 169.9517, 132.5165, 103.2882, 82.24062, 72.68908, 44.26601 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Blume, Mutschler 1994 - Verapamil - Verapamil - PO - 240 mg - Plasma - agg. (n=24)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 120.0, 121.0, 122.0, 123.0, 124.0, 124.5, 125.0, 125.5, 126.0, 127.0, 128.0, 130.0, 132.0, 134.0, 136.0, 144.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Maeda 2011 - Verapamil 0.1 mg - Verapamil - PO - 0.1 mg - Plasma - agg. (n=8)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2065.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Maeda 2011", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21716273", "Type": "String" }, { "Name": "Source", "Value": "Fig. 2a", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil 0.1 mg", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 8.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "0.1 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral drug solution", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 0.1 mg - Verapamil - PO - 0.1 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 2.025601E-05, 3.07433E-05, 2.137137E-05, 2.071814E-05, 1.46114089E-05, 7.968963E-06, 4.72337024E-06, 2.405073E-06, 1.113843E-06 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 0.1 mg - Verapamil - PO - 0.1 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 0.01167419, 0.02631286, 0.02843031, 0.03071814, 0.02253934, 0.01530643, 0.008240744, 0.004793716, 0.001501311 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 0.1 mg - Verapamil - PO - 0.1 mg - Plasma - agg. (n=8)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 12.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Maeda 2011 - Verapamil 0.1 mg - Norverapamil - Norverapamil - PO - 0.1 mg - Plasma - agg. (n=8)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16578.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Maeda 2011", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21716273", "Type": "String" }, { "Name": "Source", "Value": "Fig. 2b", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil 0.1 mg - Norverapamil", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 8.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Norverapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "0.1 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral drug solution", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 0.1 mg - Norverapamil - Norverapamil - PO - 0.1 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 440.584 }, "Values": [ 1.0626E-05, 2.2157E-05, 1.3454E-05, 1.545E-05, "NaN", 1.4659E-05, 1.2837E-05, "NaN", "NaN" ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 0.1 mg - Norverapamil - Norverapamil - PO - 0.1 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 440.584 }, "Values": [ 0.006956, 0.020293, 0.027708, 0.027923, 0.02639, 0.032208, 0.027422, 0.021726, 0.016788 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 0.1 mg - Norverapamil - Norverapamil - PO - 0.1 mg - Plasma - agg. (n=8)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 12.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Smith 1984 - PO 120 mg Verapamil control - Verapamil - PO - 120 mg - Plasma - agg. (n=8)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 1329.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Smith 1984", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/6478741/", "Type": "String" }, { "Name": "Source", "Value": "Fig.1", "Type": "String" }, { "Name": "Grouping", "Value": "PO 120 mg Verapamil control", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 8.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": ".", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Smith 1984 - PO 120 mg Verapamil control - Verapamil - PO - 120 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.13402, 0.105844, 0.080321, 0.064372, 0.047594, 0.044354, 0.040838, 0.025194, 0.019631, 0.0148738 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Smith 1984 - PO 120 mg Verapamil control - Verapamil - PO - 120 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6, "LLOQ": 5E-09 }, "Values": [ 123.48, 95.196, 71.059, 63.998, 38.763, 36.077, 35.034, 17.15, 12.18, 8.3282 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Smith 1984 - PO 120 mg Verapamil control - Verapamil - PO - 120 mg - Plasma - agg. (n=8)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 5.0, 6.0, 7.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Maeda 2011 - Verapamil 16 mg - Verapamil - PO - 16 mg - Plasma - agg. (n=8)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2067.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Maeda 2011", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21716273", "Type": "String" }, { "Name": "Source", "Value": "Fig. 2a", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil 16 mg", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 8.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "16 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral drug solution", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 16 mg - Verapamil - PO - 16 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ "NaN", "NaN", 0.009859134, 0.00696238875, 0.005310204, 0.00293325214, 0.002018102, 0.001424566, 0.0005627576 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 16 mg - Verapamil - PO - 16 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 5.930745, 10.19538, 9.077854, 7.480826, 5.705616, 3.727594, 2.168375, 1.530643, 0.6046619 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 16 mg - Verapamil - PO - 16 mg - Plasma - agg. (n=8)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 12.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Maeda 2011 - Verapamil 16 mg - Norverapamil - Norverapamil - PO - 16 mg - Plasma - agg. (n=8)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16580.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Maeda 2011", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21716273", "Type": "String" }, { "Name": "Source", "Value": "Fig. 2b", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil 16 mg - Norverapamil", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 8.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Norverapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "16 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral drug solution", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 16 mg - Norverapamil - Norverapamil - PO - 16 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 440.584 }, "Values": [ 0.0022123, 0.006186, 0.006693, 0.0067235, 0.005174, 0.004424, 0.00377760013, 0.0035813, 0.0025277 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 16 mg - Norverapamil - Norverapamil - PO - 16 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 440.584 }, "Values": [ 2.4157, 9.248, 10.591, 10.337, 9.614, 8.456, 6.973, 6.178, 3.8475 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 16 mg - Norverapamil - Norverapamil - PO - 16 mg - Plasma - agg. (n=8)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 12.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Maeda 2011 - Verapamil 3 mg - Verapamil - PO - 3 mg - Plasma - agg. (n=8)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2066.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Maeda 2011", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21716273", "Type": "String" }, { "Name": "Source", "Value": "Fig. 2a", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil 3 mg", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 8.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "3 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral drug solution", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 3 mg - Verapamil - PO - 3 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.000104452796, 0.0004271767, 0.000538651657, 0.000444032019, 0.0002804143, 0.0002750559, 0.000206934419, 0.0001397858, 6.771688E-05 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 3 mg - Verapamil - PO - 3 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 0.3012948, 0.7927927, 0.8903891, 0.8240743, 0.5817091, 0.4436688, 0.3012948, 0.196842, 0.08082822 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 3 mg - Verapamil - PO - 3 mg - Plasma - agg. (n=8)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 12.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Maeda 2011 - Verapamil 80 mg - Verapamil - PO - 80 mg - Plasma - agg. (n=8)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2068.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Maeda 2011", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21716273", "Type": "String" }, { "Name": "Source", "Value": "Fig. 2a", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil 80 mg", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 8.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "80 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral drug solution", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 80 mg - Verapamil - PO - 80 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.0352025442, 0.0303367116, 0.0259422082, 0.020601619, 0.01694856, 0.01245701, 0.00773019344, 0.005408483, 0.002373744 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 80 mg - Verapamil - PO - 80 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 30.12948, 60.46619, 49.82864, 41.0625, 32.55405, 24.82893, 13.89495, 9.436043, 4.02756 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 80 mg - Verapamil - PO - 80 mg - Plasma - agg. (n=8)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 12.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Maeda 2011 - Verapamil 3 mg - Norverapamil - Norverapamil - PO - 3 mg - Plasma - agg. (n=8)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16579.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Maeda 2011", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21716273", "Type": "String" }, { "Name": "Source", "Value": "Fig. 2b", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil 3 mg - Norverapamil", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 8.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Norverapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "3 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral drug solution", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 3 mg - Norverapamil - Norverapamil - PO - 3 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 440.584 }, "Values": [ 0.2028, 0.5639, 0.7762, 0.9783, 1.0508, 0.985100031, 0.8455, 0.7314, 0.4591 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 3 mg - Norverapamil - Norverapamil - PO - 3 mg - Plasma - agg. (n=8)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 12.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Maeda 2011 - Verapamil 80 mg - Norverapamil - Norverapamil - PO - 80 mg - Plasma - agg. (n=8)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16581.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Maeda 2011", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/21716273", "Type": "String" }, { "Name": "Source", "Value": "Fig. 2b", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil 80 mg - Norverapamil", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 8.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Norverapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "80 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral drug solution", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 80 mg - Norverapamil - Norverapamil - PO - 80 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 440.584 }, "Values": [ 17.392, 61.46, 57.18, 55.37, 52.75, 46.02, 35.036, 26.885, 17.564 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Maeda 2011 - Verapamil 80 mg - Norverapamil - Norverapamil - PO - 80 mg - Plasma - agg. (n=8)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 12.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Wing et al. 1985 - 10mg Verapamil without cimetidine, IV - Verapamil - IV - 10 mg - Plasma - indiv.", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16111.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Wing et al. 1985", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/3986090/", "Type": "String" }, { "Name": "Source", "Value": "Figure 1", "Type": "String" }, { "Name": "Grouping", "Value": "10mg Verapamil without cimetidine, IV", "Type": "String" }, { "Name": "Data type", "Value": "individual", "Type": "String" }, { "Name": "N", "Value": 1.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "IV", "Type": "String" }, { "Name": "Dose", "Value": "10 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "i.v. infusion", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Wing et al. 1985 - 10mg Verapamil without cimetidine, IV - Verapamil - IV - 10 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|Individual" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 95.257, 56.051, 44.207, 43.3739967, 32.506, 33.652, 27.766, 19.931, 12.0949993, 6.506, 4.173, 3.17599988 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Wing et al. 1985 - 10mg Verapamil without cimetidine, IV - Verapamil - IV - 10 mg - Plasma - indiv.|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.167, 0.334, 0.5, 0.667, 0.917, 1.167, 2.167, 3.167, 4.167, 6.167, 8.167, 10.1670008 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Norverapamil - PO - 40 mg - Plasma - agg. (n=12)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16120.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Sawicki, Janicki 2002", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/11996822/", "Type": "String" }, { "Name": "Source", "Value": "Table 1", "Type": "String" }, { "Name": "Grouping", "Value": "Healthy volunteers; conventional tablets", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 12.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Norverapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "40 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Norverapamil - PO - 40 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 440.584 }, "Values": [ 0.00319, 0.00554, 0.00602, 0.00755000068, 0.00756, 0.00429, 0.00474, 0.00243, 0.00186, 0.00113 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Norverapamil - PO - 40 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 440.584, "LLOQ": 4E-10 }, "Values": [ 11.7300005, 27.35, 24.5299988, 21.6300011, 21.23, 15.4199991, 10.01, 5.95000029, 3.87999988, 1.77 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Norverapamil - PO - 40 mg - Plasma - agg. (n=12)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 12.0, 24.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Verapamil - PO - 40 mg - Plasma - agg. (n=12)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16119.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Sawicki, Janicki 2002", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/11996822/", "Type": "String" }, { "Name": "Source", "Value": "Table 1", "Type": "String" }, { "Name": "Grouping", "Value": "Healthy volunteers; conventional tablets", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 12.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "40 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Verapamil - PO - 40 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.00261, 0.00735, 0.00888, 0.00897, 0.00601, 0.00626, 0.00628, 0.00266, 0.00315, 0.00114 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Verapamil - PO - 40 mg - Plasma - agg. (n=12)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6, "LLOQ": 1.23E-09 }, "Values": [ 12.8200006, 31.670002, 27.45, 24.289999, 21.12, 17.51, 12.0599995, 7.75999975, 5.21, 2.19 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Verapamil - PO - 40 mg - Plasma - agg. (n=12)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0, 12.0, 24.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Johnston 1981 - Verapamil PO - Verapamil - PO - 120 mg - Plasma - agg. (n=6)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2060.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Johnston 1981", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/7295469", "Type": "String" }, { "Name": "Source", "Value": "Fig. 2", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil PO", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 6.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "tablets", "Type": "String" }, { "Name": "Food state", "Value": "Fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Johnston 1981 - Verapamil PO - Verapamil - PO - 120 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.0613553524, 0.06294663, 0.04949343, 0.04728672, 0.03504897, 0.03383327, 0.02775384, 0.02706956, 0.02250521, 0.01809619 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Johnston 1981 - Verapamil PO - Verapamil - PO - 120 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 103.004, 86.7645, 81.9716, 74.8566, 66.5587, 50.955, 32.84, 27.3561, 28.7903, 24.1135 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Johnston 1981 - Verapamil PO - Verapamil - PO - 120 mg - Plasma - agg. (n=6)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Johnston 1981 - Verapamil IV - Verapamil - IV - 0.1 mg/kg - Plasma - agg. (n=6)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 2059.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Johnston 1981", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/7295469", "Type": "String" }, { "Name": "Source", "Value": "Fig. 1", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil IV", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 6.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "IV", "Type": "String" }, { "Name": "Dose", "Value": "0.1 mg/kg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "iv infusion", "Type": "String" }, { "Name": "Food state", "Value": "Fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Johnston 1981 - Verapamil IV - Verapamil - IV - 0.1 mg/kg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.01445411, 0.01375493, 0.009853722, 0.00629121, 0.00516381, 0.004351917, 0.004329432, 0.002818642, 0.002119744 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Johnston 1981 - Verapamil IV - Verapamil - IV - 0.1 mg/kg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 54.1777, 43.7314, 38.8621, 33.2764, 28.4371, 25.1287, 20.0742, 17.1085, 14.9718 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Johnston 1981 - Verapamil IV - Verapamil - IV - 0.1 mg/kg - Plasma - agg. (n=6)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.08, 0.17, 0.33, 0.5, 0.75, 1.0, 1.5, 2.0, 2.5 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "John et al. 1992 - Healthy volunteers - Verapamil - PO - 40 mg - Plasma - agg. (n=6)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16118.0, "Type": "Double" }, { "Name": "Study Id", "Value": "John et al. 1992", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/1389935/", "Type": "String" }, { "Name": "Source", "Value": "Figure 1", "Type": "String" }, { "Name": "Grouping", "Value": "Healthy volunteers", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 6.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "40 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral tablet", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "John et al. 1992 - Healthy volunteers - Verapamil - PO - 40 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.01005272, 0.008450785, 0.008616406, 0.008948134, 0.01121243, 0.008671531, 0.006848975, 0.00662774, 0.005633775, 0.005689145, 0.00552328, 0.004805185, 0.004915877 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "John et al. 1992 - Healthy volunteers - Verapamil - PO - 40 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6 }, "Values": [ 9.882849, 22.4647, 34.0094, 42.172596, 44.4968, 39.0882, 32.4193, 28.4148, 24.681, 21.4881, 17.303299, 13.2537, 8.77603 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "John et al. 1992 - Healthy volunteers - Verapamil - PO - 40 mg - Plasma - agg. (n=6)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.25, 0.5, 0.75, 1.0, 1.25, 1.5, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Johnston 1981 - Verapamil PO - Norverapamil - PO - 120 mg - Plasma - agg. (n=6)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16577.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Johnston 1981", "Type": "String" }, { "Name": "Reference", "Value": "https://www.ncbi.nlm.nih.gov/pubmed/7295469", "Type": "String" }, { "Name": "Source", "Value": "Fig. 2", "Type": "String" }, { "Name": "Grouping", "Value": "Verapamil PO", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 6.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Norverapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "120 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "tablets", "Type": "String" }, { "Name": "Food state", "Value": "Fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Johnston 1981 - Verapamil PO - Norverapamil - PO - 120 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 440.584 }, "Values": [ 0.0230937, 0.02534991, 0.01709561, 0.0154259289, 0.01282795, 0.02307729, 0.0299852975, 0.0142884, 0.02901339, 0.02886296 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Johnston 1981 - Verapamil PO - Norverapamil - PO - 120 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 440.584 }, "Values": [ 74.76379, 59.0201, 69.7769, 67.6878, 68.70119, 68.24, 64.8656, 44.5168, 47.1609, 42.6066 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Johnston 1981 - Verapamil PO - Norverapamil - PO - 120 mg - Plasma - agg. (n=6)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Mooy et al. 1985 - Normal volunteers, 80mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=6)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16104.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Mooy et al. 1985", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/4029246/", "Type": "String" }, { "Name": "Source", "Value": "Table 3 and Table 4", "Type": "String" }, { "Name": "Grouping", "Value": "Normal volunteers, 80mg PO", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 6.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "80 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Mooy et al. 1985 - Normal volunteers, 80mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.017395, 0.022295, 0.04949, 0.013475, 0.01029, 0.007105, 0.005145, 0.00441, 0.005635 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Mooy et al. 1985 - Normal volunteers, 80mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6, "LLOQ": 2E-09 }, "Values": [ 18.6, 47.5, 66.7, 35.0, 28.9, 20.0, 12.9000006, 10.3, 10.1 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Mooy et al. 1985 - Normal volunteers, 80mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=6)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Mooy et al. 1985 - Normal volunteers, 3mg IV - Verapamil - IV - 3 mg - Plasma - agg. (n=5)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16101.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Mooy et al. 1985", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/4029246/", "Type": "String" }, { "Name": "Source", "Value": "Table 1 and Table 2", "Type": "String" }, { "Name": "Grouping", "Value": "Normal volunteers, 3mg IV", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 5.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "IV", "Type": "String" }, { "Name": "Dose", "Value": "3 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "i.v. infusion", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Mooy et al. 1985 - Normal volunteers, 3mg IV - Verapamil - IV - 3 mg - Plasma - agg. (n=5)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.04964, 0.01766, 0.0035, 0.004, 0.00089, 0.002, 0.00245, 0.00423 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Mooy et al. 1985 - Normal volunteers, 3mg IV - Verapamil - IV - 3 mg - Plasma - agg. (n=5)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6, "LLOQ": 2E-12 }, "Values": [ 47.0, 15.7, 11.2, 9.5, 8.4, 8.099999, 7.1, 6.5 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Mooy et al. 1985 - Normal volunteers, 3mg IV - Verapamil - IV - 3 mg - Plasma - agg. (n=5)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.1666667, 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 5.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Mooy et al. 1985 - Normal volunteers, 80mg PO - Norverapamil - PO - 80 mg - Plasma - agg. (n=6)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16105.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Mooy et al. 1985", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/4029246/", "Type": "String" }, { "Name": "Source", "Value": "Table 3 and Table 4", "Type": "String" }, { "Name": "Grouping", "Value": "Normal volunteers, 80mg PO", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 6.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Norverapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "80 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Mooy et al. 1985 - Normal volunteers, 80mg PO - Norverapamil - PO - 80 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 440.584 }, "Values": [ 0.019845, 0.03479, 0.057575, 0.018865, 0.018865, 0.0151900006, 0.00931, 0.01127, 0.00931 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Mooy et al. 1985 - Normal volunteers, 80mg PO - Norverapamil - PO - 80 mg - Plasma - agg. (n=6)|ObservedData|Peripheral Venous Blood|Plasma|Norverapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 440.584, "LLOQ": 2E-09 }, "Values": [ 19.6, 50.4, 55.5, 53.7, 51.3, 42.3000031, 32.9, 29.5, 25.1 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Mooy et al. 1985 - Normal volunteers, 80mg PO - Norverapamil - PO - 80 mg - Plasma - agg. (n=6)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Smith 1984 - IV 10 mg Verapamil control - Verapamil - IV - 10 mg - Plasma - agg. (n=8)", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 1327.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Smith 1984", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/6478741/", "Type": "String" }, { "Name": "Source", "Value": "Fig.1", "Type": "String" }, { "Name": "Grouping", "Value": "IV 10 mg Verapamil control", "Type": "String" }, { "Name": "Data type", "Value": "aggregated", "Type": "String" }, { "Name": "N", "Value": 8.0, "Type": "Double" }, { "Name": "Molecule", "Value": "Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "IV", "Type": "String" }, { "Name": "Dose", "Value": "10 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": ".", "Type": "String" }, { "Name": "Food state", "Value": ".", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "RelatedColumns": [ { "Name": "Var", "QuantityInfo": { "Path": "Smith 1984 - IV 10 mg Verapamil control - Verapamil - IV - 10 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticStdDev" }, "DataInfo": { "Origin": "ObservationAuxiliary", "AuxiliaryType": "ArithmeticStdDev", "MolWeight": 454.6 }, "Values": [ 0.19185, "NaN", 0.018451, 0.017302, 0.019076, 0.016245, 0.014168, 0.010131, 0.012209, 0.0078614, 0.006115 ], "Dimension": "Concentration (mass)", "Unit": "mg/l" } ], "QuantityInfo": { "Path": "Smith 1984 - IV 10 mg Verapamil control - Verapamil - IV - 10 mg - Plasma - agg. (n=8)|ObservedData|Peripheral Venous Blood|Plasma|Verapamil|ArithmeticMean" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.6, "LLOQ": 5E-09 }, "Values": [ 339.58, 135.57, 55.034, 36.566, 28.12, 24.714, 17.981, 13.189, 11.926, 9.5676, 6.282 ], "Dimension": "Concentration (mass)", "Unit": "ng/ml" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Smith 1984 - IV 10 mg Verapamil control - Verapamil - IV - 10 mg - Plasma - agg. (n=8)|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.0333, 0.16670002, 0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 3.0, 4.0, 5.0 ], "Dimension": "Time", "Unit": "h" } }, { "Name": "Mikus et al. 1990 - 160mg verapamil without cimetidine, PO - S-Verapamil - PO - 160 mg - Plasma - indiv.", "ExtendedProperties": [ { "Name": "DB Version", "Value": "OSP DATABASE", "Type": "String" }, { "Name": "ID", "Value": 16141.0, "Type": "Double" }, { "Name": "Study Id", "Value": "Mikus et al. 1990", "Type": "String" }, { "Name": "Reference", "Value": "https://pubmed.ncbi.nlm.nih.gov/2359015/", "Type": "String" }, { "Name": "Source", "Value": "Figure 3", "Type": "String" }, { "Name": "Grouping", "Value": "160mg verapamil without cimetidine, PO", "Type": "String" }, { "Name": "Data type", "Value": "individual", "Type": "String" }, { "Name": "N", "Value": 1.0, "Type": "Double" }, { "Name": "Molecule", "Value": "S-Verapamil", "Type": "String" }, { "Name": "Species", "Value": "Human", "Type": "String" }, { "Name": "Organ", "Value": "Peripheral Venous Blood", "Type": "String" }, { "Name": "Compartment", "Value": "Plasma", "Type": "String" }, { "Name": "Route", "Value": "PO", "Type": "String" }, { "Name": "Dose", "Value": "160 mg", "Type": "String" }, { "Name": "Times of Administration [h]", "Value": 0.0, "Type": "Double" }, { "Name": "Formulation", "Value": "oral solution", "Type": "String" }, { "Name": "Food state", "Value": "fasted", "Type": "String" }, { "Name": "Comment", "Value": ".", "Type": "String" } ], "Columns": [ { "Name": "Avg", "QuantityInfo": { "Path": "Mikus et al. 1990 - 160mg verapamil without cimetidine, PO - S-Verapamil - PO - 160 mg - Plasma - indiv.|ObservedData|Peripheral Venous Blood|Plasma|S-Verapamil|Individual" }, "DataInfo": { "Origin": "Observation", "AuxiliaryType": "Undefined", "MolWeight": 454.611 }, "Values": [ 0.031719, 0.035278, 0.029864, 0.027773, 0.024431, 0.019656, 0.016873, 0.012695, 0.013402, 0.010244, 0.00806, 0.007406, 0.006194, 0.004835, 0.003723 ], "Dimension": "Concentration (molar)", "Unit": "µmol/l" } ], "BaseGrid": { "Name": "Time", "QuantityInfo": { "Path": "Mikus et al. 1990 - 160mg verapamil without cimetidine, PO - S-Verapamil - PO - 160 mg - Plasma - indiv.|Time", "Type": "Time" }, "DataInfo": { "Origin": "BaseGrid", "AuxiliaryType": "Undefined" }, "Values": [ 0.5, 0.75, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0, 6.0, 8.0, 9.0, 11.0, 12.0, 15.0 ], "Dimension": "Time", "Unit": "h" } } ], "ObservedDataClassifications": [ { "Name": "IV SD", "Classifiables": [ "Barbarash 1988 - Verapamil IV control - Verapamil - IV - 10 mg - Serum - agg. (n=6)", "McAllister 1982 - Verapamil 10 mg IV - Verapamil - IV - 10 mg - Plasma - agg. (n=20)", "Streit 2005 - intravenous verapamil during normoxia (5 mg) - Verapamil - IV - 5 mg - Plasma - agg. (n=10)", "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 5 mg - Plasma - indiv.", "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 25 mg - Plasma - indiv.", "Eichelbaum 1984 - Subject 4 - R-Verapamil - IV - 50 mg - Plasma - indiv.", "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 5 mg - Plasma - indiv.", "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 7.5 mg - Plasma - indiv.", "Eichelbaum 1984 - Subject 4 - S-Verapamil - IV - 10 mg - Plasma - indiv.", "Streit et al. 2005 - intravenous verapamil during normoxia (5 mg) - Norverapamil - IV - 5 mg - Plasma - agg. (n=10)", "Abernethy et al. 1985 - 10mg Verapamil without cimetidine, IV - Verapamil - IV - 10 mg - Plasma - indiv.", "Freedman et al. 1981 - Control Subject (Subject number 4) - Verapamil - IV - 13.1 mg - Plasma - indiv.", "Abernethy et al. 1993 - Representative younger subject - Verapamil - IV - 20 mg - Plasma - indiv.", "Abernethy et al. 1993 - Representative younger subject - R-Verapamil - IV - 20 mg - Plasma - indiv.", "Abernethy et al. 1993 - Representative younger subject - S-Verapamil - IV - 20 mg - Plasma - indiv.", "Johnston 1981 - Verapamil IV - Verapamil - IV - 0.1 mg/kg - Plasma - agg. (n=6)", "Mooy et al. 1985 - Normal volunteers, 3mg IV - Verapamil - IV - 3 mg - Plasma - agg. (n=5)", "Smith 1984 - IV 10 mg Verapamil control - Verapamil - IV - 10 mg - Plasma - agg. (n=8)", "Wing et al. 1985 - 10mg Verapamil without cimetidine, IV - Verapamil - IV - 10 mg - Plasma - indiv." ] }, { "Name": "po SD", "Classifiables": [ "Barbarash 1988 - Verapamil PO control - Verapamil - PO - 120 mg - Serum - agg. (n=6)", "McAllister 1982 - Verapamil 80 mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=20)", "McAllister 1982 - Verapamil 120 mg PO - Verapamil - PO - 120 mg - Plasma - agg. (n=20)", "McAllister 1982 - Verapamil 160 mg PO - Verapamil - PO - 160 mg - Plasma - agg. (n=20)", "Hla 1987 - conventional Verapamil 120mg once daily (day 1) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)", "Karim 1995 - Verapamil total IR fasting - Verapamil - PO - 240 mg - Plasma - agg. (n=12)", "Karim 1995 - Verapamil total SR fed - Verapamil - PO - 240 mg - Plasma - agg. (n=12)", "Abernethy et al. 1985 - 120mg Verapamil without cimetidine, PO - Verapamil - PO - 120 mg - Plasma - indiv.", "Vogelgesang et al. 1984 - Healthy volunteers - R-Verapamil - PO - 250 mg - Plasma - indiv.", "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Verapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)", "Choi et al. 2008 - 60mg Verapamil in absence of oral atorvastatin - Norverapamil - PO - 60 mg - Arterial Plasma - agg. (n=12)", "Ratiopharm 1988 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)", "Ratiopharm 1988 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)", "Ratiopharm 1989 - Unknown - Verapamil - PO - 80 mg - Plasma - agg. (n=16)", "Ratiopharm 1989 - Unknown - Norverapamil - PO - 80 mg - Plasma - agg. (n=16)", "Boehringer 2018 - Unknown - R-Verapamil - PO - 120 mg - Plasma - agg. (n=12)", "Boehringer 2018 - Unknown - S-Verapamil - PO - 120 mg - Plasma - agg. (n=12)", "Boehringer 2018 - Unknown - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)", "Boehringer 2018 - Unknown - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=12)", "Härtter et al. 2012 - 120mg po SD - R-Verapamil - PO - 120 mg - Plasma - agg. (n=19)", "Härtter et al. 2012 - 120mg po SD - S-Verapamil - PO - 120 mg - Plasma - agg. (n=19)", "Härtter et al. 2012 - 120mg po SD - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)", "Härtter et al. 2012 - 120mg po SD - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=19)", "Blume, Mutschler 1983 - Verapamil - Verapamil - PO - 40 mg - Plasma - agg. (n=12)", "Blume, Mutschler 1990 - Verapamil - Verapamil - PO - 40 mg - Plasma - agg. (n=24)", "Blume, Mutschler 1989 - Verapamil - Verapamil - PO - 80 mg - Plasma - agg. (n=18)", "Blume, Mutschler 1987 - Verapamil - Verapamil - PO - 120 mg - Plasma - agg. (n=12)", "Maeda 2011 - Verapamil 16 mg - Verapamil - PO - 16 mg - Plasma - agg. (n=8)", "Maeda 2011 - Verapamil 16 mg - Norverapamil - Norverapamil - PO - 16 mg - Plasma - agg. (n=8)", "Maeda 2011 - Verapamil 0.1 mg - Verapamil - PO - 0.1 mg - Plasma - agg. (n=8)", "Maeda 2011 - Verapamil 0.1 mg - Norverapamil - Norverapamil - PO - 0.1 mg - Plasma - agg. (n=8)", "Maeda 2011 - Verapamil 3 mg - Verapamil - PO - 3 mg - Plasma - agg. (n=8)", "Maeda 2011 - Verapamil 3 mg - Norverapamil - Norverapamil - PO - 3 mg - Plasma - agg. (n=8)", "Maeda 2011 - Verapamil 80 mg - Verapamil - PO - 80 mg - Plasma - agg. (n=8)", "Maeda 2011 - Verapamil 80 mg - Norverapamil - Norverapamil - PO - 80 mg - Plasma - agg. (n=8)", "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Verapamil - PO - 40 mg - Plasma - agg. (n=12)", "Sawicki, Janicki 2002 - Healthy volunteers; conventional tablets - Norverapamil - PO - 40 mg - Plasma - agg. (n=12)", "John et al. 1992 - Healthy volunteers - Verapamil - PO - 40 mg - Plasma - agg. (n=6)", "Johnston 1981 - Verapamil PO - Verapamil - PO - 120 mg - Plasma - agg. (n=6)", "Johnston 1981 - Verapamil PO - Norverapamil - PO - 120 mg - Plasma - agg. (n=6)", "Mooy et al. 1985 - Normal volunteers, 80mg PO - Verapamil - PO - 80 mg - Plasma - agg. (n=6)", "Mooy et al. 1985 - Normal volunteers, 80mg PO - Norverapamil - PO - 80 mg - Plasma - agg. (n=6)", "Smith 1984 - PO 120 mg Verapamil control - Verapamil - PO - 120 mg - Plasma - agg. (n=8)", "Wing et al. 1985 - 80mg Verapamil without cimetidine, PO - Verapamil - PO - 80 mg - Plasma - indiv.", "Mikus et al. 1990 - 160mg verapamil without cimetidine, PO - R-Verapamil - PO - 160 mg - Plasma - indiv.", "Mikus et al. 1990 - 160mg verapamil without cimetidine, PO - S-Verapamil - PO - 160 mg - Plasma - indiv." ] }, { "Name": "po MD", "Classifiables": [ "Backman 1994 - Verapamil - Verapamil - PO - 80 mg - Plasma - agg. (n=9)", "Hla 1987 - conventional Verapamil 120mg twice daily (day 10) - Verapamil - PO - 120 mg - Plasma - agg. (n=10)", "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 1 - 5 and 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)", "Jorgensen 1988 - Conventional Verapamil 120 mg BID (day 8) - Verapamil - PO - 120 mg - Plasma - agg. (n=12)", "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 1 - 5 and 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)", "Jorgensen 1988 - Sustained release Verapamil 240 mg OD (day 8) - Verapamil - PO - 240 mg - Plasma - agg. (n=12)", "Shand 1981 - Verapamil day 1 - Verapamil - PO - 120 mg - Plasma - agg. (n=6)", "Shand 1981 - Verapamil day 3 (after 7th dose) - Verapamil - PO - 120 mg - Plasma - agg. (n=6)", "Johnson 2001 - Verapamil Steady State - Verapamil - PO - 80 mg - Plasma - agg. (n=12)", "Härtter et al. 2012 - 120mg po bid - R-Verapamil - PO - 120 mg - Plasma - agg. (n=20)", "Härtter et al. 2012 - 120mg po bid - S-Verapamil - PO - 120 mg - Plasma - agg. (n=20)", "Härtter et al. 2012 - 120mg po bid - R-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)", "Härtter et al. 2012 - 120mg po bid - S-Norverapamil - PO - 120 mg - Plasma - agg. (n=20)", "van Haarst et al. 2009 - Verapamil only - Verapamil - PO - 180 mg - Plasma - agg. (n=10)", "van Haarst et al. 2009 - Verapamil only - Norverapamil - PO - 180 mg - Plasma - agg. (n=10)", "Blume, Mutschler 1994 - Verapamil - Verapamil - PO - 240 mg - Plasma - agg. (n=24)", "Johnson 2001 - Verapamil Steady State - Norverapamil - PO - 80 mg - Plasma - agg. (n=12)" ] } ], "SimulationClassifications": [ { "Name": "IV SD", "Classifiables": [ "iv_R-Verapamil 50 mg (5 min), Eichelbaum 1984, n=1", "iv_Verapamil 3 mg SD (5min), Mooy 1985, n=5", "iv_Verapamil 5 mg SD (5min), Streit 2005, n=10", "iv_Verapamil 0.1 mg/kg SD (5min), Johnston 1981, n=6", "iv_Verapamil 10mg SD (10min), Abernethy 1985, n=1", "iv_Verapamil 10mg SD (10min), Barbarash 1988, n=6", "iv_Verapamil 10mg SD (5min), McAllister, Kirsten 1982, n=20", "iv_Verapamil 13.1 mg SD (13min), Freedman 1981, n=1", "iv_Verapamil 20mg SD (30min), Abernethy 1993, n=1", "iv_R-Verapamil 5 mg (5 min), Eichelbaum 1984, n=1", "iv_R-Verapamil 25 mg (5 min), Eichelbaum 1984, n=1", "iv_S-Verapamil 5 mg SD (5min), Eichelbaum 1984, n=1", "iv_S-Verapamil 7.5 mg SD (5min), Eichelbaum 1984, n=1", "iv_S-Verapamil 10 mg SD (5min), Eichelbaum 1984, n=1", "iv_Verapamil 10 mg (bol), Smith 1984, n=8", "iv_Verapamil 10mg SD (10min), Wing 1985, n=1" ] }, { "Name": "PO SD", "Classifiables": [ "po_Verapamil 120 mg SD (IR), Haertter 2012, n=19", "po_Verapamil 16 mg SD (sol), Maeda 2011, n=8", "po_Verapamil 80 mg SD, Mooy 1985, n=6", "po_Verapamil 120 mg SD, Johnston 1981, n=6", "po_Verapamil 120mg SD, Abernethy 1985, n=1", "po_R-Verapamil 250mg SD, Vogelgesang 1984, n=1", "po_Verapamil 0.1 mg SD (sol), Maeda 2011, n=8", "po_Verapamil 3 mg SD (sol), Maeda 2011, n=8", "po_Verapamil 80 mg SD (sol), Maeda 2011, n=8", "po_Verapamil 40 mg SD, John 1992, n=6", "po_Verapamil 40 mg SD, Sawicki, Janicki 2002, n=12", "po_Verapamil 60 mg SD, Choi 2008, n=12", "po_Verapamil 80 mg SD, Ratiopharm 1988, n=16", "po_Verapamil 80 mg (2 40mg tab) SD, Ratiopharm 1989, n=16", "po_Verapamil 120 mg (IR tab) SD, Boehringer 2018, n=12", "po_Verapamil 120 mg SD, Hla 1987, n=10", "po_Verapamil 80 mg SD, Blume, Mutschler 1989, n=18", "po_Verapamil 120 mg SD, Blume, Mutschler 1987, n=12", "po_Verapamil 40 mg SD, Blume, Mutschler 1990, n=24", "po_Verapamil 40 mg SD, Blume, Mutschler 1983, n=12", "po_Verapamil 120 mg SD, Barbarash 1988, n=6", "po_Verapamil 80mg SD, McAllister, Kirsten 1982, n=20", "po_Verapamil 120mg SD, McAllister, Kirsten 1982, n=20", "po_Verapamil 160mg SD, McAllister, Kirsten 1982, n=20", "po_Verapamil 240 mg SD, Karim 1995, n=12", "po_Verapamil 120 mg SD, Smith 1984, n=8", "po_Verapamil 80mg SD, Wing 1985, n=1", "po_Verapamil 160 mg SD, Mikus 1990, n=1" ] }, { "Name": "PO MD", "Classifiables": [ "po_Verapamil 240 mg QD (SR), Blume, Mutschler 1994, n=24", "po_Verapamil 80 mg tid 7rep, Johnson 2001, n=12", "po_Verapamil 120 mg (IR) bid 3days, Haertter 2012, n=20", "po_Verapamil 120 mg MD, Hla 1987, n=10", "po_Verapamil 180mg PO BID 3days,van Haarst 2009, n=10", "po_Verapamil 80mg PO TID 5rep, Backman 1994, n=9", "po_Verapamil 120mg PO BID 8days, Jorgensen 1988, n=12", "po_Verapamil 240mg PO OD 8days sustained realese, Jorgensen 1988, n=12", "po_Verapamil 120mg PO TID 7rep, Shand 1981, n=6" ] } ] }